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Abstract 
The islets of Langerhans are multicellular aggregates within the pancreas containing 
beta cells that sense changes in blood glucose level and respond by secreting insulin. 
The cells within the islets communicate with each other through gap junctions. The 
3D structure of the islets is crucial for their metabolic function. Artificial 
reconstruction of isolated beta cells into 3D cell aggregates has led to the generation 
of Pseudoislets (PIs) which mimic islets of Langerhans and can produce insulin. 
However, the lifespan of PIs is generally a few days in culture after which, central cell 
death occurs. The overall aim of this project was to improve PI viability and 
biofunction through development of two new techniques. The first technique being 
developed was a series of coating solutions consisting of Pluronic F127 (F127) and 
gelatin type A (Gelatin), which systematically altered the substrate properties of cell 
culture plates where PIs were formed by suspension culture. The second technique 
was generation of gelatin beads, functioning as microchannels inside of PIs, and drug 
carriers when loading with anti-inflammation agents to reduce inflammation and 
central necrosis. The beta cell line, BRIN-BD11, was used to form PIs. 
 
Coating solutions with different ratios of gelatin and F127 (90%, 95%, 98% and 100% 
of Gelatin in the mixture) have been designed. Surfaces coated with these coating 
solutions generated different ATR-FTIR spectra, contact angle (CA) values and 
protein adsorption capacities and the changes were dependent on the original substrate 
chemistry. The coating of suspension culture plates with gelatin alone failed to 
generate suspended PIs, while coating with F127 alone resulted in the generation of 
large, irregular PIs. On the other hand, coating suspension culture plates with a 
combination of gelatin and F127 solutions formed suspended PIs of differing sizes. 
The lower the percentage of gelatin in the mixture for the coating, the higher the size 
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of PIs. The higher the F127 content, the more hydrophilic the surface was, which led 
to lower CA values of the substrate. Coating solutions containing 95-98% Gelatin 
produced homogenous and smaller PIs than on F127 coating. PIs formed on 98% 
Gelatin coated plates had larger size but more homogenous morphology (268 ± 10 
µm) than PIs produced on ULA plate (235 ± 30 µm). These larger PIs exhibited 
comparable cell viability, the same level of insulin expression in GSIS and Western 
blotting assays and higher gene expression of key beta cell markers than smaller PIs 
formed on ULA plates. Furthermore the larger PIs expressed more of the gap junction 
protein, connexin 36, in comparison to PIs generated on ULA plates, revealing the 
optimised configuration of cells in these PIs. Altogether, regulating the hydrophicility 
of suspension culture plates by F127 and gelatin ratio in the coating solution changed 
the physical properties of PI and altered the expression of key beta cell markers. 
 
Gelatin beads (GBs) of 30-40 µm sizes were produced by Water/Oil emulsion 
techniques. The degree of swelling and stability of GBs was controlled by crosslinking 
with 5% glutaraldehyde (GA) vapour for 6 hours. The incorporation of 40 µm GBs 
into PIs (25-50 GB/per PI) significantly increased the proliferation and cellular 
viability of the PIs for both large and small sized PIs. Loading of anti-inflammatory 
cytokines, IL-10 and anti-IL-1β into GBs allowed for sustained release of these agents 
over time. Incorporation of IL-10 and anti-IL-1β loaded GBs to PIs revealed a 
synergetic effect in the improvement of the proliferation/viability of PIs regardless of 
PIs size (large or small). LDH release from the PIs was decreased dramatically and 
insulin release was increased significantly. Thus GBs played active roles as 
microchannels and drug carriers which improved the viability and function of PIs.  
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1.1 Pancreas 
The pancreas is an organ situated in the abdomen. It has an important role in the 
breakdown of large molecules of the food to produce cellular fuel. It has two main 
functions: an exocrine function which helps in digestion and an endocrine function that 
regulates blood glucose levels.(1) 
 
1.1.1 Anatomy of Pancreas 
The pancreas is an endocrine organ and lies in the upper left abdomen. It is located behind 
the stomach, with the head of the pancreas encircling the duodenum as shown in Figure 
1.1.(2) 
 
Figure 1.1 The image illustrating the location of the Pancreas in the human 
body(3) 
 
 
This figures shows the location of Pancreas within the gastrointestinal tract. 
 
The pancreas is classified as a heterocrine gland because it contains both endocrine and 
exocrine glandular tissue. The exocrine tissue accounts for about 99% of the pancreas by 
weight with the endocrine portion accounting for the remaining 1%. The exocrine cells 
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in the acini produce digestive enzymes, which enter the ducts. The ducts of many acini 
connect to form larger and larger ducts, which feed into the large pancreatic duct.(1) 
 
On the other hand, the endocrine portion of the pancreas comprises tiny bundles of cells 
called islets of Langerhans.(2) The islets contain five different types of cells; alpha cells, 
beta cells, delta cells, F or polypeptide (PP) cells and epsilon cells as shown in Figure 1.2. 
A capillary network transports secreted islet hormones around the body. Alpha and beta 
cells account for the vast majority of islet cells. Alpha cells (~10-15% of total islet cells) 
produce glucagon, which increases blood glucose levels. Beta cells (~80-85% of total 
islet cells) produce insulin, which decreases blood glucose levels.(4) 
 
Figure 1.2 Diagram of pancreatic islets and surrounding acini(5) 
 
 
The diagram illustrates the distribution of pancreatic cells in islets. 
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1.1.2 Physiology of Pancreas 
The exocrine gland secretes digestive enzymes such as amylase, lipase and trypsin to the 
gut, which aid break down protein, lipids, carbohydrates, and nucleic acids. While the 
endocrine gland that consists of approximately 1 million islets of Langerhans that secrete 
many hormones including:(5) 
 
a. Insulin produced by beta cells 
b. Glucagon produced by alpha cells.  
c. Somatostatin produced by delta cells. 
d. A pancreatic polypeptide produced by F or polypeptide cells. 
e. Ghrelin produced by Epsilon cells. 
 
Islets of Langerhans cells work as a micro-organ to maintain glucose homeostasis. The 
beta cell is the most plentiful cell in the islet and senses circulating glucose concentrations 
in the blood. The beta cell responds to elevated glucose concentrations by secreting 
appropriate levels of insulin.(6) Beta cell function and proliferation are controlled by 
regulatory signals from both the pancreatic and non-pancreatic environment.(7) Firstly, a 
dense vascular network exists within the islets, which facilitates the transport of oxygen 
and nutrients to the islet to maintain cellular health, while transporting secreted insulin 
away from the islet. Beta cells interact with the endothelial cells of the capillary network 
via the vascular basement membrane. It has been known that beta cells secrete vascular 
endothelial growth factors to stimulate vascular development. Whereas, the endothelial 
cells produce a basement membrane rich with laminin, which supports and promotes 
insulin gene expression and beta cells proliferation.(8) Secondly, cell-cell communication 
between beta cells through many transmembrane receptors (via circulation factors) which 
have an important effect on insulin gene expression and glucose-stimulated insulin 
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secretion (GSIS) via circulation of beta cells with other cells which might be endocrine 
and non-endocrine cells for example of vascular neuronal or haematopoietic origin.(9) 
Thirdly, there is reciprocal communication between alpha cells and beta cells to maintain 
glucose homeostasis.(10) The mechanism by which nutrients stimulate insulin secretion is 
related to ATP messenger and ATP-sensitive potassium channel. Homeostasis of blood 
glucose is maintained by insulin that is secreted from beta cells. Also, it has been found 
that at glycolytic intermediate and principal substrate of mitochondria stimulate glucagon 
secretion from alpha cells.(11) Glucagon secretion was decreased and insulin release was 
increased when the concentration of glucose was elevated.(11) Fourthly, islets are rich with 
neurons from the sympathetic and parasympathetic nervous system as shown in Figure 
1.3. The parasympathetic nervous system and sympathetic nervous system have 
contrasting influence on insulin secretion from beta cells, for instance; feeding induces 
parasympathetic neural activity to pancreas, which stimulates insulin secretion, Whereas, 
induce sympathetic neural system activation by stress for example, will inhibit insulin 
secretion and increase glucagon secretion. 
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Figure 1.3 Summary of beta cells interactions with the pancreatic 
environment(14) 
 
 
This figures outlines the factors, which regulated beta cells secretion including the 
communication between cells, alpha cells, nerves tissue and vascular tissues. 
Islet cells exert autocrine and paracrine effects on neighbouring cells.  
 
Autocrine signalling may modulate their activities through by-products of their 
function.(8,12) For example, the secretion of insulin negatively affects glucagon secretion. 
Insulin inhibits glucagon and somatostatin. While somatostatin also negatively affects 
insulin and glucagon secretion. Also, glucagon induces somatostatin secretion.(13) It has 
been shown through an examination of functional areas of the rat pancreas that ventral 
and dorsal islets exist. They found glucagon production from dorsal islets contained 10 
times as much glucagon as ventral islets, even though insulin and total protein contents 
were similar. While basal rates of insulin secretion and proinsulin biosynthesis were 
observed in both dorsal and ventral islets.(8) 
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1.2 Pancreatic beta cells function 
 
1.2.1 Metabolic function of insulin  
Insulin is a peptide hormone secreted by beta cells in the pancreas. It normalises 
carbohydrate and fat metabolism. Insulin regulates the absorption of glucose from the 
blood to skeletal muscles and adipose tissue. 
 
The human insulin protein is composed of 51 amino acids and has a molecular weight of 
5.8 kD. It is a dimer of an A-chain and B-chain, which are connected by disulphide 
bonds.(14) Although insulin from animal sources differs somewhat in strength from that 
of humans, porcine insulin is nearly similar to human insulin and was often administered 
to diabetic patients in the past.(12) Insulin is synthesized from a single chain precursor 
called preproinsulin, which is converted to proinsulin in the endoplasmic reticulum.  
Proinsulin is composed of three fragments: a carboxylic terminal (A- chain), an amino-
terminal (B-chain) and C-peptide, which is located between the A and B-chains.(15) 
Proinsulin is packed into small granules within the Golgi complex, which then moves to 
the cell surface. As the granules mature, proteases spilt proinsulin into equal amounts of 
insulin and c-peptide, allowing the insulin molecule which comprises the A and B chains 
linked by disulphide bridges as illustrated in Figure 1.4, to adopt its active 
configuration.(16) 
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Figure 1.4 Stages of insulin synthesis(16) 
 
 
This Figure illustrates the steps by which insulin hormones are synthesised from 
polypeptide chain preproinsulin then proinsulin and active insulin plus C-chain are 
formed.  
 
1.2.2 Molecular regulation of insulin secretion from beta cells 
The complex architecture of pancreatic islets cell-cell communication has been confirmed 
to be crucial for normal islet function.(13,17–19) The vital role of homologous contact 
between beta cells is supported by observations in rodents in which islets were dissociated 
into a single cell suspension, and the ability of beta cells from these islets to respond to 
glucose was decreased.(20) Thus researchers suggest that intercellular contact coordinates 
the function of beta cells by synchronising activities.(21) This interaction is mediated by 
cell adhesion molecules and gap-junction proteins. Beta cells are interconnected by gap 
junctions, which form channels across the extracellular space. The channels allow direct 
exchange of small cytoplasmic molecules such as glucose from one cell to another. This 
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ensures electrical coupling and promotes insulin secretion. Several adhesion molecules 
such as integrins and cadherins are known to be expressed in islets and to have an 
important role in the maintenance of islet architecture.(8,18) 
 
Recent studies have examined in detail the cytoarchitecture of human islets.(8,18,22) 
Comparing with animal models has proved that the pattern of distribution of islets cells 
is unique in that the different endocrine cell types are distributed uniformly through the 
islets and not sorted into central and peripheral compartments.(23) Heterogeneity regarding 
insulin secretion also exists between human beta cells and implies that insulin secretion 
is affected by cell-cell contact. To this end, homologous and heterologous intercellular 
communication in beta cells have a crucial influence on insulin secretion, and this may 
be related to the particular hierarchical of human islets.(8) The secretion of insulin from 
single beta cells and aggregated cells pairs in comparison with beta and non-beta cells 
have been studied. It has been demonstrated that insulin secretion from the aggregates of 
beta cells is higher than non-beta cells.(8) 
 
The secretion of islet hormones is highly regulated and coordinated to ensure maintenance 
of glucose homeostasis through actions on peripheral tissues including the liver, muscles 
and adipose tissue. Insulin provokes glucose uptake by peripheral tissues. While glucagon 
causes the liver to convert stored glycogen to glucose which releases into  bloodstream 
when blood glucose levels fall.(24) 
 
The mechanism of insulin secretion is complicated, and the signal transduction is 
different from other extracellular stimuli. It starts with taking glucose into the cell by 
glucose transporter 2 (GLUT2) which will flip inside the cells and provoke insulin 
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secretion. While in most other extracellular stimuli, they start with binding to plasma 
membrane receptor then activation of intracellular secondary signals.(23) 
 
1.2.3 Role of ATP and calcium ion  
Incretins are gut hormones which secreted from endocrine cells into blood within short 
time after oral nutrients. Two types of incretins have been known; glucose-dependent 
insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1). The incretins help 
common actions of pancreas via potent enhancers of glucose-stimulated insulin release. 
Dipeptidyl peptidase rapidly-4 (DPP-4) is enzyme deactivated the action of both 
incretins. A lack of incretins secretion or a rise in their clearance are pathogenic factors 
in diabetes.(25 
The insulin secretion pathway starts with glucose entry into beta cells. This is mediated 
through glucose transports proteins (GLUTs). There are 12 types of GLUT with GLUT2 
facilitating glucose entry into the beta cell. The entrance of glucose into beta cell increases 
the ATP/ADP ratio due to the metabolism of glucose via the glycolysis pathway and 
oxidative phosphorylation.(26) The elevated ATP/ADP ratio leads to closure of the ATP-
dependent K+ channel (KATP) leading to depolarisation of the plasma membrane. After 
that, the voltage-gated calcium channels opens allowing entry of calcium ions into the 
beta cell. The entrance of calcium causes subsequent insulin exocytosis. Also, other 
stimuli that may also regulate insulin secretion include neurotransmitters, amino acids 
and fatty acids which regulated by hormones such as growth hormone, cortisol, 
epinephrine and glucagon.(27–29) Through the accumulation of positive charge of cationic 
amino acid in the presence of glucose inside of the cell because of more ATPs are formed. 
Thus, depolarisation of cell membrane which leads to open voltage-gated Ca+2 channel 
and Ca+2 stimulates insulin exocytosis as shown in Figure 1.5.(29) 
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The relation between protein ingestion and insulin secretion has been studied in vitro 
using beta cells; some studies confirm that amino acid like arginine, leucine, and 
phenylalanine have a strong insulinotropic effects.(26) In addition to that Randle’s work 
confirms that in fasting state the rate of fatty acids oxidation will be increased leading to 
the suppression of glucose oxidation and activation of gluconeogenesis which will affect 
insulin secretion.(27) 
Figure 1.5 The flowchart showing the mechanism of insulin production(29) 
 
 
This flowchart demonstrates the mechanisms by which insulin release is stimulated by 
nutrients and amino acids. There are two mains mechanisms. (A) The direct 
depolarisation of plasma membrane through cationic amino. (B) Metabolism of amino 
acids such as alanine, glutamine and leucine. Both of them depend on the cellular content 
of ATP inside of the beta cell. 
 
1.2.4 Cell-cell contact  
Cell-cell interactions are indispensable for initiation of insulin secretion in response to 
glucose. Primary beta cells connect with each other through adhesion molecules including 
N-, R-, E-cadherin and neural cell adhesion molecule (NCAM).(2,30) The extracellular 
domain of E-cadherin (E-CAD) produces calcium-dependent homodimers with cadherins 
of neighbouring cells, hence facilitating cell-cell adhesion. The essential role of E-CAD 
on aggregation of beta cells has been investigated using a mouse model.(31) It has been 
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shown that ectopic expression of a dominant negative E-cadherin substituted with type 
N- and E-CAD in the beta cells of mouse embryos transiently interfered with clustering 
of beta cells.(30,31) 
 
Some researchers have suggested that E-CAD brings beta cells close and helps in 
secretion of insulin via intra-islets signalling in vivo.(32) It has been demonstrated that both 
E-CAD and NCAM play essential roles in the cellular organisation of pancreatic islets. 
Also, studies showed that a loss of E-CAD in beta cells led to impaired insulin secretion 
and reduction of beta cell size.(32) E-CAD and NCAM are present in both beta cells and 
non-beta cells in rat islets, although NCAM expression level is much higher in non-beta 
cells.(33) E-CAD is responsible for homotopic interactions which are necessary for cell 
type segregation.(33) While cell-cell interaction is essential for survival and function 
improvements of beta cells, these issues have not been observed in alpha cells.(34) 
 
1.2.4 Connexins  
Connexins (Cx) are channels on cell membranes resulting from the opposition of two 
transmembrane structures. Two connexions, in particular, Cx43 and 36, play a crucial 
role in regulating pancreatic function.(35) Previous studies have investigated the 
contribution of connexin 36 (Cx36) in beta cell function. Cell-cell communication 
between beta cells by Cx36 is involved in controlling insulin secretion.(35) It was found 
that Cx36-dependent signalling plays a physiological role in the regulation of beta cell 
function and the expression of Cx36 is correlated to insulin secretion through intercellular 
synchronisation of Ca2+ transients induced during stimulation. Therefore, the alteration 
in the Cx36 level has an impact on the development and maintenance of the dysfunction 
of beta cells that will end with diabetes.(35)  
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1.3 Diabetes Mellitus 
Diabetes Mellitus (DM) is a group of metabolic disorders characterised by 
hyperglycaemia with metabolic disorders of carbohydrates, fats and proteins resulting 
from defects in insulin secretion, insulin action or both. The hyperglycaemia can be 
defined as a condition of increase of glucose level in blood plasma to above of 11.1 
mmol/L (200 mg/dL) called ‘fasting plasma glucose’. The symptom of diabetes is not 
easy to diagnosis at an early stage, but the symptom of DM can be noticeable when the 
level of glucose 15-201 mmol/L (~ 250-300 mg/dL). The levels of glucose which are 
measured to be hyperglycaemia could be different from person to another, because of the 
person’s renal threshold of glucose and overall glucose tolerance. 
 
There are two major types of diabetes, Type 1 diabetes where the body can't form insulin 
(the hormone responsible for glucose metabolism) and Type 2 diabetes in which the 
insulin is either absent or not functioning well. A condition is known as pre-diabetes in 
which the blood glucose level is higher than normal, but not high enough to be called 
diabetes. Diabetes warning signs can be mild especially with Type 2 diabetes, polyuria, 
polydipsia and polyphagia are the main symptoms for diabetes, there are several tests that 
help in diabetes diagnosis like blood glucose test, oral glucose tolerance test, urine 
glucose test and ketone bodies in urine. 
 
The complications of DM include coronary heart disease, kidney failure, blindness, limb 
amputation and premature death. Besides, the complications of DM include long-term 
damage, dysfunction and insufficiency of the various organs. These range from 
autoimmune destruction of the pancreatic cells that result in insulin deficiency to 
abnormalities in the production of insulin. The symptoms of hyperglycaemia include 
polyuria, polydipsia, weight loss, sometimes with polyphagia and blurred vision.(36) It has 
14 
 
estimated that 415 million people are suffering from DM in 2015, which is 1 in 11 of the 
world population,(19) and the number of people with DM will reach to 642 million by 
2040. 
 
1.3.1 Types of Diabetes 
The commonest types of diabetes are type 1 diabetes (T1DM) and type 2 diabetes 
(T2DM).(37) T2DM is the most common form of DM and is characterised by disorders of 
insulin action and insulin secretion; either of which may be the predominant feature. Not 
all patients have insulin resistance and impaired insulin secretion at clinical 
presentation.(38) 
 
The long-term effects of DM include progressive development of specific complications 
of retinopathy with potential blindness. The end-stage of DM complications include 
impaired wound healing will be the risk of foot ulcers may lead to a risk for lower limb 
amputations; renal failure since the blood vessels in the kidneys are injured and cannot 
clean the blood properly with accumulating of waste materials in the blood.(38) The direct 
and indirect effects on the human vascular tree are the main source of morbidity and 
mortality in both T1DM and T2DM. 
 
1.3.2 Type 1 diabetes and current treatments 
Type 1 diabetes mellitus (T1DM) results from beta cell destruction in the pancreas and is 
characterised by an absolute absence of insulin production. T1DM accounts for 5-10% of 
all types of diabetes. It is caused by autoimmune, genetic, and environmental factors. 
T1DM was previously referred to as insulin-dependent diabetes mellitus (IDDM) or 
juvenile onset diabetes as it presents relatively early in life, and frequently before the age 
of thirty.(39,40) It has been known that T1DM is characterised by the presence of anti-
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glutamic acid decarboxylase (anti-GAD) or insulin antibodies in islet cells, which triggers 
autoimmune processes leading to beta cell destruction.(41,42) 
 
Current treatment for T1DM depends on exogenous insulin injection therapy. It includes 
many daily injections and insulin pump therapy (chronic subcutaneous injection). Insulin 
pump therapy could lead to lipodystrophy which results from long-term injection at the 
same place. Although insulin therapy allows a monitor of the control level of blood 
glucose through daily glucose monitoring, strict blood glucose control could be difficult 
because of environmental variation, for instance, age, diet exercise or pregnancy. The 
complication of the exogenous insulin injection therapy may lead to long-term 
complications of DM for example retinopathy, neuropathy and nephropathy.(43) 
Therefore, looking for alternative management of T1DM is crucial. Cell therapy 
represents one of the new treatment methods and is a promising technique to be used 
widely in the future.(44) 
 
1.4 Cell therapy 
The number of patients with diabetes mellitus in the world is steadily increasing. Looking 
for new methods to prevent or cure this disease has been a crucial medical issue. Effective 
treatment is required to prevent the long-term complications of T1DM. One of the 
alternative methods of treatment for T1DM is islet transplantation in which islets are 
transferred from a donor pancreas to a T1DM patient. The newly implanted islets start to 
make and release insulin helping T1DM patients to avoid daily injection of insulin. 
However, since the 1970s most of the attempts to reproduce a success in human islets 
transplantation ended with disappointment mainly due to islet rejection and the limited 
supply of islets for transplantation.(45) 
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In 2000s researchers at the University of Alberta in Edmonton (Canada) established a 
new procedure for islet transplantation by increasing the number of transplanted islets 
which had been typically used, shortening the time between isolation of islets from a 
donor pancreas and transplantation into the recipient, and the use of a new 
immunosuppressive protocol.(46) This protocol used three different types of 
immunosuppressive drug. By the end of the 1st year post-transplantation, 50-68% of 
patients did not need insulin supplement. However, after five years only 10% of patients 
are free of daily insulin injection mainly due to islets rejection. So, in order to protect 
these cells from attack by the immune system, several methods have been developed 
including encapsulation of islets with a coating to protect them from the immune system 
while allowing them to release insulin.  
 
The bioreactor ßAir has already developed one of the immune protection methods. Beta-
O2 Technologies Company uses “bioreactor ßAir, a proprietary implantable bioartificial 
pancreas”. The reactive ßAir adapts a new chamber system containing islets of 
Langerhans in which cells have high viability and immunoprotection to produce insulin. 
This new device was applied for human transplantation in 2012 in Dresden’s Technical 
University (Germany) with follow-up for 10 months. The outcome was positive. After 
that, the experts at Uppsala University (Sweden) checked the blood glucose level and 
βAir implanted patients. They found this device is effective for the treatment of the 
patients with diabetes if the oxygen is fed daily through a needle to the device.(46) 
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1.5 Generation and characterisation of tissue-engineered Pseudoislets  
 
1.5.1 The principle of Pseudoislets  
Due to a large number of animals needed to perform DM studies, researchers looked for 
alternative methods that may help to reduce the number of animals needed for initial 
experiments, and for better cell therapy. As such, pseudoislets (PIs) are considered a 
replacement for the real islets for research purposes. 
 
Pseudoislets (PIs) are three-dimensional islet cell clusters. It is hoped to recapitulate the 
function of native islets by PIs. The use of PIs in research began in the 1980s. Researchers 
discovered that the digestion of dog pancreas with trypsin formed a single cell suspension, 
which could re-aggregate in 4-8 days in rotational cultures.(47) PIs could include all islet 
cell types and were stable for about 28 days. These PIs also could release hormones in 
response to appropriate stimuli.(47) 
 
The principles and functions of PIs have been described and discussed in the past. 
Intensive research continues to maximise their insulin secretion, viability and 
transplantation potential. There are a few factors regulating to PI’s structure including 
cell source (species source), cell types, single or multiple cell types and methods to 
generate PIs. 
 
1.5.2 Pseudoislets structure  
PI generation should mimic native islets. Research has been conducted on the effect of a 
few factors, such as cell sources, single or multiple pancreatic cells types in the PIs, 
additional cell type in PIs on bio-functional PI’s structure. 
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The first selection of islet cells for PIs generation is from animals, i.e. primary cells. There 
are a wide variety of islet species used in the research including, rat, mouse, dog,(48,49) 
monkeys,(50) cats(51) and pig.(52) Recently, another method of generating islet aggregates 
have been reported.(53) This method relies on methylcellulose/particles to control the 
number of polystyrene microsphere in PIs. This aggregation took place within less than 
half an hour, and the aggregation of cells can be altered to allow different arrangements 
when different cell types are used in the same PIs.(54,55) Other sources of PIs have been 
used from neonatal pig islets,(56) neonatal rats,(35,57) cadaveric pancreas from children(58) 
and neonatal human tissue.(59) 
 
To gain more information regarding insulin secreted through in vitro study, insulin-
producing cell lines have been used to generate and study PI formation. Many rodent 
insulinoma cell lines have been established from transgenic animals expressing the SV40 
antigenic oncogene from the insulinoma gene promoter. These cell lines include the 
MIN6, βHC, βTC cell lines.(60,61) These cell lines retain many of the characteristics of 
fully differentiated beta cells. The RINm5F cell line was produced from a transplantable 
rat insulinoma,(60) and several derived cell lines have been generated from their clones. 
For example, the BRIN-BD11 cell lines(60) was generated via electrofusion of RINm5F 
clone and normal rat islets.(60) Likewise, the INS-1 cell line was derived from the original 
radiation tumour, which can produce a high level of insulin secretion and can maintain 
insulin secretory responsiveness over a prolonged period of culture.(60) Human insulin-
releasing cell lines including 1.1B4. 1.4E7 and 1.1E7 have been generated by 
electrofusion of freshly isolated human pancreatic beta cells with the immortal human 
PANC-1 epithelial cell line.(60) A novel human electrofusion-derived beta cell line with 
stable features similar to those of primary pancreatic beta cell in terms of structure and 
function has been reported.(60) 
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The effect of including other islets cell types into PIs on insulin production has been 
investigated. It has been found that using different ratios of alpha cells to beta cells of 
1:2, 1:1, 2:1 would produce different levels of insulin.(62) It has been reported that PIs 
comprising 8,000 cells in a 1:8 alpha/beta cell ratio, produced more insulin with 
enhancement by 3 times compared with PIs formed from beta cells only. Furthermore, 
Kelly et al.  have investigated heterotypic PIs composed of alpha, beta and delta cells. 
The PIs can produce normal pattern insulin release in response to different types of 
stimulation.(63) They found that PIs generated from mixed three types of cell lines (insulin 
(MIN6), glucagon (αTC 1.9) and somatostatin (TGP52) produce more insulin than PIs 
formed from MIN6 only in vitro  after 7 days of culture.(63) 
 
Researchers compared PIs produced from a mixture of original pancreatic beta cells and 
transformed (RINm5F) cells. (64)They found that the native beta cells occupied the centre 
of the PI surrounded by zones of non-beta cells, while RINm5F cells were located in the 
peripheral region. They revealed that RINm5F cells might not share the same surface 
features of native beta cells completely.(64) 
 
Nikolova et al.  have found that pancreatic beta cells in vitro do not form a basement 
membrane. They used VEGF-A to attract endothelial cells which form capillaries with 
vascular basement membranes next to the beta cells.(65) 
 
The formation of PIs involves engineering approaches; various tissue-engineering 
methods have been developed, which will affect cell-cell contact and the architecture of 
PIs which is crucial for function. 
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1.5.3 Established techniques for formation of Pseudoislets 
 
1.5.3.1 Cellular self-assembly 
Cellular self-assembly is one of the common techniques used for the production of PIs. 
Self-assembly mimics natural processes which happen during embryogenesis, 
morphogenesis and organogenesis.(66) It is a spontaneous and reversible association of 
small molecular units into big organised structure design by non-covalent interactions.(67) 
For example, the re-aggregation of pancreatic cells has shown a spontaneous fusion in 
vitro into clusters, which mimic the native islets. Some studies suggested that differential 
adhesion could be the reason behind the self-assembly behaviour. For instance, Hauge-
Evans et al.  have found that culturing MIN6 cells on gelatin coated plates for 7 days 
elicited the formation of PIs.(20) This process was dependent upon the presence of E-CAD 
as it could be inhibited in the presence of an anti-CAD antibody or absence of Ca+2 needed 
for E-CAD binding. These PIs had improved functionality as they showed a greater 
glucose-stimulated secretion of insulin when compared to a monolayer of MIN6 
cells.(20,68) Therefore, regulation of the cell-cell adhesion through alterations in the 
extracellular matrix (ECM) could be a useful strategy to improve the success of islets 
transplantation. For example, Liu et al.(69)  in 2015 showed that beta cells and ECM 
interaction improved cell self-assembling techniques which may be used to develop 
treatment efficacy of transplantation of islets.(69) 
 
1.5.3.2 Hanging drops 
The hanging drop method has been used to crystallise proteins, achieve embryonic body 
formation by stem cells and evaluate tumour invasion.(70) Hanging drop cultivation 
depends on microgravity forces in the droplet, which stimulates cellular interactions. The 
classic hanging drop technique depends upon culturing a small drop of cells, which allows 
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cells to grow and the spheroid islets formed as shown in Figure 1.6. The hanging drop 
technique was also used to study the microbiology of bacteria in confined and controlled 
environments. This technique has allowed cell drops to be maintained without spreading 
the culture. Moreover, the hanging drop technique has been used to genetically modify 
the function in islet spheroids with controlled size and morphology.(71–73) 
 
Figure 1.6 The hanging drop sizes is optimised by the diameter of plateau on the 
bottom of plate(74) 
 
 
This Figure shows the way by which the hanging drop is confined by the diameter of the 
plateau on the bottom surface of the plate. 
 
1.5.3.3 Suspension culture 
The simplest method used to promote the formation PIs is to grow the beta cells in 
suspension. The surface characteristics of suspension culture containers induce beta cells 
attaching to each other rather than to the surface of the culture containers. In general, 
many cell types differentiate and lose their normal phenotype when grown under 2D cell 
attachment culture conditions.(75) The suspension culture is used to prevent this problem 
in pancreatic islets culture, helping islets to maintain their functional properties. However, 
beta cells display different morphologies based on the surface properties of the materials 
on which they are cultured. For example, beta cells cultured in a low cell attachment 
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microenvironment formed PIs with an islet-like structure after 7 days of culturing.(76,77) 
While the use of bacterial petri dish formed PIs with a smaller size compared to those 
formed on ultra-low attachment culture plates.(78) Both PIs formed on the ultra-low 
attachment, and bacterial petri dish displayed improved abilities to secrete insulin.(75,78) 
Several studies have used treated tissue culture plastic for the production of suspension 
cultures.(79,80) 
 
On the other hand, human mesenchymal stem cells have been used to generate insulin-
producing cells and combine with pellet suspension culture to induce them to differentiate 
into beta cell type.(81) Lin et al. (81)  have found that suspension culture and stem cells 
could be stimulated by adding ECM such as laminin and fibronectin.(81) 
 
Lehmann et al.  have reported that the smaller sized PIs have better biological function 
since small islets display superiority in human islets transplantation clinically.(82) Also, 
Yang and colleagues have found that the treatment of the surface of the plastic dish with 
collagen, Lipidure and type IV collagen impacted on PIs sizes, viability and insulin 
secretion. They found that Lipidture gave the best viability as shown Figure 1.7.(83) 
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Figure 1.7 Live/dead staining images showing the cell viability of MIN6 cells 
grown on different substrates(83) 
 
 
This figure illustrates live/dead staining MIN 6 monolayer cells and PIs. The survival rate 
(F) of each group is shown. 
 
1.5.4 Functional assessment 
 
1.5.4.1 Morphology 
The component and hierarchical structure of islets play a crucial role in beta cell 
physiology.(34) The morphology of PIs can be visualised initially through using light 
microscopy to get live images for PIs. For further details of PIs morphology, thin section 
of PIs could be observed by light microscopy after PIs stained with Hematoxylin and 
eosin.(84) The cell-cell connection/arrangement within PI, which relate to PI morphology, 
can be assessed by immunofluorescence methods as well.(85,86)Key protein and hormone 
expressions from the pancreatic beta cells in PIs can be illustrated by staining with 
specific antibodies, for instance, insulin, GLUT2 and Cx36. The expression can be 
quantified or qualified using fluorescence microscopy and/or confocal microscopy.(60,83) 
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Immunofluorescence staining of cell types in PIs revealed that alpha cells tend to be 
peripherally distributed, while beta cells form the core of the PIs.(87) Electron microscopy 
has been used to study intracellular components of PIs, which revealed well-preserved 
cell ultrastructure and intracellular membrane connection in PIs (Figure 1.8) 
 
It has been found that beta cell functionality was enhanced when the cell-cell 
communication is formed in 3D PIs. The PI structure is shown in Figure 1.8 confirming 
improvements in insulin release in comparison to 2D culture.(87) Also, researchers have 
found that insulin production is altered in relation to the expression of E-cadherin and gap 
junction proteins between the cells.(88) The pancreatic cell lines can be grown into 2D 
monolayer configuration or reconstituted to 3D aggregates depending on the types of cell 
culture substrate. Beta cells have formed PIs when cultured in low cell attachment 
surfaces(75,89) or bacterial Petri dishes, but generate 2D monolayer when culturing in tissue 
culture plates.(83) 
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Figure 1.8 Images of a pancreatic beta PIs (BRIN-BD11) by different 
microscopic techniques(87) 
 
 
(This figure shows (1) section stained with Hematoxylin and eosin, imaged by light 
microscopy, X400. (2) Thin section electronic microscopy of PIs, X660. The scale bar = 
1.0 μm. (3) Thin section electronic microscopy showing membrane features of two 
components in PIs, X78,000. The scale bar = 1.0 μm. 
 
1.5.4.2 Immunohistochemistry 
Immunohistochemistry (IHC) is a powerful process using the principle of antibodies 
binding specifically to antigens in biological tissues to detect the antigens, e.g. proteins 
or enzymes in cells of a tissue section. It combines immunological and biochemical 
techniques to visualise specific proteins in tissues or cells via using suitable antibodies to 
bind specifically to their target antigen in the specimens.(90) Any immunohistochemistry 
method aims to detect the maximum amount of antigen with the least possible background 
which maximises the signal to noise ratio. Many methods have been used to detect the 
amount of antigen present, and each one depends on the level of sensitivity required and 
the technical capabilities in the laboratory.(91) IHC staining is widely used to determine 
specific molecular markers such as proliferation or cell death.(92) 
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IHC has been used to detect the expression of E-cadherin, Cx43, Cx36, GLUT2 and 
insulin in pancreatic beta cell studies.(34,83,93) It has been seen that these key protein 
expressions were greater when cells were arranged in a 3D configuration rather than in 
2D monolayer culture. Additionally, the expression of insulin and GLUT2 were higher in 
small PIs compared with large PIs.(27,83,94) 
 
1.5.4.3 Insulin production 
Insulin release starts with glucose which is the main simulator. The action of insulin 
occurs in a biphasic pattern. The first phase takes only a few minutes, followed by a 
sustained second phase as shown in Figure 1.9. The first phase of the release includes the 
plasma membrane fusion of a small, freely releasable pool of granules. The granules 
discharge their contents in response to nutrients and non-nutrient secretagogues. On the 
other hand, second-phase insulin secretion is triggered by nutrients. So, the shape of the 
glucose-insulin dose-response curve determines mainly by the activity of glucokinase, 
which represented the rate-limiting step for glucose metabolism in pancreatic beta cells. 
Blood glucose level below 5 mmol/L does not affect insulin release, and half-maximal 
stimulation occurs at ~8 mmol/L.(95) 
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Figure 1.9 Phases of normal insulin secretion (95) 
 
The figure shows the mechanism by which glucose regulates insulin release 
 
The ability of isolated islets to secreted insulin has been established in static cultures, 
which showed that the dynamics of insulin release significantly increase when cells are 
configured as PIs when compared with monolayer cells.(21,34,85) It has reported that PIs 
formed from rat pancreatic islets revealed clear biphasic dose-dependent insulin 
responses after half an hour glucose stimulation over the range from 5.5 to 30 mM. The 
data indicated that islets cells reaggregated into 3D structures with close morphologic 
similarities for native islets.(87) The dynamics of insulin secretion from PIs is similar to 
that of primary mouse islets, although the amount of insulin secreted from PIs has been 
reported to be less than primary islets. (75) Bereton and co-workers have reported that 
cellular interaction among beta cells are sufficient to preserve the normal pattern of 
insulin release which is different from in vivo islets in that regulation is achieved through 
glucagon and somatostatin.(62) It has been studied that MIN6 monolayer and PIs cultures 
possess similar levels of insulin release in response to basal glucose concentration.(20) 
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Glucose-induced insulin production from MIN6 PIs is significantly higher than that of 
MIN6 monolayer cells.(20) Furthermore, the use of perfusion technique showed similar 
insulin response.(20,21) 
 
Many techniques have been applied to determine insulin level. The first method is named 
as bioassays to measure insulin-like activity (serum insulin) which have been used for 
detection of the ability of human or animals to produce insulin after oral or intravenous 
injection with glucose. The level of insulin is measured at different time points of the 
injection.(98) Although the bioassays methods are used for in vitro and in vivo cases, the 
low sensitivity of this method to insulin antagonist and insulin substance its limited to use 
in routine clinical laboratory.  
 
The second method is through chromatography procedures, particularly high 
performance liquid chromatography (HPLC). HPLC has been widely used in the 
measurement of insulin, proinsulin and C-peptide level in biological fluids. The C-peptide 
produced from cleavage of proinsulin is equal to the amount of insulin.(97) So, the C-
peptide level could be used as a marker of insulin release and an assessment of beta cell 
function..  
 
The third technique is immunoassays composed of the radioimmunoassay (RIA).and the 
enzyme-linked immunosorbent assay (ELISA) which are widely used. RIA was first used 
in 1959 by Yalow et al.(98)  However, this methodology is restricted by potential safety 
concerns due to the presence of radiolabelled antigen, the instability of the reagents and 
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need for a long time incubation and washing steps.(99) ELISA involves fluorescence, in 
which the insulin in samples is determined by binding to insulin antibody labelled with 
fluorescence.(100) The advance of ELISA assay enables to detection of insulin with highly 
sensitivity.(100)  Recently a new approach has been established to be a rapid insulin assay, 
which depends on homogenous time-resolved fluorescence with more beneficial due to 
more rapid and cost-effective than other used methods. This method has been applied in 
an insulin secreting cell line in INS-1E cells and pancreatic islets.(101) 
 
1.6 Parameters controlling Pseudoislets’ viability and function 
 
1.6.1 PI Size 
The increment in the sizes of PIs leads to malnutrition and hypoxia which leads to 
necrosis and cell death in the centre of PIs.(26) Yang et al.(27) have reported that the 
diameters of PIs were inversely proportional to the amount of insulin secreted with PIs of 
100 µm in diameter secreting more insulin than PIs of 280 µm in diameter. The reason 
for the increase of insulin secretion may be due to cell viability, which is higher in small-
sized PIs. Several techniques have been applied to control PI size, which could 
consequently improve function.(35,83,93) The level of ATP has been measured within the 
production of different sizes of PIs, and the outcome showed that the larger the size of 
the PI, the lower the amount of ATP produced, which subsequently hindered 
mitochondrial membrane potential.(102) 
 
The substrate types of culture plates have been found to affect the size and morphology 
of PIs. If the cells were cultured on a low cell attachment microenvironment, the cells 
would form cell aggregations with sizes ranging 50 to 300 µm after 7 days of 
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culture.(21,68,89) However, the size of PIs was modified to about 100 µm when the cells 
were cultured in bacterial culture Petri dishes after the same period. These researchers 
suggest that using an ultra-low attachment culture plate when culturing PIs could improve 
their ability to secrete insulin in comparison to those cultured on a more adhesive 
plate.(75,83) 
 
Chawla et al.(102)  report that the use of suspension bioreactors for culturing neonatal 
porcine tissue helped to produce islet-like structures. Other research groups have proved 
that PIs grown in Lipidure and type IV collagen-coated dishes have produced a diameter 
of 100-150 µm with better cell viability. The viability and size of PIs are crucial for their 
function.(21,68,89) Also, Liu has tried to increase the functionality of cells within PIs by 
selection of PI size. He found that beta cells in the spheroids of 200 μm exhibited largest 
insulin secretion based on glucose stimulus when compared to others with sizes of 100, 
300, 400 and 500 μm.(103) Also, it has been shown that a reliable way to generate viable 
survival PIs from human islets whilst also controlling the size involves the use of agarose 
microwell platforms, which can form PIs with accuracy and with high similarity to native 
islets.(102) 
 
1.6.2 Beta cell packing density  
It is believed that controlling the density of PIs improves the viability and functionality 
of the beta cells. Previous studies have demonstrated that 50% of the transplanted cells 
had a reduced capability to secrete insulin. This is likely to be due to decreasing viability 
of cells in the centre of PIs.(105–107) 
 
Halban and colleagues have studied the effect of beta cell density on cell 
aggregation.(35,108) They found that aggregations are resulting from mixing of the beta 
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cells with non-beta cells in cluster form generated larger units via gap junctions, in which 
beta cells where located in a core surrounded by non-beta cells. Such connections were 
vital to improving cells function especially insulin production. Their study showed an 
increase of 9-fold for insulin when fused of 21% beta cells with 79% of non-beta cells by 
raising glucose concentration  from 50 to 300 mg/dl.(108) 
 
The PIs model from pancreatic beta cell has been shown much improved 3D islet-like 
structure after incorporated with a glucagon-secreting cell line (alpha TC1). The model 
showed the ability to self-organise into the structure similar to native islets which is 
crucial for their function.(107,110) 
 
Prior work has produced pseudoislets predominantly from the MIN6 insulin-secreting 
cell line. In the current study, we employed BRIN-BD11 for several reasons. Firstly, 
BRIN-BD11 cells have high expression of GLUT2 and glucokinase consistent with the 
MIN6 and βHC9 cell lines. Furthermore, the BRIN-BD11 cell line is glucose responsive 
consistent with cell lines including INS-1 and βHC.(111) Importantly; the BRIN-BD11 cell 
line proliferates at a much higher rate than MIN6, INS-1, or βTC1 cells. Therefore, the 
use of this cell line for the generation of pseudoislets would exacerbate the issues around 
large Pseudoislet size, e.g. central necrosis and allow an opportunity to address these 
issues fully.  
 
 However, the BRIN-BD11 cell line produces strong expression of hexokinase, which can 
promote higher sensitivity towards lower concentrations of glucose than βTC1, βHC. 
Another difficulty of using this cell lines is that it associates with the changing of 
characteristics over a period of continuous growth. For example, glucose responsiveness 
is largely lost after passage 55, and therefore all experiments in this project were 
32 
 
conducted below passage 40. The cells may have abnormal chromosomal content, other 
genetic mutations and another abnormal protein expression,(111) because this cell line 
culture has the ability to grow without limits which is related to their tumour origin. 
 
1.6.3 ECM expression in the PIs 
ECM in islets of Langerhans plays a crucial role in maintaining pancreatic beta cells and 
influences their physiology dramatically. Recently, it has been confirmed that the 
pancreatic ECM plays a vital role in beta cells viability and insulin secretion.(110) The 
ECM has roles during integrin-mediated cell adhesion, which affects the survival of beta 
cells and insulin secretion from beta cells. Therefore, to improve the viability of islets or 
generations of PIs, adding ECM components to PIs to re-build the native cellular matrix 
environment may be a beneficial strategy.(113)  
 
It has been confirmed that ECM structure and composition are also involved in islet 
architecture and beta cell polarity. Researchers have found three ECM dependent 
structural regions on the surface of beta cells within the intact islet. These regions provide 
specific physiological functions of the transport of glucose molecules, cell adhesion and 
exocytosis.(113,114) They found that islets cells can sense the endothelial basement 
membrane enriched in protein laminin through integrin-dependent adhesion molecules, 
which is crucial to maintaining beta cell polarity and targeted secretion.(65) 
 
The interactions between islets and ECM have been studied on the functionality of cells 
in the term of GSIS cultured in 2D, and 3D culture via ECM coated tissue culture surfaces 
under some conditions such as coated culture surfaces with collagen type IV and matrigel. 
It has been reported that beta cells cultured in gels containing collagen type IV secreted 
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more insulin when stimulated with glucose compared to beta cells  cultured with collagen 
type I , laminin, fibronectin or fibrinogen.(87) 
 
1.7 The effect of substrate chemistry on the formation of PIs by suspension 
culture  
 
1.7.1 Substrate chemistry and cell adhesion 
Cell attachment to the surface is through cell adhesion that occurs through a natural 
interaction process between the cell and the ECM. Cells adhere to the underlying ECM 
via cell-substratum bonds, which are typically receptor-ligand complexes formed 
between adhesion receptors (such as integrins) on the cell surface and their ligands in 
ECM.(113) The native ECM contains multiple ligands, which can interact with integrins. 
These include fibronectin, vitronectin, collagen and laminin.(116) 
 
For in vitro cell culture, the substrates of cell culture containers have to have the strong 
capacity to adsorb proteins including fibronectin, vitronectin, collagen, laminin. Thus, 
such substrates can become an artificial ECM containing appropriate ligands which 
promote cell adhesion.(117,118 
 
A good understanding of the relationships between the behaviour of cells and the 
physicochemical properties of the substrates such as the surface free energy, 
hydrophobicity, the presence of functional groups and surface charges is of prime 
importance to control cell adhesion, proliferation and spreading of cells.(119) Therefore, 
surface properties have a crucial influence on cell adhesion. To generate PIs on the culture 
containers, the cells must not anchor to surfaces. Blocking protein adsorption, i.e. any 
strategies to prevent ligand-integrin interaction occurring will promote PIs formation. 
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1.7.2 Substrate chemistry and cell aggregation 
Many strategies have been used to generate cell aggregates in vitro, which prevent protein 
anchoring to the substrate. Therefore, survival through cell-cell adhesion which leads to 
cell aggregation. One of most common techniques in cell aggregation is changing 
substrate chemistry for suspension culture.(119) 
 
Pluronic is a copolymer consisting of polyethylene oxide (PEO) and polypropylene oxide 
(PPO) segments. These segments can be adsorbed onto hydrophobic surfaces forming 
extremely hydrophilic environments on the surface, which can prevent protein adsorption 
and cell attachment. The amphiphilic behaviour of this molecule has been used in many 
biomedical applications for reduction of protein adsorption and cell adhesions.(120,122) 
Also, this polymer can be used to modify different types of surfaces, for instance, glass, 
polyethylene and polystyrene. In the same way, the properties of the surface can be 
modified by mixing small amounts of this block copolymer with other polymers.(122)  
 
Previous studies have reported many methods to use PEO coating for surfaces in different 
protocols including physical adsorption,(1213 covalent grafting,(124) chemisorption and 
self-assembled monolayers (SAM).(124) The results from SAM and physical adsorption 
could produce unstable surfaces. Whereas, the other methods formed poor 
reproducibility.(125-126) Furthermore, it has been investigated that collagen type 1 with a 
hydrogel of PEO could improve the differentiation of precursor cell aggregation to 
generate mature, insulin-releasing and islet-like structures.(127)  
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1.7.3 Techniques to characterise substrate chemistry 
 
1.7.3.1 Fourier transform infrared spectroscopy 
Fourier transformed infrared spectroscopy (FTIR) is a common technique used to 
determine the molecular structure and chemical composition of given samples.(128) One 
of the strengths of FTIR is the ability to obtain spectra from a wide range of solids, liquid 
and gases. Nevertheless, in several cases, some form of specimen preparation is required 
to obtain a better spectrum. In FTIR traditionally IR spectrometers have been applied to 
analyse samples by transmitting IR radiation directly through samples where the sample 
is a liquid or solid. The intensity of spectrum features is influenced by the thickness of 
the sample, and typically the thickness is a few tens of microns.(128) FTIR spectroscopy 
techniques have also been applied in biological analyses. It relies on the non-perturbative 
function process, is capable of extraction of biological data and images in diagnosis and 
assessment of cell functionality. 
 
1.7.3.2 X-ray photoelectron spectroscopy  
The X-ray photoelectron spectroscopy (XPS) is a technique that measures the element 
composition at the parts of thousand range, chemical formula and electronic state by using 
surface-sensitive quantitative spectroscopy via irradiating beams.(129) XPS is used for 
detection of surface chemistry extensively. Recently researchers have used the XPS to 
prove that coating an amphiphilicity homopolymer on surfaces reduced nonspecific 
protein adsorption. The homopolymer was immobilised onto the substrate through which 
the interactions between the polymers and proteins and using XPS was studied to measure 
protein adsorption.(130) 
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1.7.3.3 Contact angle 
A contact angle (CA) is the angle formed through the interface happening between liquid 
with a solid surface. It measures the quantities of wettability of the solid surface by a 
liquid. There is a unique CA for a given system of solid at a given temperature and 
pressure.(131) The CA has a crucial role in many industrial processes such as lubrication, 
liquid coating, printing.(132,133) As well as these, it has been applied in the academic field 
to measure special wettability, superior repellency and controlled adhesion of different 
types of surfaces.(133–135) Several studies have involved the measurement of the contact 
angles as primary data which specifies the degree of wetting when a solid and liquid 
interact.(135,137) The CA can be divided into two types; small CA and large CA. The small 
CA (angle value less than 90°), corresponds to high wettability and the associated 
surfaces are called hydrophilic. While the large CA (angle values greater than 90°) 
corresponds to low wettability, and the associated surfaces are named hydrophobic(137), 
as shown in Figure 1.9.(136) Thus the measurement of CA can predict the wettability of a 
surface and adhesion interactions among cells and different types of surfaces.  
 
Figure 1.10 Classification of the surfaces of materials according to their CAs(138) 
 
 
This figure illustrates the way by which contact angle is measured. 
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1.7.3.4 Scanning electron microscopy 
A scanning electron microscope (SEM) is a kind of electron microscope, which produces 
images of a given specimen through scanning the surface with a focused beam of 
electrons. In the SEM the electrons interact with atoms in the specimen, generating 
several signals that bear information regarding the surfaces and the composition of the 
specimen.(139) The SEM technique illustrates the details for taken sample at 
magnifications, that would be hard to obtain under normal optical microscopic 
conditions.(138) 
 
1.7.3.5 Atomic force microscopy 
Atomic force microscopy (AFM) is a technique by which a very high-resolution type of 
scanning probe microscope is used with resolution at the order of fractions of a nanometer, 
more than 1000 times better than the optical diffraction limit. The AFM information is 
gathered by touching the surface with a mechanical probe. AFM has been used to 
investigate or explore the material surface of biological systems in order to collect new 
morphological, structural and mechanical information.(141) 
 
1.8 Aims of the project 
Central necrosis in Pseudoislets is the main challenge limiting the use of PIs for the study 
of diabetes. It is accepted that this central necrosis results from a shortage of nutrients and 
oxygen diffusing to the centre of PIs, especially those of 200 µm or more in diameter. 
Therefore, the aims of this project were: 
 
 To develop two novel techniques to control the physical properties of PIs and 
enhance functionality via: (1) the development of a series of coating solutions for 
38 
 
cell suspension culture; (2) the generation of vents within PIs and drug carriers 
for PIs through use of micro-gelatin beads. 
 To identify the optimal composition of the coating solution and define the impact 
on PI morphology and function. 
 To synthesise and optimise micro-gelatin beads that could be incorporated into 
PIs to improve cell viability and insulin production  
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2 Chapter 2 Materials and Methods 
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2.1 Materials  
 
Table 2.1 List of materials, catalogues number and supplier 
Name Catalogue number Supplier 
(3-(4,5-dimethylthiazol-2yl)-
2,5diphenyltetrazolium bromide 
M2128 
Sigma-Aldrich, 
UK 
10-20% SDS-PAGE gel NT21-1020 Generon, UK 
2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic 
acid) 
A3219-100ml 
Sigma-Aldrich, 
UK 
3-isobutyl-1-methylxanthine (IBMX) I7018 
Sigma-Aldrich, 
UK 
4′,6-Diamidino-2-phenylindole (DAPI) D9542 
Sigma-Aldrich, 
UK 
4-20%  Tris-HEPES gradient mini gel NH21-420 
Thermo- Fisher 
Scientific, UK 
Acetone, for analysis A/0600/PC21 
Fisher  
Chemical, UK 
Amersham Hybond P 0.45 PVDF 10600029 
GE Healthcare 
Life Science, UK 
Anti-Connexin 36 / GJA9 antibody for WB ab139524 Abcam, UK 
Anti-GAPDH antibody ab8245 Abcam 
Anti-mouse IgG, HRP-linked Antibody 7076P2 
Cell Signaling 
Technology, UK 
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Anti-rabbit IgG, HRP-linked Antibody 7074P2 
Cell Signaling 
Technology, UK 
 
Anti-Rat IL-1β 500-P80 Peprotech, UK 
Ascorbic acid phosphate A8960 
Sigma-Aldrich, 
UK 
Boric acid B0394-100G-D 
Sigma-Aldrich, 
UK 
Bovine serum albumin (BSA) A2153-50G 
Sigma-Aldrich, 
UK 
BupH™ Tris-HEPES-SDS Running Buffer 28398 
Thermo- Fisher 
Scientific, UK 
Cell Counting Kit-8 (CCK-8) 96992 
Sigma-Aldrich, 
UK 
Cell Dissociation Buffer, enzyme-free, PBS 13151-014 
Life 
Technologies, 
UK 
Collagen from human placenta (type 4) C5533-5MG 
Sigma-Aldrich, 
UK 
Connexin 36 primary antibody SC-398063 
Santa Cruz 
Biotechnology, 
UK 
Corning ultra- low attachment surface culture dish, 
6-well plate 
EW-01835-26 
Cole-Parmer, 
UK 
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Dimethyl sulfoxide (DMSO) D2650 
Sigma-Aldrich, 
UK 
Donkey anti-goat polyclonal antibody SC-45102 
Santa Cruz 
Biotechnology, 
UK 
Donkey anti-rabbit polyclonal antibody SC-2089 
Santa Cruz 
Biotechnology 
Donkey anti-goat IgG-B SC-2042 
Santa Cruz 
Biotechnology, 
UK 
Ethanol (absolute) E0650/17 
Thermo-Fisher 
Scientific, UK 
FBS (fetal bovine serum) DE14-801F Lonza, UK 
Fibronectin F0895 
Sigma-Aldrich, 
UK 
Fluorescein isothiocyanate isomer I F7250-250MG 
Sigma-Aldrich, 
UK 
gelatin from bovine skin type B G9391-100G 
Sigma-Aldrich, 
UK 
gelatin from porcine skin, type A G6144-100G 
Sigma-Aldrich, 
UK 
Glucose Powder G7021 
Sigma-Aldrich, 
UK 
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Anti-GLUT2  Sc-9117 
Santa Cruz 
Biotechnology, 
UK 
Glutaraldehyde grade I  G5882-10X1ML 
Sigma-Aldrich, 
UK 
Glutaraldehyde grade II  G6257-10X1ML 
Sigma-Aldrich, 
UK 
Goat anti-mouse monoclonal antibody SC-16516 
Santa Cruz 
Biotechnology, 
UK 
Goat anti-mouse IgG  SC-2010 
Santa Cruz 
Biotechnology, 
UK 
Goat anti-Mouse IgG (H+L), Poly-HRP Secondary 
Antibody, HRP 
32230 
Thermo- Fisher 
Scientific, UK 
Goat anti-Rabbit IgG (H+L), Secondary Antibody, 
Alexa Fluor® 594 conjugate 
A-11037 
Thermo-Fisher 
Scientific, UK 
Halt™ Protease Inhibitor Cocktail (100X) 78429 
Thermo- Fisher 
Scientific, UK 
Hank Buffer saline solution (HBSS) H9394-500ML 
Sigma-Aldrich, 
UK 
HEPES H-3375 
Sigma-Aldrich, 
UK 
Human Laminin 5 full-length protein ab42326 Abcam, UK 
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Insulin I9278 
Sigma-Aldrich, 
UK 
Insulin (L6B10) Mouse for WB mAb #8138 
Cell Signaling 
Technology, UK 
Lucifer Yellow CH, Lithium L-453 
Life 
Technologies, 
UK 
Methanol A4561 
Thermo- Fisher 
Scientific, UK 
Mouse anti-rabbit IgG-B SC-2491 
Santa Cruz 
Biotechnology, 
UK 
Novex® Tris-Glycine SDS Running Buffer (10X) LC2675 
Thermo- Fisher 
Scientific, UK 
NuPAGE® LDS Sample Buffer (4X) NP0007 
Thermo- Fisher 
Scientific, UK 
NuPAGE® MES SDS Running Buffer (20X) NP0002 
Thermo- Fisher 
Scientific, UK 
Optical Adhesive Cover 4360954 Invitrogen , UK 
PageRuler™ Plus Prestained Protein Ladder, 10 to 
250 KD 
26619 
Thermo- Fisher 
Scientific, UK 
PageRuler™ Unstained Low Range Protein Ladder 26632 
Thermo- Fisher 
Scientific, UK 
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Paraformaldehyde P/0840/53 
Fisher Scientific, 
UK 
Penicillin, streptomycin,  BE17-745E Lonza, UK 
Phosphate buffered saline (PBS) BE17-516F Lonza, UK 
Pierce BCA protein assay kit 23221 
Thermo Fisher 
Scientific, UK 
Pierce™ 20X TBS Tween™ 20 Buffer 28360 
Thermo- Fisher 
Scientific, UK 
Pierce™ ECL Western Blotting Substrate 32109 
Thermo- Fisher 
Scientific, UK 
Pierce™ LDH Cytotoxicity Assay Kit 88954 
Thermo-Fisher 
Scientific, UK 
PluriStrainer 20 µm 43-50020-03 
Cambridge 
Bioscience Ltd 
PluriStrainer 30 µm 43-50030-03 
Cambridge 
Bioscience Ltd 
PluriStrainer 40 µm 43-50040-03 
Cambridge 
Bioscience Ltd 
Potassium phosphate PHR 1330 
Sigma-Aldrich, 
UK 
Quantifast SYBR green RT-PCR kit 204154 Qiagen, UK 
Rabbit polyclonal anti-insulin SC-9168 
Santa Cruz 
biotechnology 
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Rat-insulin ELISA 
80-INSRT-E0l-
ALP 
Stratech 
Scientific Ltd 
Rabbit anti-Goat IgG (H+L) Secondary Antibody, 
Alexa Fluor® 568 conjugate 
A-11079 Thermo- Fisher 
Scientific, UK 
Recombinant Murine IL-10 210-10 Peprotech, UK 
Radioimmunoprecipitation assay buffer ( RIPA) R0278 
Sigma-Aldrich, 
UK 
Radioimmunoprecipitation assay buffer ((RIPA) 
Lysis and Extraction Buffer 
89900 
Thermo- Fisher 
Scientific, UK 
Rnase zap R2020-250ML 
Sigma-Aldrich, 
UK 
RNeasy Mini Kit 74104 Qiagen, UK 
Rosewell Park Memorial Institute (RPMI1640) 12-918F Lonza, UK 
RPMI1640 with L-glutamine BE12-702F/12 Lonza, UK 
Sudan Black 199664-25G 
Sigma-Aldrich, 
UK 
Tip gel, 30mm, 200μl, sterile 5002306428 VWR, UK 
Tris Buffered Saline with Tween® 20 (TBST-10X) SRE0031-500ML 
Sigma-Aldrich, 
UK 
Triton X-100 9002-93-1 
Sigma-Aldrich, 
UK 
Trypan Blue Stain (0.4%) T10282 
Thermo Fisher 
Scientific, UK 
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Trypsin/EDTA10X LZBE02-007E Lonza, UK 
Tween 20 P2287 
Sigma-Aldrich, 
UK 
Ultra-Low Attachment, polystyrene, round bottom, 
sterile, 96-well plate 
CLS7007-24EA 
Sigma-Aldrich, 
UK 
UptiLight US WBlot HRP Chemilum. ECLmax 
Substrate 
58372A Interchim, UK 
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2.2 Methods 
 
2.2.1 BRIN-BD11 cell culture  
The BRIN-BD11 cell line is a hybrid cell line that is produced from the electrofusion of 
primary rat pancreatic islets with the RINm5F cell line, which is derived from the NEDH 
rat insulinoma. BRIN-BD11 cells were a generous gift from Ulster University. 
 
The cells were cultivated as a monolayer for less than forty passages. The cells were 
grown in a T25 flask with 4-5 mL of warm Roswell Park Memorial Institute (RPMI) 1640 
media supplemented with 10% fetal bovine serum (FBS) (Lonza, UK) and 1% Penicillin-
Streptomycin (Lonza, UK). The cells were examined daily using a microscope (Olympus 
CKX41, Japan), which was attached to a CCD camera (1X 2-SLP, Micropublisher S-
ORTV, Japan). The cells attached to the bottom of the plate surface and deflected light 
around their membrane. 
 
The cells were passaged when they reached 80-90% confluence through discarding old 
media and washing the cells twice with 4 mL phosphate buffer saline (PBS) (Lonza, UK). 
Pre-warmed trypsin/EDTA 1X (2 mL) (Lonza, UK) was added to the flask and incubated 
at 37 °C and 5% CO2 for 2-4 minutes. The flask was checked microscopically for cell 
detachment. Once detached, 4 mL of media was added to the flask to inactivate the 
trypsin. The cell suspension solution was transferred into a 15 mL falcon tube, and the 
tube was centrifuged at 900 rpm for 5 minutes. The supernatant was aspirated, and the 
pellet was re-suspended in 1 mL media. After that, the cells were counted using a 
hemocytometer (Counting Chamber; Thomas Scientific, UK), prior to use in experiments. 
Cells between passage number 21 and 30 were employed in the current study. 
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For prolonged storage, cells were detached from the flask with trypsin/EDTA and 
resuspended in 80% FBS, 10% RPMI and 10% DMSO (Dimethyl sulfoxide 99%, Fisher 
Scientific, UK). The cell suspension was immediately transferred to cryovials and placed 
in isopropanol filled in Mr Frosty freezing container for controlled cooling at -80 °C 
before being transferred to liquid nitrogen storage dewars. 
 
2.2.2 Generation of coating solution  
 
Coating solutions  
Pluronic F127 (Polyethene oxide (PEO)-polypropylene oxide (PPO)) polyethene oxide is 
a block copolymer with an average molecular structure of (PEO)99-(PPO)65-(PEO)99 and 
a molecular weight of 12.600 KD. A solution of 2% F127 was prepared in deionized 
water with gentle shaking at 4 °C for 20-30 minutes to aid dissolution of the polymer. A 
1% solution of gelatin type A (Sigma-Aldrich, UK) was prepared in deionized water with 
heating at 65°C for 15 minutes. 
 
Preparation of the culture plates 
Three different types of culture plates were used in this study. The first was Ultra-low 
attachment 6-well plates and 24-well plates, which are commercially available from 
Corning Inc. NY. The second type of culture plate was a 24-well flat-bottomed 
suspension cell culture plate (SARSTEDT, USA) coated with five different coating 
solutions as outlined below. The third type of plate used was a standard 24-well cell 
culture plate (SARSTEDT, UK) coated with the same five types of the coating solution.  
 
The five coating solutions used in this study comprised mixes of gelatin  
50 
 
and F-127 in varying ratios as follows: 
1. Pure gelatin type A (1% (w/v))  
2. Pure F127(2% (w/v) 
3. A mixture of 90% (w/v) gelatin type A solution and 10% (w/v) F127 solution. 
4. A mixture of 95% (w/v) gelatin type A solution and 5% (w/v) F127 solution. 
5. A mixture of 98%(w/v) gelatin type A solution and 2% (w/v) F127 solution. 
 
All the coating solutions were sterilized by filtering the solution using a 0.2 µm filter 
prior to use. 1 mL of the above coating solution per well was added, and the coated plates 
were incubated at 37 °C and 5% CO2 overnight. The coating solution was then aspirated, 
and the plates were allowed to dry inside a laminar flow hood for 2 hours 
 
2.2.3 Generation of PIs by suspension culture 
Inside a laminar flow hood, cells were seeded at a density of 2×105 cells/well in Ultra-
low attachment 6-well plates. A total of 7 mL of media was added to each well. PIs were 
generated in 24-well plates using two different cells seeding densities: 8×103 and 32×103 
cells/well, with 3 mL media added to each well. Following seeding, the plates were 
incubated for seven days at 37°C and 5% CO2. Media was not changed during the culture 
period. Images for cell aggregates were taken on day 3 and day 7 with a light microscope 
(Olympus CKX41, Japan) which was attached to a CCD camera (1X 2-SLP, 
Micropublisher S-ORTV, Japan). 
 
2.2.4 Rotary culture approaches for the generation of PIs 
To assess the role of movement in assisting the formation of PIs, plates were agitated for 
3 days after seeding inside an incubator using a Shaker (model R100 Rotates shaker, 
Luckham) at 32 rotations per minute and incubated at 37°C and 5% CO2. From day 4  to 
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day 7, plates were placed in an incubator without agitation. Media was not changed during 
the incubation period. 
 
2.2.5 Measuring the morphology and size of PIs 
Approximately 4-50 PIs were formed in each well. On day 7 of culture, the morphology 
of the PIs was assessed by light microscopy using a light microscope attached to a  CCD 
camera. Diameters of PIs cultured on different substrates were compared using ImageJ 
software. 
 
2.2.6 Measuring cell number  
Measuring of cell number was started from dissociation of PIs with HBSS free calcium 
for 4 hours in an incubator at 37 °C and 5% CO2. The suspension cells were transferred 
to 1.5 Eppendorf tubes and centrifuged for 5 minutes at 900 rpm. Then, the old media 
was discarded and the pellet suspended with 990 µL of fresh media and mixed of 10 µL 
of trypan blue and counted by using the Countess® Automated Cell Counter Invitrogen 
((MP10227). Cell counting Chamber slide is a plastic disposable which holds the sample 
in two separated chambers for duplication. The sample was mixed, and 10 µL of sample 
was used on each side of the chamber to be counted.  
 
2.2.7 Measuring PI proliferation by MTT assay  
MTT reagent (3-(4,5-dimethylthiazol-2yl)-2,5 diphenyltetrazolium bromide can be used 
to assess the proliferation of PIs as a function of redox potential. MTT is reduced via 
mitochondrial enzymes to an insoluble product which is dissolved using a detergent and 
read at 570 nm. Briefly, the PIs were examined and compared with corresponding 
monolayer cultures using the MTT assay. For monolayer cells, trypsin (150 µL per well) 
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was added to detach cells. After that 300 µL of media was added to stop the action of 
trypsin, the mixture then was transferred to a 1.5 mL Eppendorf tube and centrifuged at 
1000 rpm for 3 minutes. In the case of PIs, the cells were collected and directly transferred 
to 1.5 mL Eppendorf tubes and centrifuged for 3 minutes at 3000 rpm. Supernatants were 
removed, and the cells were washed once with 1 mL of phosphate buffered saline (PBS). 
This was followed by the addition of 100 µL of media to each Eppendorf, followed by 10 
µL of 12 mM MTT reagent (3-(4,5-dimethylthiazol-2yl)-2,5 diphenyltetrazolium 
bromide) (Sigma-Aldrich, UK). The Eppendorf tubes were incubated at 37 °C and 5% 
CO2 for 2 hours. Eppendorf tubes were then centrifuged for 3 minutes at 3000 rpm and 
85 µL of solution discarded. Finally, 220 µL of DMSO (Dimethyl sulfoxide 99%, Fisher 
Scientific, UK) was added, and the solution was placed at 37 °C for 45 minutes and the 
absorbance measured at 570 nm using a microplate reader (BioTek Instruments, USA). 
 
2.2.8 Measuring PI viability using Cell count kit-8  
The Cell count kit-8 (CCK-8) kit was used to measure the viability of the PIs 
incorporating gelatin beads as the CCK-8 assay allows cells to be recovered afterwards, 
whilst the MTT assay does not. The kit’s action depends on the presence of water-soluble 
tetrazolium salt (2-(2-methoxy -4-nitrophenyl)-3- (4-nitrophenyl-5- (2,4-disulfophenyl 2-
tetrazolium monosodium salt, WST-8) reagent, which is reduced by the dehydrogenase 
of cells to formazan dye. Consequently, the amount of formazan generated corresponds 
to the number of viable cells. Briefly, PIs were transferred from tissue culture plates into 
0.5 mL Eppendorf tubes. The medium was discarded after centrifuging for 5 minutes at 
1000 rpm. The PIs were washed once with duplicate sterilised PBS (DPBS, Lonza, UK). 
A working solution was prepared to comprise 10 µL CCK-8 (Cell Counting Kit-8, Sigma-
Aldrich; UK) plus 100 µL media, and 110 µL working solution was added to each 
Eppendorf and gently mixed by pipetting. The Eppendorf tubes were then incubated at 
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37 °C and 5% CO2 for 4-5 hours. The Eppendorf tubes were centrifuged for 5 minutes at 
1000 rpm and supernatants transferred into a 96-well plate. The intensity of colour was 
measured at 450 nm using a microplate reader.  
 
2.2.9 Measuring cytotoxicity by lactate dehydrogenase assay  
A lactate dehydrogenase (LDH) assay kit was used to assess cytotoxicity in PI cultures 
based on the fact that LDH is an oxidoreductase enzyme that catalyses the interconversion 
of lactate and pyruvate inside the cells as shown in Figure 2.1. Therefore, if cells are dead 
LDH will be found in a high amount in the media. 
 
Figure 2.1 Mechanism of LDH cytotoxicity assay 
 
 
The assay is dependent on the detection of LDH released from the damaged cells to media 
as a biomarker for cellular cytotoxicity. 
 
The determination of LDH value was conducted according to the manufacturer’s 
instructions. The procedure started with LDH assay working solution which was prepared 
by dissolving one vial of substrate mix (lyophilization) with 11.4 mL of ultrapure water 
in a 15 mL conical tube. It was mixed well by inverting gently and enveloped with 
Aluminium foil to protect the reagent from light. The reaction solution was prepared from 
the reaction mix by combining 0.6 mL of assay buffer with 11.4 mL of substrate pipetting 
the solution gently. A spontaneous LDH activity control was prepared by adding 10 µL 
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of sterile, ultrapure water to PIs in triplicate. A maximum LDH activity control was 
prepared by adding 10 µL of Lysis Buffer (10x) to PIs in triplicate. 
 
The spontaneous LDH activity control and maximum LDH activity control were kept in 
the incubator at 37 °C, 5% CO2 overnight. An LDH positive control was diluted with 1% 
(w/v) BSA in PBS in a 1:10000 ratio. Then, 50 μL of 1x LDH positive control, and RPMI, 
which served as a negative control, was placed in a 96-well flat-bottom plate in triplicate. 
Also, 50 μL of the reaction mix was transferred to each sample well and mixed carefully. 
The samples in the plate were incubated at room temperature for 30 minutes in the dark. 
Next, 50 μL of stop solution was added to each well and mixed thoroughly. Absorbance 
was measured at 490 nm and correction at 689 nm using a microplate reader. 
 
2.2.10 Glucose-stimulated insulin secretion 
PIs were transferred to Eppendorf tubes carefully and centrifuged gently at 900 rpm for 
5 minutes to create a small cell pellet before aspiration of media. The pellets were washed 
twice with 250 µL of Hank’s Buffered Saline Solution 1X (HBSS 1X) (Sigma-Aldrich, 
UK) supplemented with 1 mM calcium. The cells were primed with 250 µL of 1.1 mM 
glucose and incubated for 40 minutes at 37 °C and 5% CO2. After that, the 1.1 mM 
glucose was removed following gentle centrifugation (900 rpm for 5 minutes), and 250 
µL of 16.7 mM glucose was added. PIs were incubated for a further 20 minutes at 37 °C 
and 5% CO2. Finally, centrifugation was performed, and supernatants were transferred to 
1.5 mL Eppendorf tubes and stored at -20°C for subsequent determination of insulin 
secretion by ELISA. A standard curve of insulin was calculated using the standards 
provided with the kit and ranged from 0 ng/mL to 5.5 ng/mL. Insulin concentration 
(ng/mL) released from test samples was estimated depending on the equation of the 
standard curve. 
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The remaining PI pellets were transferred to the ice after adding 60 µL of 0.5% RIPA 
buffer (Sigma-Aldrich, UK) and allowed to lyse for 20 minutes. The Eppendorf tubes 
were centrifuged at 4 °C for 20 minutes, and the supernatant transferred to a fresh 
Eppendorf tube, which was then stored at -80 °C until needed.  
 
Total protein was quantified using the BCA protein assay (Thermo-Fisher, UK) according 
to manufacturer’s instructions. In brief, working solution was prepared using 1 parts A, 5 
parts B. A standard curve was prepared using protein solution with concentrations ranging 
from 0 µg/mL to 2 µg/mL using standard protein (2 mg/mL) provide with the kit. Next,10 
µL sample and standard were taken, and 100 µL of buffer solution was added to each 
sample and standards in each well of a 96-well plate. The mixture was incubated at 37 °C 
and 5% CO2 for 30 minutes before reading at 570 nm using microplate reader.  
 
2.2.11 RNA extraction from Pseudoislets 
PIs were collected and transferred to Corning 15 mL tube and centrifuged at 1200 rpm 
for three minutes. The media was discarded from tubes, and 1 mL of DPBS was added. 
After that, the PIs with DPBS were transferred into 1.5 mL Eppendorf tubes and 
centrifuged at 2000 rpm for 3 minutes, and the pellets were kept in ice for subsequent 
RNA extraction. For the monolayer cells, which were used as a control, the media was 
aspirated from the well and the cells washed once with DPBS, followed by addition of 
150 µL of 1x trypsin/EDTA and incubated for 2 minutes at 37 °C and 5% CO2. Next, the 
wells were examined under a microscope to check all cells were detached. After this, 250 
µL of media was added to each well and transferred to 1.5 mL Eppendorf tubes. The tubes 
were centrifuged at 2000 rpm for three minutes. After discarding the media, the tubes 
were washed once with 1 mL DPBS. After discarding the DPBS, the pellet was kept at -
80 °C for subsequent RNA extractions. 
56 
 
Total RNA was extracted from cells using the Qiagen RNAeasy Mini Kit which was 
adjusted according to cell number. Briefly, 350 µL of 90% lysis buffer was mixed with 
10% beta-mercaptoethanol and added gently to the PIs. Following lysis and 
homogenization, the lysate buffer was transferred to a 1.5 mL Eppendorf tube, and 350 
µL of 70% ethanol was added. The sample was transferred to the RNeasy Mini spin 
column and centrifuged at 14000 rpm for 15 seconds. The supernatant was discarded, and 
the total RNA remained bound to the membrane of the Mini spin column. The membrane 
was washed with 700 µL RW1 buffer and centrifuged at 14000 rpm for 15 seconds. After 
discarding of the supernatant, further washing with 500 µL of RPE was carried out and 
centrifuged at 14000 rpm for 15 seconds. The membrane was washed a final time with 
500 µL of RPE and centrifuged for 2 minutes at 14000 rpm. The RNeasy Mini spin 
column was placed in a fresh 2 mL collection tube and centrifuged at 14000 rpm for 1 
minute to remove any residual fluid. The RNA was eluted from the membrane using 30 
µL of RNase free water. RNA concentration was measured using a Nanodrop 200 
spectrophotometer (Thermo Scientific, UK) and stored at -80 °C until used. 
 
2.2.12 Quantitative real-time reverse transcription polymerase chain (qRT-PCR) 
One-step quantitative real-time reverse transcription polymerase chain (qRT-PCR) was 
conducted on PI samples using QuantiFast SYBR® Green RT-PCR Kit (Qiagen, UK). 
SYBR green is a fluorescent dye that can bind to the double strand DNA and emit light 
that can be detected by the thermocycler. Briefly, the RNA extracts were diluted using 
nuclease free distilled water to reach a final concentration of 100 ng/mL, in a final volume 
of 25 µL /well. A master mix was prepared for each well comprising 12.5 µL of SYBR 
Green, and 1 µL of the appropriate primer (10 µM). Finally, 0.25 µL of dNTP mix 
RT(enzyme) was added just before the transfer to the PCR machine. Cycling conditions 
were as follows 50 °C for 10 minutes to convert RNA to cDNA; denaturation of cDNA 
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at 95 °C for 5 minutes; 40 cycles of denaturation at 95 °C for 1 second, annealing (at 
various temperatures) for 30 seconds, and extension at 60 °C for 30 seconds. Primers 
sequences (Table 2.2) were designed using rat gene sequences from NCBI map viewer 
and PCR primer design software. The primers were bought from (Invitrogen, Thermo 
Fisher Scientific, UK). All the primers were evaluated in NCBI primer-blast. 
 
Table 2.2 Primer sequences for RT-PCR Primer sequences for RT-PCR 
Primers Sequence 
Product 
size 
Rat E-Cadherin 
F GGGTTGTCTCAGCCAATGTT” 
185 
R “CACCAACACACCCAGCATAG ” 
Rat Cx36 
F “TAACCAGGCCTGCTATGACC” 
163 
R “CAGGGCTAGGAAGACAGTCG” 
Rat Insulin 
F “GTACCTGGTGTGTGGGGAAC” 
200 
R “CCAGTTGGTAGAGGGAGCAG” 
GAPDH_EXONE 
F “C AA GGT CAT CCA TGA CAA CT” 
301 
R “GAT ACA TTG GGG TAG GAA AC” 
 
2.2.13 Immunological staining 
PIs were transferred into 1.5 mL Eppendorf tube, and the medium was discarded after 
centrifuging at 2000 rpm for three minutes. The PIs were washed with PBS twice. Three 
PIs in each Eppendorf tube were fixed with 500 µL of 4% PFA (Paraformaldehyde) 
(Thermo Fisher Scientific, UK) and placed in the cold room for 90 minutes. The PIs were 
then permeabilized with 300 µL of 0.3% (v/v) Triton X-100 (Sigma, UK) in PBS for 60 
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minutes at room temperature. Following, 300 µL blocking solution (5% (w/v) BSA 
(Sigma-Aldrich, UK), 0.15% Triton X-100 in PBS)) was added to each Eppendorf. 
 
The primary and secondary antibodies were diluted with buffer solution (1% BSA (w/v), 
0.2% (v/v) Triton X-100) as shown in Table 2.3. Primary antibodies were applied 
overnight at 4 °C. After which, the primary antibodies were removed, and the PIs were 
washed with the buffer solution three times for 5 minutes each using a centrifuge for 3 
minutes at 2000 rpm. Then the PIs were incubated with the secondary antibody for 4 
hours at room temperature. After that, the PIs were washed three times with PBS for 10 
minutes each, and the PIs were incubated in the presence of DAPI (diluted 1:100 with 
PBS) at room temperature for 60 minutes. This was followed by three washes with PBS 
for 20 minutes each. The PIs were examined using laser scanning confocal microscope 
(Olympus, Japan) sequential narrow band filter accounts for spectral bleed-through (FITC 
excitation set at 473 nm and DAPI). 
 
Semiquantitative analysis of fluorescence intensity was measured BIO file for Z-stack 
images generated by confocal microscopy. The BIO file for each sample was analyzed 
using ImageJ images to calculate the intensity of fluorescence per µm2. 
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Table 2.3 Antibody dilutions for immunostaining of PIs 
Immunogen Primary antibody 
name 
 Primary 
dilution 
Secondary antibody 
name 
Secondary 
antibody 
name  
GLUT2 Rabbit polyclonal 
IgG anti-GLUT2 
1:200 Donkey anti-Rabbit 
IgG 
1:500 
Cx36 Mouse 
monoclonal anti-
connexin 36 
1:500 Goat anti-Mouse 
IgG  
1:500 
Insulin Rabbit polyclonal 
IgG anti-Isnulin 
1:100 Donkey anti-Rabbit 
polyclonal  
1:200 
Rabbit anti-
Goat IgG 
(H+L)  
  Secondary 
Antibody, Alexa 
Fluor® 568 
conjugate 
1:1000 
 
2.2.14 Western blotting  
Total protein was extracted and quantified from monolayer and PI cell pellets as described 
in Section 2.2.12. 
 
The expression of Cx36,(83) GLUT2(75) and insulin(75) were detected by using western blot 
analysis. The dilution factors for Cx36, GLUT2 and insulin were 1:1000. Protein lysates 
(50 µg) were mixed in 0.5 mL Eppendorf tube using a 5 µL of a mixture agent consisting 
of 150 µL NUPAGE®LDS sample buffer (4x) (Thermo Fisher Scientific, UK) and 7.5 
µL 2-Mercaptoethanol (Sigma-Aldrich, UK). Next, the samples were heated to 90 °C for 
15 minutes and then centrifuged for 30 seconds at 12000 rpm. The samples were loaded 
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into a 12 % SDS-PAGE gel (Generon, UK) gently to avoid the formation of bubbles. The 
gel was immersed in the tank containing 500 mL of 1x NuPAGE® MES SDS Running 
Buffer (Thermo-Fisher Scientific, UK) and the proteins were separated on a 12% 
polyacrylamide gel at 70 V for 2 hours and 30 minutes. 
 
An additional layer of filter paper was soaked in transfer buffer and placed on top of the 
gel. All air bubbles were removed after placing on the transfer apparatus. A small strip of 
PVDF membrane was soaked in methanol and transfer buffer for about 10 minutes. The 
SDS-PAGE gel was washed with cold deionized water for 10 minutes with gentle 
shaking. After that, the gel was removed and placed directly on PVDF membrane. Finally, 
another sheet of filter paper was soaked in the transfer buffer and placed at the top of the 
gel. Separated protein was transferred from gel to the PVDF membrane in a wet western 
blotting assembly as shown in Figure 2.2. 
 
Figure 2.2 Protein transferring set-up 
 
Assembly of wet type western blot proteins in gel migrates into the membrane where they 
are adsorbed and bound in semi-dry western blotting. 
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Proteins were transferred on the ice at 30 V (240 Ω) for two hours using transfer buffer 
1x Tris-glycine SDS Running buffer (Thermo-Fisher Scientific). The non-specific 
binding sites on the membrane were blocked using 5% (w/v) non-fat dried milk for 1 hour 
at room temperature with shaking. The membrane was washed four times six minutes 
each with 1x Tris Buffered Saline with Tween®20 (TBST-20x; Thermo-Fisher 
Scientific). The primary antibodies were diluted with 5% (w/v) milk solution for Insulin 
(Cell Signaling Technology UK) of a concentration 1:1000. The membranes were added 
to the membrane four times for 6 minutes each with tris buffer saline with tween 20 Tris 
Buffered Saline with Tween® 20 (TBST) (Thermo-Fisher Scientific, UK). The 
membranes were incubated with appropriate Goat anti-Mouse horseradish peroxidase 
(HRP) (Abcam, UK) for 1h at room temperature to overnight at 4°C. After washing the 
membranes three times for ten minutes, signals were visualised using the FluorChem 
system (Bio-Techne (NASDAQ, TECH). Semi-quantitative measurement for Cx36, 
GLUT2 and insulin expression using western blot was determined using Alphapheiw 
software.(142) 
 
2.2.15 Oxygen expression 
To study the cell tissue oxygenation and bioenergetics metabolism, cell permeable 
phosphorescent probes need to be inserted or mixed to enable to follow the change in this 
tissue. Some of such probes have been used recently such as a dye called Pt(II)-tetrakis 
(pentafluorophenyl) porphyrin (PtPFPP) which is impregnated with dye named poly (9,9-
diheptylfluorene) (PA2). The PA2 is non-toxic to cells, so the dye was mixed with cells 
from the day 0 before forming PIs. Phosphorescence lifetimes were measured in air-
saturated and deoxygenated (5 mg/mL KH2PO4, 5 mg/mL Na2SO3) conditions. Large size 
nanoparticles (NPs) bearing PtPFPP and PFO dyes (135 nm) were produced.  
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At day 3 and day 7 the PIs were transferred to 12-well micro-chambers (Ibidi, Germany), 
pre-coated with a mixture of collagen IV and Poly-D-lysine. Staining with compound 1 
(PA2) was achieved by adding it in regular growth medium to cells (10–20 µM), 
incubation for 16 h and washing in the medium before imaging. The 3D spheroid culture 
was generated as described in (Section 2.2 and Section 2.3). Live cells were analysed on 
widefield fluorescence Axiovert 200 (3D culture TXRed-4040 (Semrock) emission 
filters) and one-photon excited confocal Axio Examiner Z1 (subcellular localisation, 
imaging of spheroids; using 540 nm excitation, 565–605 nm emission filters) 
microscopes essentially. This work was in collaboration with Dr Ruslan Dmitriev in 
University College Cork, Ireland.   
 
2.2.16 Water contact angle measurement  
The water contact angle (CA) measurement is a determination of the wettability of 
substrate which is crucial in terms of identifying its biocompatibility. The hydrophobic 
materials show high contact angles with less wettability because of minimal spreading of 
the water droplet in comparison to hydrophilic material that displays a low contact angle 
with greater wettability as a result of spreading of the water droplet over time. To find 
out the wettability of different plastic plates which were used to generate the PIs, contact 
angle measurement was taken using the sessile drop technique. 
 
The contact angle on a flat solid could be determined from the profile of a sessile drop 
described as the angle. Measured through liquids, especially water, where a liquid 
interface meets a solid surface. It has been used to study the wettability of surfaces, 
especially after coating. The equilibrium contact angle reveals the relative strength of 
liquid, solid and vapours molecular interaction. In this study different surfaces, were used 
to examine the measurement of contact angle on them. 
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Three types of 24-well culture plate were used in this study; cell adhesive (denoted as 
TCP), suspension culture (Sarstedt, USA, old product, denoted as SOP) and suspension 
culture (Sarstedt, USA, new product, green colour code, denoted as SGP). The bottom 
surfaces of all these plates were cut as shown in Figure 2.3 and coated with different 
solutions using the same procedure described in the Section 2.2.2. 
 
Figure 2.3 The bottom surface of the plates for FTIR, protein adsorption and CA 
measurements 
 
 
All the surfaces coated were incubated in the incubator at 37 °C overnight, and the coating 
solutions were discarded. The surfaces were placed inside of the hood for two hours to 
dry and kept at 4 °C until used. 
 
A Hamilton syringe was used (as shown in Figure 2.4). 1 µL of ultrapure H2O was placed 
onto the sample in vertical distance using Attention instrument with a CCD camera. Three 
samples from each group were measured to obtain mean CA values. 
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Figure 2.4 Image illustrating contact angle set-up 
 
 
A: A microscope was connected to the CCD camera to take water droplet’s images; B: 
Hamilton syringe and sample on the sampling stage during contact angle measurement. 
 
2.2.17 Protein adsorption  
To understand the capacity of surfaces used to produce the PIs we measured the protein 
adsorption for different surfaces that were used to form the PIs. Briefly, each surface was 
coated with 100 µL of 2% (w/v) BSA and incubated at 37°C for 2 hours. The BSA was 
then removed, and 0.1% (w/v) Coomassie Brilliant Blue Dye (500 µL) was added to each 
of the material surfaces and incubated for 4 hours. The stain solution was removed, and 
the stained surfaces were observed and imaged by light microscopy. 
 
2.2.18  Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy 
A Fourier transform infrared (FT-IR) spectroscopy is widely used to determine the 
chemical structure for a sample of interest. It uses the IR light illumination due to the 
energy range of vibration and waging between chemical bonds. The FTIR allows giving 
specific information for each function group or any bonds among the chemical structure. 
Attenuated total reflectance (ATR) technique is a valuable measurement mode for 
identification of surface chemical structure and concentration of solid samples. ATR 
technique uses a crystal which produces total internal reflection, resulting in an 
evanescent wave. When a beam of infrared light is passed through the ATR crystal, the 
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resulted evanescent wave extends into the samples a few times and reaches the detector. 
It is very suitable for the analysis of a wide range of paints, coatings and reflective 
materials on surfaces (Figure 2.5).(143) 
 
Figure 2.5 Multiple reflection ATR systems 
 
 
The figure shows the path of IR radiation in the sample for ATR-FTIR measurements. 
 
A FT-IR spectrometer (Nicolet iS50, Thermo-Fisher, UK) (Figure 2.6) was used in this 
study with a diamond ATR crystal attachment. The samples were prepared in the same 
way described in section 2.2.17. FT-IR spectra were recorded over the wavenumber range 
4000-500 cm-1, co-adding of 256 scans with 4 cm-1 resolutions. 
66 
 
Figure 2.6 The photos of FT-IR spectrometers (Nicolet iS50) 
 
 
The figure shows the sample with Nicolet iS50 spectrometer used for ATR-FTIR 
measure. 
 
2.2.19 Generation and characterisation of gelatin beads 
 
Beads synthesis 
Gelatin beads were optimised using the method of Iwanaga et al.(144) Briefly, a 15% 
(w/v) of gelatin type A (Sigma-Aldrich, UK) with 5% (w/v) glucose (Sigma-Aldrich) 
was added to 5 mL deionised water and heated to 70 °C. Meanwhile, 100 mL of olive 
oil was preheated to 70 °C with a magnetic stirrer. The aqueous solution of gelatin was 
added dropwise to olive oil with stirring at 420 rpm for 10 minutes to yield a water/oil 
emulsion. The temperature of the emulsion was directly decreased to 10°C with 
continued stirring for 30 minutes. Then, 75 mL of pre-cold acetone was added to the 
emulsion solution, followed by further stirring for 1 hour. The emulsion solution was 
then centrifuged at 4200 rpm at 5°C for 6 minutes. The formed pellets were washed three 
times with acetone and centrifuged at 4200 rpm. The formed gelatin beads were washed 
three times with acetone and centrifuged at 4200 rpm for 6 minutes each time. 
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Beads separation 
The washed beads were passed through 30 µm or 40 µm sieves (PluriStrainer, 
Cambridge Bioscience Ltd, UK) and stored in acetone until use gelatin beads generated 
by different methods were imaged using an optical microscope. The sizes of beads were 
measured and analysed using ImageJ software. 
 
Beads crosslinking using gaseous phase reaction 
The gelatin beads (GBs) were crosslinked with 5% and 10% Glutaraldehyde (GA) 
(Sigma- Aldrich, UK) in the gas phase. Briefly, one mL of GA was placed in a small vial, 
the beads (30 µm and 40µm) were placed with 5 mL acetone in another vial. These vials 
were all placed in a glass petri dish, to allow for gaseous crosslinking (CL) for a period 
of 6 hours or 12 hours. Then the GBs were transferred to 2 mL Eppendorf tubes and 
washed three times with 1mL of distilled water by centrifugation at 4200 rpm for 3 
minutes. The GB was then washed once with 1x DPBS (Dulbecco’s Phosphates-Buffered 
Saline) by centrifugation at 4200 rpm for 3 minutes. Then a 1 mL of distilled water was 
mixed with the GBs, and the GBs aqueous solution was stored in an incubator at room 
temperature for maximum 7 days. 
 
Beads swelling and degradation  
The effects of crosslinking (CL) duration on the GBs swelling were assessed at high 
temperature (65°C). The GBs were crosslinked for 6 hours or 12 hours, placed in a 96-
well plate with 200 µL distilled water, and incubated at 65°C for 20 minutes. The swelling 
of GBs (40μm and 30μm) were assessed by light microscopy. The bead images were taken, 
and size analysis was undertaken through ImageJ. 
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Beads washing and sterilisation 
For sterilisation of beads, the beads were taken out from acetone and washed with 
Industrial methylated spirit 99% (IMS) three times, followed by centrifugation at 4200 
rpm and 4 °C for 6 minutes each. Then, one mL of cold deionized water was added to 
wash beads three times at 4200 rpm and 4 °C for 6 minutes each. The crosslinked beads 
were also washed 3 times with 1x DPBS saline (1x DPBS; Sigma-Aldrich, UK) by 
centrifugation at 4200 rpm and 4 °C for 6 minutes each time. 
 
2.2.20 Incorporation of beads into PI 
The incorporated of beads was performed by three different methods. In general, about 
25 GBs beads were mixed with 32,000 cells and 45 beads for 64,000 cells. The first 
method incorporating GBs into PIs was using ULA 96 well flat bottom plate. The second 
method was forming cell pellets in Eppendorf tube. Briefly, the cells were transferred into 
1.5 mL Eppendorf tube. The GBs with cells were added to the same Eppendorf tube. The 
Eppendorf tubes were centrifuged at 1000 rpm for 4 minutes. After that, all tubes were 
placed in the incubator at 37 °C and 5% CO2 for overnight. Next day, the pellet was 
transferred to suspension plate. The third method was using ULA 96 well round bottom 
plate. BRIN-BD11 cells were mixed with the beads in 300 µL of media and centrifuged 
using plate centrifuge (ALC PK 120, DJB Labcare Ltd, UK) at 900 rpm for 6 minutes.  
The plate was incubated at 37 °C and 5% CO2. The images were taken every day. 
 
2.2.21  Optimization of cytokines’ concentrations in culture media on PIs’ viability 
In order to identify the optimum concentration of each cytokine on PIs’ viability, series 
of IL-10 concentrations from 1 ng/mL to 1000 ng/mL in the culture media were assessed 
on PI’s viability. Similarly, the optimum concentration of anti-IL-1 was estimated using 
series of anti-IL-1 concentrations from 0 µg/mL/ to 10 µg/mL in culture media for PI’s 
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viability assessment. 32,000 cells/well were cultured by using ULA 96-well round bottom 
flask (Corning@Costar, USA). The plate was centrifuged for 6 minutes at 900 rpm to 
produce a single PI per well. The plate was incubated at 37C and 5% CO2 for 7 days. 
The viability of PIs in the presence of the cytokines was assessed at day 7 through using 
CCK-8 assay. 
 
2.2.22 Incorporation of a mock drug into beads  
Alexa Fluor® 568 conjugated antibodies, as a mock drug, was used to test the 
incorporation technique and drug release form GBs. The gelatin beads (GBs) 40 µm were 
crosslinked with 5% (v/v) GA for 6 hours. The GBs were transferred into 1.5 mL 
Eppendorf tubes, and they were washed 3 times with acetone, then three times with 
deionized water and 3 times with PBS at 4000 rpm for 5 minutes each. 
 
The GBs were covered with aluminium foil and freeze dried for 2 hours using Benchtop 
freeze dryer. Dried gelatin beads were sterilised using UV radiation for 90 seconds. The 
GBs were incorporated with 10 µL of different concentrations of Alexa Fluor® 568 
conjugated antibody (Thermo-Fisher). The concentrations were 0 µg/mL, 0.56 µg/mL, 
1.25 µg/mL, 2.5 µg/mL, 5 µg/mL, 10 µg/mL. After the antibody was absorbed into the 
beads completely, the release of the antibody from the gelatin beads was measured by 
incubating the beads in PBS at 37C. 100 µL of the solution were taken at various 
sampling time points, and fluorescence was measured at excitation/emission 565/625 
from day 1 to day 7.  
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2.2.23 Incorporation of cytokines into beads  
To load cytokines into GBs, the protocols of Nakase et al.(145) have been adapted and 
modified. The optimum concentration of each cytokine was determined by investigation 
of the improvement of the PIs’ viability using CCK-8. The 100 ng/mL of IL-10 and 5 
µg/mL of the anti-IL-1 were found optimal concentrations for the PIs respectively. The 
10 µl of 100 ng/mL of IL-10 was incorporated into 25-50 GBs (for single PI) which had 
been freeze dried for two hours. The same procedure was applied to anti-IL-1: 10 µl of 
5 µg/mL of anti-IL-1 were incorporated into GBs (25-50 GBs/PI) which had freeze dried 
for two hours.  
 
The BRIN BD-11 cells were placed into Ultra-low attachment 96-well plate round bottom 
(Corning@Costar, USA) with the beads incorporated with 100 ng/mL IL-10 or 5 µg/mL 
anti-IL-1. Two types of cell densities in PIs were used in this experiment. One was 
32,000 cells/well and the second was 64,000 cells/well. Following 300 µL media of cells 
and GBs were mixed and the plate was shaken using a plate shaker at 900 RPM for 6 
minutes. 
 
2.2.24 Assessment of drugs released 
The release of incorporated mock drug from GBs was measured due to their fluorescence. 
Briefly, 100 µL of the culture media from each concentrate was taken and tested using 
the plate reader. The fluorescence intensity was measured at excitation 565 nm. 
 
IL-10 concentration was measured using ELISA assay (PeproTech, USA). Standard serial 
dilutions in triplicate were loaded into an overnight pre-coated surface with a capture 
antibody specific to IL-10 and blocked for 1 hour by blocking buffer, followed by 2 hours 
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incubation with a diluted detection antibody mixture and 30 minutes with diluted Avidin-
HRP. Each step was accompanied by discarding the contents forcibly and four times of 
washing with diluted detergent buffer. Finally, an enzymatic reaction initiated by addition 
of an ABTS-substrate (2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)) 
(Sigma.Aldric) leading to bluish-green colour development within 5-15 minutes during 
which a visible signal was detected at 405 nm via plate reader. 
 
2.2.25 Statistical analysis 
ImageJ software version 1.4.3.67 was used for measuring the diameter of PIs. The 
diameters of fifteen PIs were counted to obtain the mean value. Comparisons between 
groups were performed using unpaired Student’s t-test. Different comparisons of mean 
values were analysed using GraphPad Prism 7 with t-test and one-way ANOVA with 
multiple comparisons. P-values were considered as a significant as compared to control 
(P <0.05 - P<0.0001). 
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3 Chapter 3 Development of new techniques to enhance Pseudoislets 
biofunction 
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3.1 Introduction 
The islets of Langerhans are multicellular aggregates within the pancreas containing beta 
cells that sense changes in the blood glucose level and respond by secreting insulin. The 
cells within the islets communicate with each other through gap junctions. The 3D 
structure of the islets is crucial for their metabolic functions.(28,146) Artificial 
reconstruction of isolated beta cells into islets of Langerhans through 3D cell aggregation 
has led to the generation of Pseudoislets (PIs), which can produce insulin in a 
physiologically responsive manner.(75) 
 
There are many strategies to generate spherical aggregates from dissociated cells of 
primary tissues or differentiated stem cells. Hanging in drop culture(75) and suspension 
culture(145) have been widely used to generate cell aggregates. However, the aggregate 
size can be difficult to control using these methods.  Another promising technique, 
microwell culture, has been used to generate size-controllable PIs from embryonic stem 
cells.(148–150) GSIS was greater when pancreatic beta cells were configured as 3D cell 
aggregates, similar in size and appearance to pancreatic islets.(85,151) 
 
The simplest method used to promote the formation of PIs is to grow the beta cells in 
suspension. The method causes the beta cells to attach to each other rather than the surface 
of the culture container due to the non-adhesive property of the surface. Many cell types 
differentiate and lose their normal phenotype when grown under 2D cell culture 
conditions.(75) Suspension culture prevents this problem, thereby helping cells to maintain 
their function. Some studies have shown that beta cells display different morphologies 
based on the surface properties of the materials in which they are cultured.(83) Beta cells 
cultured in a low attachment microenvironment formed PIs with an islet-like structure.(75) 
The substrates commonly used to generate PIs by suspension culture are bacterial Petri 
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dishes which form small PIs,(83) and ultra-low attachment (ULA) culture plates in which 
larger PIs are usually formed.(152) The larger sized PIs formed on the ultra-low attachment 
plates displayed an improved ability to secrete insulin, but they suffered from central 
necrosis after 7 days of culturing.(75,153) Yang and colleagues have developed other surface 
treatments for the formation of PIs and found that the treatment of the surface with 
collagen, Lipidure and type IV collagen has an impact on PIs size, viability and insulin 
secretion.(83) They claimed that the PIs formed on the Lipidture surface had the best 
viability and insulin secretion.(83) 
 
It is a huge challenge to maintain PI functionality including insulin secretion, gap junction 
communication, cell-cell communication and viability. PI size links to cell viability and 
sensitivity to glucose challenge.(83,95,154) It is already known that ULA culture plate leads 
to heterogeneous sizes of PIs. Thus, it is desirable to develop a material coating system 
which changes the cell attachment capacity of cell culture plates, to allow the study of the 
relationship between the physical properties of PIs (size and cell packing density) and 
their function. The end goal is to characterise better substrates, which could generate a 
large number of PIs of homogenous sizes and high viability. 
 
3.2 Aim 
This study aimed to develop two new techniques to control PIs’ physical properties and 
improve their viability. The first technique was to develop a series of coating solutions 
consisting of a mixture of gelatin and Pluronic F127 that would be used for suspension 
cultures. This would allow determination of the effect of the chemical properties of the 
substrate on the size of cell aggregates. The chemical and physical properties of the 
coating surfaces were characterised in this chapter and formed the foundation to interpret 
the biological performance of PIs formed on these surfaces (Chapter 4). The second 
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technique involved the production of gelatin beads with a suitable size enabling swelling 
and incorporating into PIs. The stability, physical properties (size and shape) and the 
capacity to of the beads to carry drugs were investigated, which provided evidence for 
the biological performance on the modified PIs as detailed in Chapter 5.  
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3.3 Materials and Methods 
 
3.3.1 Materials  
Chemicals, cell culture plate types and reagent used in this chapter were listed in chapter 
2 Section 2.1. 
 
3.3.2 Generation of coating solution  
The coating of suspension plates was described in Chapter 2 Section 2.2.2. 
 
3.3.3 Generation of gelatin bead  
The generation of GBs from gelatin solution was outlined in Chapter 2 Section 2.2.19. 
 
3.3.4 Crosslinking of gelatin beads 
The GBs were separated into sizes (30 µm and 40 µm) and crosslinked for 6 and 12 hours 
using gaseous reaction as described in Chapter 2 Section 2.2.19. 
 
3.3.5 Characterisation of gelatin beads  
The gelatin beads were characterised as outlined in Chapter 2 Section 2.2.19 
 
3.3.6 Water contact angle measurement  
The contact angle measurement for different type surfaces was outlined in Chapter 2 
Section 2.2.16. 
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3.3.7 Protein adsorption 
Protein adsorption on different culture surfaces coated with different coating solutions 
was described in Chapter 2 Section 2.2.17. 
 
3.3.8 Attenuated total reflectance 
A Fourier transform infrared (FT-IR) spectroscopy used for measurement of different 
types of surface chemistry was described in Chapter 2 Section 2.2.18. 
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3.4 Results 
 
3.4.1 Characterisation of the effects of coating solutions on the substrate’s 
chemical properties 
Five coating solutions (F127, gelatin type A and three mixtures of F127 and gelatin, (98%, 
95%, 90% of gelatin type A) have been used to coat three types of cell culture plates. 
Suspension culture plate 1 (old product (SOP)); suspension culture plate 2 (green product 
(SGP)); and tissue culture plate 3 (TCP). We hypothesised that the variation of F127 
percentage in the coating solutions would change the chemical properties of cell culture 
plates and that this change is dependent on the substrate chemistry of the original plates. 
Figure 3.1 summarises the coating groups. Three characterisation techniques have been 
used to demonstrate the changes: ATR-FTIR spectroscopy has been used to identify 
changes in chemical properties; contact angle measurement revealed any changes in 
hydrophilicity; while Brilliant blue staining displayed the protein adsorption capacity of 
the surface. 
 
3.4.1.1 Attenuated total reflection-Fourier transform infrared spectroscopy (ATR-
FTI study 
ATR-FTIR spectroscopy is a method used to determine the molecular structure and 
chemical composition of samples.(155) Our initial investigations examined the change of 
chemical properties of the culture substrates after coating by ATR-FTIR spectroscopy. 
The spectra shown in the following sections are the representative data from each group. 
Each spectrum was collected through 256 scans and experiments were repeated 3-5 times 
by duplicated samples.   
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Figure 3.1 The experimental variables used for coating plates 
 
 
The design was used for generating different types of tissue culture plates through coating with gelatin A solution and F127 solution and mixture of 
both solutions. The concentrations of F127/gelatin in the mixtures are 100%/0%, 10%/90%, 5%/95%, 2%/98% and 0%/100% 
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3.4.1.1.1 Effect of coating solution on SOP plate 
 
3.4.1.1.1.1 Uncoated SOP surface 
Figure 3.2 is the ATR-FTIR spectrum of the uncoated suspension surfaces (SOP). Bands 
of the IR spectrum showed typical groups of polystyrene substance.(156) The peak at 3081 
cm-1 - 3001 cm-1 region was assigned to C-H aromatic stretching; 2923 cm-1 and 2850 
cm-1 bands were due to CH2 asymmetric and symmetric tension; the bands in 1601 cm
-1  
and 1493 cm-1 were associated with arenes C=C stretching.(156) The IR band at 1069 cm-1 
was for flexion C-H in the plane.(156) Another sharp band at 680 cm-1 was for arenes C-H 
bending. There was a weak band around 3400 cm-1, which could be the result of special 
surface treatment for the suspension plate. 
 
Figure 3.2 The ATR-FTIR spectrum of uncoated SOP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate.   
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3.4.1.1.1.2 SOP surface coated with F127 
Coating the suspension surface with F127 solution resulted in a dramatic change of the 
spectrum (Figure 3.3). The decoration of F127 on the polystyrene substrate presented 
medium strength bands at 2980-2880 cm-1 which were due to CH2 and CH3 stretching. 
Another weak band at 1454 cm−1 was commonly related to methyl, methylene groups in 
PEO and PPO blockers. Furthermore, the strong band at 1100 cm-1 was C-O stretching. It 
was noticed that the characteristic bands of the uncoated plate at 3081 cm-1-3001 cm-1 
were not clear. These results demonstrate that the PEO and PPO blockers of F127 
substance have covered the SOP surface. 
 
Figure 3.3 The ATR-FTIR spectrum of F127coated SOP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. 
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3.4.1.1.1.3 SOP surface coated with 100% gelatin 
The SOP plate coated with 100% gelatin showed a characteristic protein spectrum (Figure 
3.4). There were five individual band regions. The strong bands at 3200-3500 cm -1 were 
for amide A, O-H and N-H stretching.(158,159) The bands at 2900 cm-1 were for CH2 and 
CH3 stretching.
(158,159) The strong band at 1650 cm-1 was for Amide I (C=O stretching), 
1500 cm-1 for amide II (NH bending), and the weak band (Amide III) at 1229 cm-1 for 
NH stretching.(160,161) It was also noticed that the characteristic bands of the uncoated 
plate at 3081-3001 cm-1 were not clear. These results again demonstrate that the gelatin 
has covered the SOP surface. 
 
Figure 3.4 The ATR-FTIR spectrum of 100% gelatin coated SOP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate.  
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3.4.1.1.1.4 SOP surface coated with 98% gelatin 
The ATR-FTIR spectrum for the surface coated with 98% gelatin is displayed in Figure 
3.5. Overall, the spectrum was very similar to that of the gelatin coated spectrum (Figure 
3.4). The characteristic and strong bands of amide A, I and II at 3200-3500 cm -1,
 1650 
cm-1 and 1547 cm-1, respectively, were observed. However, there were three additional 
peaks appearing more clearly than with the 100% gelatin coated surface: a peak at 3100-
3000 cm-1 region, a peak at 2900 cm-1 1400 cm-1 region, and 1150 cm-1 region which may 
result from the F127 component of the coating solution. 
 
Figure 3.5 The ATR-FTIR spectrum of 98% gelatin coated SOP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. The circled peaks refer to methyl and 
methylene groups stretching at 3000-2950 cm-1 and C=O stretching at 1100 cm-1 
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3.4.1.1.1.5 SOP surface coated with 95% gelatin 
The ATR-FTIR spectrum of surface coated with 95% gelatin (Figure 3.6) demonstrated 
further differences between that of 98% gelatin coating, pure gelatin coating and F127 
coating. Again, the spectrum was very similar to the 100% gelatin coated spectrum 
(Figure 3.4). The characteristic and strong bands of amide A, I and II at 3200-3500 cm-1,
 
1650 cm-1 and 1547 cm-1 respectively were again clearly observed. However, the intensity 
of the three peaks at 3100 cm-1 regions, at 2900 cm-1 and 1400 cm-1 regions and 1150 
cm-1 became stronger and more obvious than in the spectrum of surfaces coated with 98% 
gelatin. This is consistent with the increase of the F127 component in the coating mixture 
solution. 
 
Figure 3.6 The ATR-FTIR spectrum of 95% gelatin coated SOP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. The circled peaks refer to methyl and 
methylene groups stretching at 3000-2950 cm-1 and C=O stretching at 1100 cm-1 
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3.4.1.1.1.6 SOP surface coated with 90% gelatin  
The coated SOP surface had quite a different spectrum when a solution of 90% gelatin 
and 10% F127 was applied (Figure 3.7), First, the intensity ratio of amide A to amide I 
and II reduced in comparison to the spectrum of the surface coated with a 100% gelatin 
solution. Secondly, the intensity of the three new peaks: the peak at 2950 cm-1 region, the 
peak at 2900 cm-1 region, 1400 cm-1 region and 1150 cm-1 became stronger and more 
obvious than the spectrum of 98% and 95% gelatin coated surfaces (Figure 3.6). The 
strong peak at 1100 cm-1 was from C=O stretching of PPO or PPE group, indicating the 
strong F127 component is appearing on the surface. 
 
Figure 3.7 The ATR-FTIR spectrum of 90% gelatin coated SOP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. The circled peaks refer to methyl and 
methylene groups stretching at 3000-2950 cm-1 and C=O stretching at 1100 cm-1 
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3.4.1.1.2 Effect of coating solution on TCP plate 
 
3.4.1.1.2.1 Uncoated TCP surface 
For adhesive tissue culture plate (TCP), ATR-FTIR spectra were also found to be 
dependent on the coating solution used. Bands of uncoated TCPs pronounced typical 
groups in polystyrene substance.(156) Peaks were observed at 3100-2900 cm-1 which were 
assigned to C-H aromatic stretching (alkenyl C-H stretching), and 2850 cm-1 bands were 
due to CH2 asymmetric and symmetric tension. The bands at 1601 cm
-1  and 1493 cm-1 
were associated with arenes C=C stretching.(157) while another sharp band at 680 cm-1 
was for arenes C-H bending (Figure 3.8). 
 
Figure 3.8 The ATR-FTIR spectrum of uncoated TCP 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate.   
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3.4.1.1.2.2 TCP surface coated with F127  
After coating the adhesive surface with the F127 solution, peaks observed at 3010-2900 
cm-1 were due to CH2 and CH3 stretching, and peaks observed at 1640 cm
-1 resulting from 
the stretching vibration of C=O stretching. Another band was observed at 1500 cm−1, 
which is commonly related to methyl, methylene groups in PEO and PPO blocker. Also, 
the strong band at 1150 cm-1 was C=O stretching as a result of the PPO blocker. A sharp 
peak in the 1389 cm-1 region resulted from C-H bending, and the weak absorbance at 680 
cm-1 was for arenes C-H bending, which related to the surface of polystyrene (Figure 3.9). 
The results demonstrated that the PEO and PPO blockers in F127 had coated the TCP 
surface. 
 
Figure 3.9 The ATR-FTIR spectrum of F127 coated TCP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. The circled peak refers to the peak of 
C=O stretching at 1150 cm-1.   
88 
 
3.4.1.1.2.3 TCP surface coated with 100% gelatin 
The TCP surface coated with 100% gelatin showed a characteristic protein spectrum 
(Figure 3.10). There were five individual band regions. The strong bands at 3500-3200 
cm -1 reflected amide A (N-H stretching); the second band at 2900 cm-1 was for CH2 and 
CH3 stretching. The third sharp band at 1650 cm
-1 resulted from Amide I, with the fourth 
band at 1547 cm-1 for amide II, and the fifth band at 1229 cm-1 for N-H stretching. It was 
also shown that the characteristic bands of the uncoated plate at 3081-3001 cm-1 and 
1600-1400 cm-1 were largely absent. These results demonstrate that the gelatin has 
covered the TCP surface (Figure 3.10). 
 
Figure 3.10 The ATR-FTIR spectrum of 100% gelatin coated TCP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. The circled peak refers to the peak of 
C=O stretching at 1150 cm-1. 
 
3.4.1.1.2.4 TCP surface coated with 98% gelatin 
ATR-FTIR spectrum for the TCP surface coated with 98% gelatin (Figure 3.11) exhibited 
similarity to the spectrum of TCPs coated with 100% gelatin coating (Figure 3.10). 
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However, the intensity of the bands at 3200-3500 cm -1,
 1650 cm-1 and 1547 cm-1 
representing amide A, I and II(158,159) respectively, were less pronounced in the spectrum 
of TCPs coated with 100% gelatin. Furthermore, the peaks at 680-860 cm -1 were for 
arenes C-H bending for polystyrene appeared at low intensity to indicated the surface is 
likely to be coated with gelatin only and poorly absorbed F127 except there was a weak 
band at region 1150 cm-1 for C=O stretching in PPO. (160,161) 
 
Figure 3.11 The ATR-FTIR spectrum of 98% gelatin coated TCP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. The circled peak refers to the peak of 
C=O stretching at 1150 cm-1. 
 
3.4.1.1.2.5 TCP surface coated with 95% gelatin 
The ATR-FTIR spectrum for TCP surface coated with 95% gelatin (Figure 3.12) 
displayed similarity to the spectrum of 98% gelatin coating. However, the 
characterisation and spectrum of amide A, I and II at 3500-3200 cm -1,
 1650 cm-1 and 1547 
cm-1, respectively, were slightly decreased when compared with those generated by a 
coating of 98% gelatin (Figure 3.11). Furthermore, the region at 1100 cm -1  was more 
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intense than in 98%, which could relate to C-O-C stretching in F127.(162-164) Overall, the 
ATR-FTIR results suggested that the TCP surface was coated with gelatin. 
 
Figure 3.12 The ATR-FTIR spectrum of 95% gelatin coated TCP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. The circled peak refers to the peak of 
C=O stretching at 1150 cm-1. 
 
3.4.1.1.2.6 TCP surface coated with 90% gelatin 
The ATR-FTIR spectrum of TCPs following coating with a solution of 90% gelatin is 
shown in Figure 3.13 and was largely comparable to that of TCPs coated with a 95% 
gelatin solution. However, the spectrum at 3500-3200 cm-1 for amide A, the region at 
1650 cm-1 for amide I and the region at 1550 cm-1 for amide II were slightly less 
pronounced as the gelatin concentration was reduced. The increase in the percentage of 
F127 resulted in unclear spectrums for PEO or PPO. 
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Figure 3.13 The ATR-FTIR spectrum of 90% gelatin coated TCP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. The circled peak refers to the peak of 
C=O stretching at 1150 cm-1. 
 
3.4.1.1.3 Effect of coating solution on SGP surface 
 
3.4.1.1.3.1 Uncoated SGP surface  
The ATR-FTIR spectra for SGP also varied according to the type of coatings but were 
most closely related to the spectra of TCPs as shown in Figure 3.8. Peaks at 3081 cm-1 - 
3001 cm-1 were assigned to C-H aromatic stretching; 2923 cm-1 and 2850 cm-1 bands were 
due to CH2 asymmetric and symmetric tension; the bands in 1600-1400 cm
-1 were 
associated with arenes C=C stretch. Another sharp band at 680 cm-1 was for arenes C-H 
bending. There was a weak band around 3320 cm-1, which could be the result of special 
surface treatment for the suspension plate (Figure 3.14). 
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Figure 3.14 The ATR-FTIR spectrum of uncoated SGP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate.  
 
3.4.1.1.3.2 SGP surface coated with F127  
After coating the SGP surface with the F127 solution, it was seen that a clear change in 
the spectrum had been formed (Figure 3.15). The decoration of the F127 on the 
polystyrene peaks presented medium strength bands at 2980--2880 cm-1 which were due 
to CH2 and CH3 stretching. Another weak band at 1454 cm
−1 was commonly related to 
methyl and methylene groups in PEO, PPO blockers. Furthermore, the strong band at 
1100 cm-1 was C=O stretching. It was noticed that the characteristic bands of the uncoated 
plate at 3081-3001 cm-1 and 1601 and 1400 cm-1   for C=O stretching did not show clearly. 
These results proved that the PEO and PPO blockers have covered on the SGP surface 
(Figure 3.15). 
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Figure 3.15 The ATR-FTIR spectrum of F127 coated SGP surface 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate.  
 
3.4.1.1.3.3 SGP surface coated with 100% gelatin  
Gelatin showed a characteristic protein ATR-FTIR spectrum (Figure 3.16). Similarly. 
The spectrums of gelatin-coating on the SGP surface displayed five individual band 
regions. The strong bands at 3500-3200 cm -1 were for amide A, O-H and N-H 
stretching;(158,159) the band at 2900 cm-1 was for CH2 and CH3 stretching. The strong band 
at 1650 cm-1 was for Amide I, 1547 cm-1 for amide II, C=O stretching and the band at 
1115 cm-1 for stretching C=O.(160,162) It was also observed that the characteristic bands of 
the uncoated plate at 3081-3001 cm-1 and 1600-1400 cm-1 were not observed. These 
results demonstrate that the gelatin has covered the SGP surface. (Figure 3.16). 
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Figure 3.16 The ATR-FTIR spectrum of 100% gelatin coated SGP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate.  
 
3.4.1.1.3.4 SGP surface coated with 98% gelatin  
ATR-FTIR spectrum for SGP coated with 98% gelatin solution was shown in Figure 3.17. 
In general, the spectrums were very similar to 100% gelatin coating (Figure 3.16). What 
it peaked at 3329 cm-1 was for Amine A, N-H stretching and O-H stretching. Also, 
pronounced a peak at 1639 cm-1 was for Amide I, C=O stretching, 1534 cm-1 for Amide 
II, N-H, and C-H vibration (Figure 3.17).  
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Figure 3.17 The ATR-FTIR spectrum of 98% gelatin coated SGP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. 
 
3.4.1.1.3.5 SGP surface coated with 95% gelatin 
The spectrum of surface coating with 95% gelatin (Figure 3.18) confirmed the additional 
difference between that of 98% gelatin coating, pure gelatin coating and F127 coating. 
Once more, the spectrum was very similar to gelatin coated spectrum. The characteristic 
and strong bands of amide A, I and II at 3200-3500 cm -1,
 1650 cm-1 and 1547 cm-1, 
respectively, were presented clearly. However, the intensity of the three new peaks: a 
shoulder peak at 3100 cm-1 regions, a small peak at 2900 cm-1 region and 1400 cm-1 was 
reduced on the surface.  
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Figure 3.18 The ATR-FTIR spectrum of 95% gelatin coated SGP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. 
 
3.4.1.1.3.6 SGP surface coated with 90% gelatin  
When F127 content increased to 10% in the coating mixture, i.e. a mixing solution with 
90% gelatin and 10% F127, the coated SGP surface had quite a different spectrum than 
the surfaces with other coating solutions. First, the intensity ratio of amide A to aimed I 
and II reduced in comparison to pure gelatin coated sample. Secondly, the intensity of the 
three new peaks: a shoulder peak at 3100 cm-1 regions, a small peak at 2900 cm-1 region 
and 1400 cm-1 became stronger and more obviously than the spectrum in 95% gelatin 
coated surface (Figure 3.19).  
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Figure 3.19 The ATR-FTIR spectrum of 90% gelatin coated SGP surface 
 
 
ATR-FTIR spectrum shows the characteristic peaks. Data are presented as 4-5 
independent experiments conducted in duplicate. 
 
3.4.1.2 Combinational analysis of the chemical properties of TCP, SOP and SGP 
plate surfaces  
In order to find out the mechanisms of the coating effect on the properties of the surfaces 
(SOP, SGP and TCP), a combinational analysis of their FTIR spectra was undertaken. 
Figure 3.20 shows the ATR-FTIR spectra of uncoated surfaces of culture plates. The 
characteristic polystyrene spectrum was displayed for the three plates.(156) Compared with 
other surfaces (SGP and TCP), the aromatic C=C bending at 1700-1500 cm-1 was more 
intensity for TCP comparing to SGP. Furthermore, TCPs showed an increase in the 
intensity around 1150 cm-1, which is flexion C-H in the plan, than in SOP. This did not 
appear in SGP. There was also a shoulder region around 3500-3200 cm-1 in TCP which 
did not appear clearly on other surfaces. SO, different surfaces, even uncoated, showed 
significant variation in their ATR-FTIR spectrum (Figure 3.20). 
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Figure 3.20 Comparison of ATR-FTIR spectra for uncoated surfaces (SOP, SGP 
and TCP) 
 
The arrows refer to amine A, N-H stretching and O-H stretching at 3500-3200 cm-1 and 
the aromatic C=C bending at 1700-1500 cm-1. 
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3.4.1.3 Combinational analysis of single component coating solutions on SOP, TCP 
and SGP plate surfaces 
As shown in Figure 3.21 it was seen that coating withF127 had displayed various 
absorbance intensity values for the three surfaces. The absorbance intensity ratio between 
the peak at 3060- 2900 cm-1 which were for CH2 and CH3 stretching, to peak at 1640 cm
-
1 for to C=O stretching in PEO and PPO was used for the comparison. This ratio was 2.2 
for SOP surface, and the ratio was decreased slightly to 2.15 for another suspension plate 
(SGP), whereas, the ratio in TCP surface was declined to 1.5 (Table 3.1), indicating that 
the original surface property played an essential role to different IR spectra (Figure 3.21). 
This might result from the quantity of PEO-PPO-PEO molecules on the surfaces that 
might lead to different hydrophobicity on each surface. These results were close the 
previous studies.(165,166) The difference in the ATR-FTIR spectra of each type substrates 
coating with F127 was consistent with the trend of their CA value and protein staining. 
The CA values showed that the order of SOP < SGP < TCP after F127 coating. This might 
be because of higher PEO blocker adsorbed on TCP (Figure 3.24 and Figure 3.25).   
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Figure 3.21 Comparison of ATR-FTIR spectra for surfaces (SOP, SGP and TCP) 
coated with F127 
 
 
The arrows refer to bands of CH2 and CH3 stretching groups at 3000-2800 cm 
-1 and for 
C=O stretching at 1100 cm -1. 
 
Coating with 100% gelatin expressed different ATR-FTIR spectra for the surface. The 
major modification in the surface was shown in the absorbance intensity ratio of 3200-
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2900 cm -1 for amide A and O-H and N-H stretching, to 1650 cm-1 for C=O stretching. 
The ratio was 1.5, 2.2 and 1.5 for SOP, SGP and TCP respectively (Figure 3.22 and Table 
3.1). 
 
Figure 3.22 Comparison of ATR-FTIR spectra for surfaces (SOP, SGP and TCP) 
coated with 100% gelatin 
 
 
The arrows refer to bands of Amid A groups at 3200-2900 cm -1 and for C=O at 1650 cm 
-1. 
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Table 3.1 ATR-FTIR absorbance band ratio for SOP, SGP, and TCP surfaces 
coated with F127 and 100% gelatin 
ATR-FTIR 
absorbance 
ratio 
SOP SGP TCP 
F127 100% 
gelatin 
F127 100% 
gelatin 
F127 100% 
gelatin 
(3060- 2900 
cm-1) / 1640 
cm-1 
2.2 1.5 2.15 2.2 1.5 1.5 
 
3.4.1.4 The surface property changes depended on F127 percentage in the coating 
solution and the type of culture plates. 
After coating of surfaces with a mixture of gelatin solution and F127 solution, the surfaces 
showed different ATR-FTIR spectrums depending on surface types as well as coating 
solution type (Figure 3.23). Two ratios of absorbance bands; 3500-3200 cm-1 for amide 
A stretching to absorbance 3000-2900 cm-1 for methyl stretching (Ratio 1), 1700-1600 
cm-1 for amide I, II to absorbance 1200-1100 cm-1 for C-O, C-C (Ratio 2) were calculated 
from the spectra (Table 3.2). SOP surface was very sensitive to the percentage change of 
mixture components since the ratio 1 was 3 at 98% gelatin, decreased slightly to 1.25 at 
95% gelatin and became 0.97 for 90% gelatin, indicating that the amount of gelatin was 
less on the surface compared to F127 coating. 
 
While this phenomenon was different for TCP coating; the ratio 1 for the three coating 
solution was nearly the same, indicating that the surface (TCP) was covered with gelatin, 
and the percentage change of F127 in coating solution did not give a clear difference in 
the ATR results. Whereas, the SGP surface showed the similar trend of SOP surface 
which means that this surface also was sensitive to the difference in the coating mixture. 
 
On the other hand, the ratio 2 produced a variety of information. The ratio 2 for SOP were 
9, 3 and 0.04 for 98%, 95% and 98% respectively, indicating that PEO and PPO 
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molecules dominated the surface after 90% gelatin coating than other types. While, this 
ratio changed marginally for TCP (98%, 95%, 90% gelatin), illustrating that the PEO and 
PPO blockers had covered with gelatin. While the ratio 2 for SGP surface showed a large 
response to the coated mixture, declining from 9 in 98% coated to 3.7 but still higher than 
SOP, which was 0.97 (Figure 3.33 and Table 3.2). These data indicate that coated surfaces 
with F127, gelatin and mixtures of them led to different PEO or PPO or gelatin groups 
on the surface coated, which changed their hydrophobicity. The hydrophobicity and 
quantity of gelatin on the coating surface determined CA value and protein 
adsorption.(Figure 3.24 and Figure 3.25). 
 
Figure 3.23 Comparison of ATR-FTIR spectra for SOP, SGP and TCP coated 
with  F127 and 100% gelatin solutions in different ratios 
 
 
Arrows refer to ATR-FTIR absorbance selected for measurement of ratios. 
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Table 3.2 ATR-FTIR absorbance band ratio for SOP, SGP, and TCP surfaces 
coated with a mixture of F127 and gelatin solution at different ratios 
 ATR-FTIR 
absorbance 
ratio 
SOP SGP TCP 
98% 95% 90% 98% 95% 90% 98% 95% 90% 
(Ratio 1 3500-
3200)/(3000-
2900)Ratio 1 
3 1.25 0.97 2.4 1.6 1 2 2.1 2.1 
(Ratio 2 (1700-
1600)/(1200-
1100) 
9 3 0.04 9 5.3 3.7 1.8 2.6 2.2 
 
3.4.2 Effect of coating solution on contact angle measurements  
Water contact angles of all surfaces were measured by the spreading degree of 1 µl water 
drop using a Hamilton Syringe. It was demonstrated that the contact angles (CA) of 
uncoated surfaces of the three types, TCP, SOP and SGP, were higher than all coated 
surfaces as shown in Figure 3.24, and 3.25. The highest CA was observed on the SOP 
surface, followed by the SGP surface. The lowest CA was observed on the TCP surface. 
 
When coating with F127, gelatin and the mixture of the two components, the CA of the 
surfaces changed considerably and appeared to be dependent on the surface property of 
the original surface. 
 
The CA values decreased dramatically (P < 0.0001) on surfaces coated with F127, 90% 
gelatin, 95% gelatin, 98% gelatin and 100% gelatin when compared with those of 
uncoated plates. However, the differences between the groups were not significant. The 
general order of CA on TCPs was as follows: Non-coated >> 100% gelatin > 98% gelatin 
> 95% gelatin > 90% gelatin and >100% F127. 100% gelatin coated showed the highest 
CA value in the TCP surfaces (Figure 3.24, and 3.25). 
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The coating reduced the CA on suspension surfaces, and significantly on SOP. While 
coating the surface with F127 showed the lowest reduction in CA. While coating with 
100% gelatin resulted in a relatively large CA. Accordingly, the CA of the surface 
coatings was proportional to the percentage of F127. The order of CA in SOPs was as 
follows; 90% gelatin < 95% gelatin < 98% gelatin and <100% gelatin as shown in Figure 
3.24, Figure 3.25. The CA in SGPs followed the same pattern (Figure 3.24, and Figure 
3.25). 
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Figure 3.24 Water contact angle images for the substrates, TCP, SOP and SGP, coated with gelatin, F127and the mixture of the two 
components (90%, 95%, 98% of gelatin) 
 
 
The representative images of water contact angles on the surfaces of three type 24 well plates, TCP, SOP, SGP coating with different solutions, N=6. 
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Figure 3.25 Quantitative presentation of water contact angle of cell culture plates, 
TCP, SOP and SGP, coated with gelatin, F127 and the mixtures in comparison to 
uncoated surface 
 
 
The effect of different coating types on three type surfaces of 24 well plates, TCP, SOP, 
SGP, on the contact angle value. Data are presented as mean ± SD from 6 independent 
experiments conducted in triplicate. **** < 0.0001 compared with uncoated as control. 
 
3.4.3 Effect of coating solution on protein adsorption capacity 
Protein adsorption on solid substrates depends on the properties of both the proteins and 
the substrate. Polarity, charge, surface energy, chemistry and morphology of protein are 
crucial for the interaction between surfaces and protein and the subsequent protein 
adsorption on it.(167) The adsorbed proteins on a surface can be visualized by Brilliant 
blue staining. 
 
TCP surfaces showed more protein staining when compared with other surfaces 
regardless of coating type. It was observed that TCP surfaces coated with 100% gelatin 
displayed the highest staining and the surfaces coated with F127 showed the lowest 
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protein adsorption. Moreover, the staining intensity order of TCPs coated with a mixture 
of gelatin, and F127 was 90% <95% < 98 (Figure 3.26).  
 
Protein adsorption on SOP surfaces was low for all groups. The uncoated surface and 
100% gelatin surface showed the highest protein adsorption, although this was still poorly 
detected F127 coating showed no protein staining. The staining intensity order of SOPs 
coated with a mixture of gelatin, and F127 was 90% <95% < 98 (Figure 3.26). SGP data 
following a similar trend to that of SOP data (Figure 3.26).  
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Figure 3.26 The effect of surface coating on protein adsorption 
 
 
Protein adsorption was determined by staining with a Brilliant blue dye. Data were assessed by light microscopy using a 20X objective. Scale bars = 
200 µm  
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3.4.4 Assessment of the effect of crosslinking reaction conditions and particle size 
on the stability of gelatin beads 
 
3.4.4.1 The effect of crosslinking conditions on the concentration of 40 µm gelatin 
beads 
 
Crosslinking with 5% glutaraldehyde  
To prepare gelatin beads (GBs) of controlled size, 5% Glutaraldehyde (GA) was tested .d 
for crosslinking the protein.(168) GBs with a particle size < 40 µm were crosslinked with 
5% GA using a vapour approach. The crosslinking reaction time varied from 1, 3, 6 and 
12 hours denoted as, 1-hCL, 3-hCL. 6–hCL and 12-hCL, respectively. Figure 3.27A 
displays images of the crosslinked GBs incubating at 37°C for different periods. Light 
microscopy images showed that the CL time was crucial for swelling of the beads. GBs 
crosslinked for 1 hour and 3 hours showed more swelling during incubation, and they 
were degraded after 7 days’ incubation (Figure 3.27A). GBs crosslinked with 5% GA for 
6-hCL lasted until day 7 and displayed evidence of swelling (Figure 3.27A, B). However, 
crosslinking of GBs with 5% GA for 12 hours led to less/or non-swollen GBs. 
 
Figure 3.27B is the quantitive presentation of the GBs size change with the incubation 
experiments at different reaction times (1-hCL, 3-hCL, 6–hCL and 12–hCL) with 5% GA 
by using ImageJ to determine the change in the size of GBs after incubation with PBS. 
The 40 µm GBs showed a significant increase in swelling (P<0.05-P<0.0001) following 
in for 1-hCL during incubation from day 1 incubation (day 1-IN) to day 7. The 40 µm 
GBs at 1 and 3-hCL had disappeared after 1 day incubation with PBS at 37 °C. 
Furthermore, long-time incubation (6-hCL or 12-CL) displayed a significant increase 
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(P<0.01-P<0.0001) in the swelling of 40 µm after 3 days and 7 days from the incubation 
with PBS GBs at 37 °C (Figure 3.27B). 
 
Figure 3.27 Optical microscopy images of 40 μm GBs crosslinked with 5% GA for 
varying durations and incubated in PBS for up to one week 
 
 
A. gelatin beads (40 µm) crosslinked (CL) with 5% GA for 1-h-CL; 3-hCL 6-hCL ,12-
hCL and incubated in PBS at 37°C for 7 days. B: Quantitative calculation of the GBs 
sizes as a function of incubation time and crosslinking duration. Data are presented as 
mean ± SD from 7-8 independent experiments conducted in triplicate. **P<0.01, 
***P<0.001 and ****P<0.0001 compared with GBs size at zero incubation (Zero-IN) 
using a 20X objective; Scale bar=100 µm. 
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Crosslinking with 10% glutaraldehyde  
GBs (< 40 µm) were crosslinked with 10% GA using a vapour approach for 1, 3, 6, and 
12 hours (1-hCL, 3-hCL, 6–hCL and 12–hCL) to check the effect of increasing the 
concentration of the crosslinking agent. Figure 3.28 shows images of the crosslinked GBs 
incubating at 37 °C for different periods. Light microscopy images show that the CL time 
is crucial for swelling of beads at 37 °C. GBs crosslinked for 1 hour showed more 
swelling during incubation time than 3–hCL even after 7 days. The GBs crosslinked with 
10% GA for 3–hCL and 6–hCL showed swelling of GBs on day 7 (Figure 3.28A, B). 
Crosslinking of GBs with 10 % for 12 hours led to less formation of GBs or non-swelling. 
 
Figure 3.28B is a quantitative presentation of the size change in GBs following 
crosslinking with 10% GA. ImageJ was used to determine the change in the size of GBs 
after incubation with PBS for 1-hCL, 3-hCL, 6–hCL and 12–hCL. Following 1-hCL, 
40µm GBs displayed significant increases in swelling (P<0.05 and P<0.0001). Longer-
term cross-linking (6-hCL or 12-hCL) did not elicit a significant increase in the swelling 
of 40 µm GBs for all incubation times at 37 °C. (Figure 3.28B).  
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Figure 3.28 Optical microscopy images of 40 μm GBs crosslinked with 10% GA 
for varying durations and incubated in PBS for up to one week 
 
 
A: gelatin beads (40 µm) crosslinked with 10% GA for 1-hCL; for 3-hCL and 6-hCL for 
12-hCL and incubated in PBS at 37°C for up to one week. B: Quantitative calculation of 
the GBs sizes as a function of incubation time and crosslinking duration. Data are 
presented as mean ± SD from 7-8 independent experiments conducted in triplicate. 
*P<0.05, ***P<0.001 compared with GBs size at Zero-IN using a 20X objective; Scale 
bar=100 µm.   
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3.4.4.2 The effect of crosslinking conditions on the generation of 30 µm gelatin beads 
 
Crosslinking using 5% glutaraldehyde  
GBs with a particle size < 30 µm were crosslinked with 5% GA using a vapour approach. 
The crosslinking reaction time varied from 1, 3, 6 and 12 hours denoted as, 1-hCL, 3-
hCL. 6–hCL and 12-hCL respectively. Figure 3.29A displays images of the crosslinked 
GBs incubating at 37°C for different periods.  
 
Figure 3.29B is a quantitative presentation of the GBs size change in the incubation 
experiments at different reaction times with 5% GA by using ImageJ to determine the 
change in the size of GBs after incubation with PBS following 1-hCL, 3-hCL, 6–hCL and 
12–hCL. The 30 µm GBs crosslinked with 5% GA displayed significant swelling of GBs 
after 1-hCL (P<0.05) and following 7 days’ incubation with PBS at 37 °C. Furthermore, 
3-hCL also showed significant (P<0.051) increases in the diameter of GBs following 7 
days’ incubation at 37 °C. (Figure 3.29B). Other crosslinking periods (6-hCL and 12-
hCL) did not display a significant change in particle size during the incubation period for 
7 days (Figure 3.29B)  
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Figure 3.29 Optical microscopy images of 30μm GBs crosslinked with 5% GA for 
varying durations and incubated in PBS for up to one week. 
 
 
 A: gelatin beads (30 µm) crosslinked with 5% GA for 1; 3 L and 12-hCL then incubated 
in PBS at 37°C for up to one week. B: Quantitative calculation of the GBs sizes as a 
function of incubation time and crosslinking duration. Data are presented as mean ± SD 
from 7-8 independent experiments conducted in triplicate. *P<0.05 compared with GBs 
size at Zero-IN using a 20X objective; Scale bar=100 µm. 
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Crosslinking using 10% glutaraldehyde  
GBs with a particle size < 30 µm were crosslinked with 10% GA using a vapour approach. 
The crosslinking reaction time varied from 1, 3, 6 and 12 hours denoted as, 1-hCL, 3-
hCL. 6–hCL and 12-hCL respectively. Figure 3.30A displays images of the crosslinked 
GBs incubating at 37°C for different periods. Light microscopy images showed that, in 
this instance, CL time did not affect GB swelling at any time point examined. 
 
Figure 3.30B is a quantitative presentation of the GBs size change in the incubation 
experiments at different reaction times with 10% GA by using ImageJ to determine the 
change in the size of GBs after incubation with PBS 1-hCL, 3-hCL, 6–hCL and 12–hCL. 
Consistently, an effect of CL time on GB swelling was not observed.  
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Figure 3.30 Optical microscopy images of 30 µm GBs crosslinked with 10% GA 
for varying durations and incubated in PBS for up to one week 
 
 
A: gelatin beads (30 µm) crosslinked with 10% GA for 1-h-CL; for 3-hCL and 6-hCL for 
12-hCL and incubated in PBS at 37°C for up to one week. B: Quantitative calculation of 
the GBs sizes as a function of incubation time and crosslinking duration. Data are 
presented as mean ± SD from 7-8 independent experiments conducted in triplicate using 
a 20X objective; Scale bar=100 µm.  
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3.5 Discussion 
The important issue for the study of the physiology of beta cells is to rebuild a three-
dimensional structure in vitro known as Pseudoislets (PIs).(169) PIs present more native 
integrity of islets for beta cell culture enabling of biomimicking of beta cell function. The 
improvement of beta cells’ activities in PIs is partially attributed to promoting cell-cell 
contact leading to enhanced glucose sensing, insulin production and insulin 
release.(20,94,109,170,171)  
 
One of the most well-known technique to generate PIs is through suspension culture using 
ultra low attachment; which formed heterogeneous sizes of PIs and bigger PIs. Most of 
the PIs suffered from central necrosis after 7 days of culture. Thus, in this chapter, we 
developed a new coating solution strategy to generate cell culture substrates allowing 
better PI formation. The effects of gelatin solution, F127 and mixture of them on the 
surface property change when suspension and cell adhesion culture plates were being 
used for investigation. 
 
3.5.1 The possible mechanisms which led the different treated surfaces 
During the study, the production of our chosen suspension culture plate ceased, and we 
were therefore forced to choose an alternative product from the same supplier. Given this, 
we examined the properties of both old (SOP) and new products (SGP) and confirmed 
that the spectrums of ATR-FITR were different despite both products originating from 
the same supplier. Furthermore, a coating of the surface with gelatin solution, F127 and 
with a mixture of both significantly altered the hydrophobicity of culture plates, 
consistent with prior studies.(155,172–175) Similarly, the CA values and Protein adsorption 
varied according to the hydrophobicity of the surfaces which is again, consistent with the 
literature.(123,173,175–178) These differences may arise from the structure of F127 triblock 
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which is composed of two hydrophilic sides named PEO and a hydrophobic middle 
portion termed PPO (Scheme 3.1). Therefore, it would be expected that the PPO would 
attach to the surface allowing the free PEO chains to extend into the air.(179) PEO is highly 
hydrophilic and highly flexible chain. Once PEO molecules are on the outer surface, the 
surface becomes very hydrophilic and has a strong capacity to repel protein 
attachment.(180) Conversely, on a hydrophilic surface, such as that coated with F127, the 
opposite will take place. Furthermore, it has reported that the density and conformation 
of the adsorbed PEO-PPO-PEO vary depending on the chain length of the PEO and PPO 
blocks. (181) Based on these facts, we could explain the different surface properties, FTIR 
spectra, CA and protein adsorption capacity, after SOP, TCP, SGP plates were coated 
with different coating solutions and resulting change in these patterns when F127 or 
gelatin concentrations were increased or decreased. It is expected that F127 can reduce 
bimolecular adsorption(181) and for that reason, SOP surfaces coated with F127 showed 
the lowest CA value and no protein adsorption. 
 
 
 
Scheme 3. 1 Illustration of the chemical composition of Pluronic F127 
 
Coating plate with 100% gelatin is capable of making the PEO long chain anchor to the 
surface but allows the PPO short chain to extend into the air without the long flexible part 
usually observed (Scheme 3.2), and thereby might account for the poor protein adsorption 
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on this surface.(182) Therefore, the CA value was lowest on this surface, and protein 
adsorption was not observed. These surfaces response could lead to generation of 
aggregates with different sizes. 
 
 
 
Scheme 3. 2 Illustration of the hypothesis of the molecular composition and chain 
morphology on SOP surface coating with a variation of F127 and gelatin percent in 
the solution 
 
3.5.2 PPO block of F127 toward air and gelatin dominating the TCP plate when 
coating TCP plates 
When the F127 solution was used to coat adhesive plates, i.e. to a hydrophilic surface, it 
is likely that the hydrophilic blocks were attached to the plate surface, and the 
hydrophobic block was toward air, i.e. in contact with the cells (Scheme 3.3). Such 
hydrophobic surfaces can adsorb proteins and lead to cell attachment. Nevertheless, the 
degree of protein adsorption was poor because the PPO block does not readily adsorb 
protein. For that reason, the adhesive properties of the TCP property were likely to 
support the ATR-FTIR spectra displaying low peak intensity related to Pluronic F127. 
Furthermore,  the contact angle results showed more wettability when the surfaces were 
coated with F127, indicating that the PEO segment attached to surface and PPO sigment 
become toward air. The PPO segments adsorbed proteins or PPO segments easily, which 
led to highly hydrophilic environment producing relatively high protein adsorption and 
lower CA value compared to uncoated TCP surfaces (Scheme 3.3). Coating with 100% 
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gelatin displayed incremental increases in the intensity of the gelatin spectrum, which 
likely formed semi-hydrophilic surfaces, which may increase the CA value compared 
with the F127 coating. This is consistent with other studies.(176,178,183,185) 
 
 
 
Scheme 3. 3 Illustration of the hypothesis of the molecular composition and chain 
morphology on TCP surface coating with a variation of F127 percent and gelatin 
percent in the solution 
 
The data presented here suggest that coating solution can be used to manage cell 
attachment to the surface. Previous studies have proved that suspension surfaces coated 
with an F127 solution would prevent cell attachment(173,180,185). Gelatin coating has 
previously been shown to generate a 2D monolayer.(75,180) Therefore, mixing gelatin 
solution and F127 may oppose gelatin’s behaviour,(186) and explain the different 
environmental properties on the surface coated with varying percentages of F127 and 
gelatin. Coating with F127 solution and a mixture of F127-gelatin solutions modified 
culture surfaces to include highly hydrophobic lipid motifs and to limit cellular adhesion.  
 
To date, there are few methods for conjugating protein or peptide ligands that address all 
of these concerns. The most promising methods so far have focused on decreasing the 
surface energy of the base material to which the ligand(s) of interest is 
immobilised.(173,187) This could reduce unwanted protein adsorption and consequently 
diminish nonspecific cell adhesion. Coating material with a non-ionic-hydrophilic 
polymer is an effective means of decreasing its surface energy. One such coating 
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substance is polyethylene oxide (PEO), which is well known for its ability to repel 
proteins and has been used to modify synthetic materials to provide them with a barrier 
to reduce protein adsorption.(180,188) Although producing such a PEO film at the material 
surface provides the necessary inert interface, it can be a challenge to modify the PEO 
chains further.  
 
3.5.3 The stability of gelatin beads can be controlled precisely  
Crosslinking of gelatin by GA results in the reaction of alpha-amine groups of lysine and 
hydroxylysine side groups with aldehydes(189). Seldom, other groups for instance 
carboxyl, amide, imidazoyl or guanidine may be involved.(189,190) The amine groups 
present in gelatin are likely to react with aldehyde group in GA producing the relatively 
labile Schiff’s base or aldimine (Scheme 3.4). It has been investigated that crosslinking 
of gelatin with GA leads to higher stability of gelatin due to imide bridge formation on 
the GBs surfaces(191) The aldehyde is very reactive and usually used for crosslinking of 
gelatin beads.(192) According to previous studies,(193,194) the aldehyde can react with an 
amino group of proteins like gelatin even in the presence of water, forming Schiff’s base. 
GA has two functional (aldehyde) groups which lead to a crosslinking reaction; the 
aldehyde groups from GA react with amino groups of gelatin and forming stable imine 
bridge, and hence the GBs become insoluble even in a hot environment.(195) Also, an 
investigation of the reactive amino acid with aldehyde gelatin can indicate the formation 
of intermediate alkanolamine linkages and resulting dehydration products. Schiff’s base 
under alkaline pH can produce stable ketoamines.(196)  
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Scheme 3. 4 Crosslinking of gelatin by glutaraldehyde(188) 
 
Generation of spherical gelatin beads requires crosslinking to decrease the solubility. GA 
is widely used to crosslink GBs through the formation of non-soluble networks on the 
beads surface. However, the use of crosslinker could lead to a toxic side effect from the 
remaining GA.(197) The crosslinking of GBs with GA can be done through a liquid phase 
or via gas phase. In this study, we used the gas phase. The crosslinked of GBs with vapour 
GA instead of using liquid crosslinking decreased the remaining amount of GA in gelatin 
beads, which would affect cell viability after the GBs are incorporated.  
 
Crosslinking of GBs depends on the concentration of GA, which increases the number of 
the insoluble net on the surface of GBs and vice versa. This feature would be suitable to 
function as a microchannel inside PIs over a prolonged period. The 40 µm GBs displayed 
more swelling at 6-hCL than 30 µm at the same crosslinking time, likely due to the larger 
surface area leading to a greater number of unreacted amino groups. Thus, 40 µm GBs 
would swell more than another type. For that reason, 40 µm beads dissolved at 1-hCL 
and 3-hCL when treated with 5% GA. 
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3.6 Conclusions  
Coating of surfaces with a mixture of F127 and gelatin solution altered the surface 
properties significantly. Previous studies have proved that F127-coated surfaces are 
protein resistant.(198,199) We have demonstrated for the first time that coating the surface 
with a mixture of F127 solution and gelatin solution can produce different ATR-FTIR 
spectra and a variety of CA values with different protein adsorption capacities. FTIR 
analysis showed that each surface had different spectra according to the type of the 
surface and the percentage of the mixture used for coating. Adsorption of PPO or PEO 
blockers of F127 on the substrate was the hydrophobicity dependent of the substrates. 
The CA values, and protein adsorption also agreed with FTIR results to prove that the 
coating with the high percentage of F127 led to lower contact angles and low protein 
anchored to surface.  
 
GBs with diameters below 40 µm can be changed by crosslinking reaction with GA under 
gaseous phase to enhance swelling and stability over time. The swelling degree of the 
GBs can be controlled by GA concentration or reaction duration to be used for drug 
carrier and incorporated into cells. We have found that 5% GA with 6 h crosslinking is a 
better way to produces swelling GBs but not dissolve in short time with low GA effect 
by using vapour way rather than using liquid method for crosslinking of the GBs. 
 
In the following chapters, the viability and function of PIs will be examined following 
the application of different coating solutions and incorporation of GB into PIs. 
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4 Chapter 4 Generation of Pseudoislets on different coating substrates   
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4.1 Introduction 
Diabetes mellitus is one of the most common diseases globally and affects a significant 
number of the world’s population. It has two major types: Type 1 and Type 2 diabetes 
mellitus (T1D and T2D respectively). T1D is characterised by the complete loss of beta 
cells as a consequence of the autoimmune destruction of beta cells in the pancreas,(4)  
which regulate insulin secretion and blood glucose homoeostasis. The islets of 
Langerhans are multicellular aggregates within the pancreas in which the beta cells sense 
changes in the blood glucose level and respond by secreting insulin.(4) The cells within 
the islets communicate with each other through calcium-dependent gap junctions.(21) The 
detrimental effects of uncontrolled blood glucose call for the development of therapeutic 
strategies that help in restoring insulin levels in a manner that mimics the physiological 
regulation of glucose. 
 
The 3D spherical structure of the islets is crucial for their metabolic functions. Artificial 
reconstruction of isolated β-cells into islets of Langerhans through 3D cell aggregation 
has led to the generation of Pseudoislets (PIs). Although a useful model, the viability of 
PIs is reduced when cultured for prolonged periods of time.(75) Some of these PIs exhibit 
ultrastructural characteristics reminiscent of intact islets(153) and can secrete insulin in 
response to secretagogues with higher efficiency than monolayer cells. Hence, PIs are a 
perfect experimental model for studying pancreatic endocrine cell function in a 3D 
configuration, which mimics the islets of Langerhans. 
 
To date, PIs have been generated on a variety of tissue culture plastics with varying 
success.(83) Manipulation of the substrate on which PIs are generated may assist in the 
generation of PIs of stable size and with enhanced viability and sustainability in 
comparison with traditional culture methods. Pluronic F127, a non-ionic triblock 
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copolymer of poly (ethylene oxide)-block-poly (propylene oxide)-block-poly (ethylene 
oxide) (PEO-b-PPO-b-PEO), is applied to coat the originally hydrophobic surface leading 
to an oil/water phase transfer.(186) Also, F127 is quite stable in culture media and displays 
excellent biocompatibility, and low toxicity.(186) Gelatin can be defined as heterogeneous 
water-soluble of hydrophobic proteins of high molecular weight present in collagen. The 
proteins are extracted by boiling skin, tendons, ligaments, and/or bones in water. Gelatin 
type A is derived from the acid-cured tissue while gelatin type B is derived from the lime-
cured tissue. Collagen derived gelatin has biocompatible and biodegradable properties 
and is widely used in medical research. 
 
4.2 Aim 
This study sought to investigate the effect of coating tissue culture plates with varying 
ratios of F127 and gelatin with the view to optimising a protocol for the generation of PIs 
of stable size and prolonged viability, which display enhanced functionality in terms of 
insulin secretion.  
  
128 
 
4.3 Materials and Methods 
 
4.3.1 Materials  
Chemicals, plates types and reagents used in this chapter are listed in Chapter 2, Section 
2.1. 
 
4.3.2 PIs formation  
PIs were generated on tissue culture plastic coated with different solutions as described 
in Chapter 2, Section 2.2.3. Static and dynamic formation of PIs were undertaken. Only 
the data of PIs generated through static culture and on SOP coating plates were presented 
in the chapter.  The data of PIs formed assisted by shaking, and other types of plates were 
presented in the Appendix. 
 
4.3.3 PI morphology characterisation 
The morphology and size of the PIs were assessed as described in Chapter 2, Section 
2.2.5. 
 
4.3.4 PIs cell counting 
A number of cells in PIs generated on surfaces coated with different coating solutions 
was counted by the method described in Chapter 2 Section 2.2.6. 
 
4.3.5 Assessment of cell viability of PIs 
Changes in the cellular viability of the cells were assessed using colourimetric MTT assay 
as outlined in Chapter 2, Section 2.2.7, and the CCK-8 assay as described in Chapter 2, 
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Section 2.2.8. The measurement of cytotoxicity of PIs by LDH assay was described in 
Chapter 2 Section 2.2.9. 
 
4.3.6 Assessment of glucose-stimulated insulin secretion  
PIs were primed with 1.1 mM glucose and then exposed to 16.7 mM glucose as outlined 
in Chapter 2, Section 2.2.10. Assessment of glucose-stimulated insulin secretion from the 
supernatants was assessed by ELISA as outlined in Chapter 2, Section 2.2.10. 
 
4.3.7 Quantitative Polymerase Chain Reaction  
The expression of Cx36, GLUT2 and Insulin mRNA were assessed by qPCR as described 
in Chapter 2, Section 2.2.11 Briefly, total RNA was extracted and a one-step qPCR 
reaction conducted as outlined in Section 2.2.12. 
 
4.3.8 Immunological staining  
The expression and localisation of Cx36, GLUT2 and Insulin protein was assessed by 
immunocytochemistry as outlined in Chapter 2, Section 2.2.13 
 
4.3.9 Western blotting  
The expression of Cx36, GLUT2 and Insulin were additionally assessed using Western 
blotting as described in Chapter 2, Section 2.2.14. 
 
4.3.10 Oxygen expression 
The expression of oxygen from PIs grown on different coating solutions and coating types 
were assessed using the PA2 probe, as described in Chapter 2, Section 2.2.15. 
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4.4 Results 
 
4.4.1 Morphology of the PIs 
Light microscopy was used to assess the morphology of BRIN-BD11 cells cultured on 
SOP with different coating solutions and at different seeding densities after day 3 and day 
7. The coated surfaces with 90%, 95%, 98%, 100% gelatin were denoted as 90%, 95%, 
98%, 100% respectively. The two negative controls, non-coated TCP and SOP were 
denoted as Adhesive and Uncoated respectively. The positive control, the ultra-low 
attachment plate was denoted as ULA. The 100% F127 coated was denoted as F127. As 
shown in Figure 4.1 and Figure 4.2, cells were grown on adhesive surfaces and uncoated 
surfaces, anchored to the surface and formed a 2D monolayer at day 3 and day 7 
regardless of the starting seeding density. Furthermore, cells cultured on plates coated 
with 100% gelatin solution also formed a 2D monolayer. However, PIs were successfully 
generated using F127 as a coating solution (Figure 4.1 and Figure 4.2). In this instance 
though, there was little apparent difference between the seeding densities, and therefore, 
a combination of gelatin and F127 was used for further experiments as indicated in Figure 
4.1 and Figure 4.2. PIs generated on 90% gelatin were larger than those generated in 95% 
gelatin, which in turn were larger than those generated in 98% gelatin. Furthermore, PIs 
generated in 98% gelatin appeared more homogeneous in size (Figure 4.1 and Figure 4.2). 
PIs generated on commercial ULA varied largely in size and morphology.  
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Figure 4.1 PI morphology with cell seeding density 8,000 cells/well grown on the substrates coating with different solutions. 
 
 
The effect of different coating solutions on the PI formation and morphology assessed by light microscopy (using a x10 objective) over 7 days culture. 
BRIN-BD11 cells were seeded at 8,000 cells/well. Scale bars = 200 µm.
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Figure 4.2 PI morphology with cell seeding density 32,000 cells/well grown on the substrates coating with different coating solutions 
 
 
The effect of different coating solutions on the PI formation and morphology assessed by light microscopy (using a x10 objective) over 7 days culture. 
BRIN-BD11 cells were 32,000 cells/well. Scale bars = 200 µm. 
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4.4.2 Effect of coating solutions on the number of PIs 
Cells were seeded onto 96 well plates treated with different coating solutions as indicated 
in Table 4.1 at two cell densities (8,000 cells/well and 32,000 cells/well). The number of 
PIs formed in each well varied significantly according to the coating solution used. 
Overall, the number of PIs generated in wells coated with a solution of F127 alone was 
the lowest (mean of 3-4 PIs). Furthermore, there was no obvious increase in the mean PI 
number between wells seeded at 8,000 cells/well and 32,000 cells/well (Table 4.1). 
 
Table 4.1 Mean number of PIs per well  at day 7 
          Type 
Density 
ULA F127 90% 95% 98% 
8,000 
cells/well 
30 ± 1 3 ± 1 8 ± 2 20 ± 3 30 ± 4 
32,000 
cells/well 
45± 5 4 ± 1 10 ± 1 30 ± 4 38 ± 5 
 
BRIN-BD11 cells were seeded at 8,000 cells/well, and 32,000 cells/well, and the effect 
of different coating solutions on the mean number of PIs formed in each well assessed. 
Data are presented as mean ± SD (n= 4).   
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4.4.3 Effect of coating solutions on PI diameter 
The effect of the coating solution on the mean diameter of PIs was assessed after 3 and 7 
days of culture and is shown in Figure 4.3 and Figure 4.4. In all instances, the largest PIs 
were observed when tissue culture plastic was coated with a solution of F127 alone. PIs 
grown on a solution of F127 alone were significantly larger (P<0.0001) than PIs 
generated on uncoated ultra-low attachment (ULA) plates regardless of seeding density 
or the number of days in culture (Figure 4.3 and Figure 4.4)  
 
PIs generated on surfaces coated with a mixture of F127 and gelatin decreased in diameter 
as the percentage of gelatin increased. Again, this was independent of the starting seeding 
density or the number of days in culture (Figure 4.3 and Figure 4.4.). In the presence of 
90% gelatin, the diameter of PIs was significantly greater than that of PIs grown on 
untreated ULA plates after 3 and 7 days in culture regardless of the starting seeding 
density was 8,000 cells/well (P<0.001; Figure 4.3A, B) or 32,000 cells/well (P<0.01; 
Figure 4.4A, B). Similar observations were recorded in the presence of 95% gelatin 
(P<0.05; Figure 4.3A, B). When the percentage of gelatin was increased to 98%, a 
significant difference in PI size over PIs grown on ULA plates was no longer observed 
(Figure 4.3 and Figure 4.4.). 
  
135 
 
Figure 4.3  Effect of the coating solutions on PI size for cell seeding density 8,000 
cells/well.  
 
 
BRIN-BD11 cells were seeded at densities of 8,000 cells/well and the impact of the 
coating solution on PI size assessed after 3 days (A) and for 7 days (B). Data are presented 
as mean ± SD from 4-5 independent experiments conducted in triplicate. *P<0.05 
***P<0.001 and ****P<0.0001 compared with PIs generated on Ultra-low attachment 
(ULA) plates. 
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Figure 4.4 Effect of the coating solutions on PI size for cell seeding density 32,000 
cells/well  
 
 
BRIN-BD11 cells were seeded at densities of 32,000 cells/well, and the impact of the 
coating solution on PI size assessed after 3 days (A) and for 7 days (B). Data are presented 
as mean ± SD from 4-5 independent experiments conducted in triplicate. *P<0.05 and 
**P<0.01 and ****P<0.0001 compared with PIs generated on Ultra-low attachment 
(ULA) plates. 
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4.4.4 Effect of coating solutions on the number of cells within PIs  
The effect of the coating solution on the mean cell number of PIs was assessed after 3 
and 7 days and is shown in Figure 4.5 and Figure 4.6. The number of cell growing on 
different surfaces was measured (after dissociation the PIs with HBSS free of calcium) 
using automated cell accounted with Trypan blue. 
 
When the seeding density of 8,000 cells/well was used, a significant higher (P<0.01) in 
cell number was observed on the surface of an adhesive plate; and a significantly lower 
(P<0.01) in PIs formed on the surface coated with F127 at day 3 compared with cell 
number formed on ULA (Figure 4.5A). At day 7, the cell number was significantly higher 
(P<0.0001) on adhesive and uncoated (P<0.01) plates; and significantly lower (P<0.01) 
in the PIs formed in F127 coated plate comparing with that in the PIs generated on a ULA 
surface (Figure 4.5B). 
 
When the seeding density of 32,000 cells/well (Figure 4.6) was used, the mean cell 
number of PIs was significantly lower (P<0.01) for cells proliferate on uncoated surfaces 
and surfaces coated with F127  than that of cells of PIs cultured on a ULA surface at day 
3 (Figure 4.6A). While at day 7, the cell number of PIs was significantly higher (P<0.0001 
and P<0.05) on adhesive uncoated and 100% gelatin plates. While significantly lower 
(P<0.05) cells number of PIs formed in F127 coated plate was observed comparing with 
cell numbers in the PIs generated on a ULA surface (Figure 4.6B). 
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Figure 4.5 Effect of the coating solution on PI cell number for cell seeding density 
8,000 cells/well  
 
BRIN-BD11 cells were seeded at densities of 8,000 cells/well and the impact of the 
coating solution on cell numbers after 3 days (A) and for 7 days (B) using automated cell 
counter. Data are presented as mean ± SD from 3-4 independent experiments conducted 
in triplicate. **P<0.01 and ****P<0.0001 compared with cell number formed on ULA.  
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Figure 4.6 Effect of the coating solutions on PI cell number for cell seeding 
density 32,000 cells/well  
 
 
BRIN-BD11 cells were seeded at densities of 32,000 cells/well and the impact of the 
coating solution on cells numbers assessed after 3 days (A) and for 7 days (B) using 
automated cell counter. Data are presented as mean ± SD from 4-5 independent 
experiments conducted in triplicate. *P<0.05, **P<0.01 and ****P<0.0001 compared 
with cell number formed on ULA.  
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4.4.5 Effect of the coating solution on mitochondrial respiration of PIs (MTT 
assay)  
The effect of the coating solutions on the mitochondrial respiration rate of PIs was 
assessed after 3 and 7 days and at different starting seeding densities for 8,000 cells/well 
(Figure 4.7) and for 32,000 cells/well (Figure 4.8) using MTT assay. The MTT assay was 
used as a surrogate for cellular proliferation on the basis that non-respiring mitochondria 
are reflective of poorly proliferating cells. MTT values in 8,000 cells/well were 
significantly higher (P<0.01-P<0.0001) in the cells grown on an adhesive, uncoated 
surfaces and 100% gelatine coated surface compared with those of cells grown on a ULA 
surface at day 3 and day 7 culture. (Figure 4.7). 
 
For another cell seeding density (32,000 cells/well), MTT data at day 3 revealed that there 
were no significant differences on proliferation of cells on different surface types except 
cells proliferated (P<0,05) on surface coated with 98% gelatin comparing those of cells 
in PIs generated on a ULA surface at the same day. In the case of cells proliferation at 
day 7, MTT data was exhibited higher (P<0.00l- P<0.0001) proliferation rate in cells 
grown on an adhesive, uncoated surfaces and 100% gelatine than the proliferation of cells 
in PIs generated on a ULA surface. While MTT data showed lower values (P<0.001) in 
PIs formed in the F127 surface compared with PIs generated on a ULA surface (Figure 
4.7B). 
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Figure 4.7 Effect of the coating solution on mitochondrial respiration of PIs 
(MTT assay) for cell seeding density 8,000 cells/well 
 
 
BRIN-BD11 cells were seeded at densities of 8,000 cells/well, and the impact of the 
coating solution on the proliferation of PIs assessed after 3 days (A) and for 7 days (B) 
using MTT assay. Data are presented as mean ± SD from 4-5 independent experiments 
conducted in triplicate. *P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001 compared 
with the viability of cells grown on a ULA surface   
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Figure 4.8 Effect of the coating solution on mitochondrial respiration of PIs 
(MTT assay) for cell seeding density 32,000 cells/well 
 
 
BRIN-BD11 cells were seeded at densities of 32,000 cells/well, and the impact of the 
coating solution on the proliferation of PIs assessed after 3 days (A) and for 7 days (B) 
using MTT assay. Data are presented as mean ± SD from 4-5 independent experiments 
conducted in triplicate. *P<0.05, ***P<0.01 ****P<0.0001 compared with the viability 
of cells grown on a ULA surface.  
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4.4.6 Effect of the coatng solution on the proliferative rate of PIs (CCK-8 assay) 
The effect of the coating solution on the proliferative rate of cells within PIs was assessed 
after 3 and 7 days in culture for cell seeding density 8,000 cells/well (Figure 4.9) and for 
cell seeding density 32,000 cells/well (Figure 4.10). The proliferative rate of cells seeded 
at an initial density of 8,000 cells/well did not show much difference on different surfaces 
after 3 days in culture except for cells grown on 98% and 100% gelatin coated surface 
(Figure 4.9A). They showed higher proliferation rate than cells grown on a ULA surface. 
After 7 days culture, the proliferation rate significantly increased (P<0.05) on cells 
cultured on adhesive surfaces. On the other hand, CCK-8 results displayed significant 
reduction (P<0.001) in the proliferative rate for PIs generated on F127 coated surface 
when compared with cells grown on a ULA surface (Figure 4.9B). 
 
When an initial seeding density of 32,000 cells/well was used, the proliferative rate of 
cells seeded did not show much difference on different surfaces after 3 days in culture 
except for the proliferation rate for cells in PIs grown on 98% gelatin coated surface 
((P<0.05) in comparing with proliferation rate of cells in PIs formed on a ULA surface 
(Figure 4.10A). After 7 days culture, the proliferation rate significantly increased 
(P<0.05) comparing with proliferation rate of cells in PIs formed on a ULA surface. On 
the other hand, CCK-8 results displayed significant increase (P<0.001-P<0.0001) for 
cells grown on the surfaces of adhesive, uncoated and 100% gelatin coated while the 
proliferation rate significantly reduced (P<0.001) in PIs formed on F127 surface when 
compared with PIs formed on a ULA surface (Figure 4.10B). 
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Figure 4.9 Proliferation (CCK-8 assay) of PIs generated on surfaces coated with 
different coating solutions for cell seeding density 8,000cells/well 
 
 
BRIN-BD11 cells were seeded at densities of 8,000 cells/well, and the impact of the 
coating solution on the proliferation of PIs assessed after 3 days (A) and for 7 days (B) 
using CCK-8 assay. Data are presented as mean ± SD from 4-5 independent experiments 
conducted in triplicate. *P<0.05,**P<0.01, and ****P<0.0001 compared with cells 
proliferated on ULA.  
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Figure 4.10 Proliferation of PIs generated on surfaces coated with different 
coating solutions for cell seeding density 32,000 cells/well 
 
 
BRIN-BD11 cells were seeded at densities of 32,000 cells/well, and the impact of the 
coating solution on the proliferation of PIs assessed after 3 days (A) and for 7 days (B) 
using CCK-8 assay. Data are presented as mean ± SD from 3-4 independent experiments 
conducted in triplicate. *P<0.05, ***P<0.001, and ****P<0.0001 compared with cells 
proliferated on ULA.  
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4.4.7 Effect of coating solution on glucose-stimulated insulin secretion from PIs 
The effect of the coating solution on glucose-stimulated insulin secretion (GSIS) from 
PIs was assessed after 7 days and is shown in Figure 4.11. At a starting seeding density 
of 8,000 cells/well, GSIS in response to 16.7 mM glucose was significantly decrease 
(P<0.01 and 0.0001) in all instances except PIs formed on surfaces coated 95% gelatin 
and 98% gelatin which showed non-significant increases in GSIS when compared with 
GSIS of PIs formed on ULA surfaces (Figure 4.11A). A similar effect was observed with 
a starting seeding density of 32,000 cells/well. However, in this instance, PIs generated 
on PIs formed on surfaces coated 95% and 98% gelatin showed increase in the GSIS but 
not reach to the significant different (Figure 4.11B) when compared with GSIS of PIs 
formed on ULA surface.  
 
Figure 4.11 Effect of coating solution on glucose-stimulated insulin secretion of 
PIs 
 
GSIS in response to 16.7 mM glucose was measured by ELISA after 7 days culture. PIs 
were generated from two different seeding densities: 8,000 cells/well (A) and 32,000 
cells/well (B). Data are presented as mean ± SD (N=6 assayed in duplicate) *P<0.05, 
**P<0.01 and ****P<0.0001 compared with PIs were formed on ULA plate. 
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4.4.8 Effect of coating solution on the mRNA expression of Connexin 36, GLUT2  
and insulin in PIs  
The generation of PIs on tissue culture plastic coated with different solutions resulted in 
differential expression of Cx36, GLUT2 and insulin mRNA as shown in Figure 4.12. The 
mRNA expression of Cx36 (Figure 4.12A), GLUT2 (Figure 4.12B) or Insulin (Figure 
4.12C) varied according to coating types. mRNA was significantly reduced (P<0.001 
P<0.01) in PIs cultured on the surface coating with F127 solution alone or cells were 
grown on the plate coating with 100% gelatin when compared with PIs formed on a ULA 
surface. This study displayed that the coating of 98% gelatin to grow PIs showed a 
significant improvement (P<0.01) in gene expression of Cx36 compared with that of PIs 
formed on a ULA surface (Figure 4.12A). Furthermore, PIs grown on the surface coating 
with the solution of 90%, and 95% gelatin resulted in an increase mRNA of Cx36 but did 
not reach a significant level as shown in Figure 4.12A. GLUT2 and insulin gene mRNA 
results showed an increase in PIs grown on 98% gelatin coated surface without 
significance but showed a significant decrease on PIs grown on the uncoated surface or 
coated with F127 or 100% gelatin (P <0.01-P<0.0001) (Figure 4.12B, C), when compared 
with PIs, formed on a ULA surface.  
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Figure 4.12 Effect of coating solutions on mRNA expressions of Connexin 36, 
GLUT2 and insulin in PIs 
 
 
The effect of the coating solutions on the mRNA expression of Cx36 (A), GLUT2 (B) 
and insulin (C) of the PIs were assessed by qPCR after PIs in culture for 7 days. Data are 
presented as the mean ± standard deviation (SD) with n=4. **P<0.01, ***P<0.001 and 
****P<0.0001 compared with PIs were formed on ULA plate. 
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4.4.9 Connexin 36 staining in PIs grown on substrates coating with different 
coating solutions 
To assess the expression and localisation of Cx36 a key gap junction protein essential in 
the maintenance of cell-cell communication between beta cells, immunocytochemistry 
using an antibody against Cx36 was performed (Figure 4.13). Cells cultured in the 
presence of 100% gelatin formed a monolayer and shown no enhancement in Cx36 
staining over cells grown on an adhesive surface (Figure 4.13 and Figure 4.14). However, 
in all other instances, the culture of cells as PIs on tissue culture plastic treated with 
various coating solutions significantly enhanced Cx36 staining (P<0.001 – 0.0001; Figure 
4.14). Over that of cells grown on an adhesive surface. PIs generated on a coating solution 
of 98% gelatin showed the highest expression of Cx36. 
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Figure 4.13 Connexin 36 staining in PIs cultured on substrates coated with different coating solutions 
 
 
The effect of the coating solution on Cx36 staining after 7 days of culture was assessed by immunocytochemistry using confocal microscopy. 
Microscope magnification used was a 40X objective. Scale bars = 100 µm.  
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Figure 4.14 Connexin 36 expression in PIs grown on substrates coated with 
different coating solutions  
 
 
Semi quantified measurement of Cx36 stained images by using ImageJ software. Data 
are presented as mean ± SD from 4-5 independent experiments conducted in triplicate. 
***P<0.001 and ****P<0.0001 compared with adhesive control.  
 
4.4.10 GLUT2 staining in PIs cultured on a substrate coated with different coating 
solutions 
To assess the expression and localization of the glucose transporter GLUT2, 
immunocytochemistry using an antibody against GLUT2 was performed (Figure 4.15). 
Cells cultured in the presence of 100% gelatin showed no enhancement in GLUT2 
staining over cells grown on an adhesive surface (Figure 4.15 and Figure 4.16). However, 
in all other instances, the culture of cells as PIs on tissue culture plastic treated with 
various coating solutions significantly enhanced GLUT2 staining (P<0.01 – 0.0001; 
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Figure 4.16). Over that of cells grown on an adhesive surface. PIs generated on a coating 
solution of 98% gelatin showed the highest expression of GLUT2.
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Figure 4.15 GLUT2 staining in PIs cultured on the substrates coated with different coating solutions  
 
 
The effect of the coating solution on GLUT2 staining after 7 days of culture was assessed by immunocytochemistry using confocal microscopy 
quantified using ImageJ. Microscope magnification used was a 40X objective. Scale bars = 100 µm 
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Figure 4.16 GLUT2 expression in PIs cultured on the substrates coated with different 
coating solutions 
 
Semi quantified measurement of GLUT2 staining images by using ImageJ. Data are presented 
as mean ± SD from 4-5 independent experiments conducted in triplicate. **P<0.01, 
***P<0.001 and ****P<0.0001 compared with adhesive control.  
 
4.4.11 Insulin staining in PIs cultured on substrates coated with different coating 
solutions 
To assess the expression and localization of insulin, immunocytochemistry using an antibody 
against insulin was performed (Figure 4.17). In all instances, the culture of cells as PIs on tissue 
culture plastic treated with various coating solutions significantly enhanced insulin staining 
(P<0.01 – 0.0001; Figure 4.17 and 4.18B) over that of cells grown on an adhesive surface. PIs 
generated on the substrate with a coating solution of 98% gelatin or on ULA plates showed the 
highest, and comparable increased expression of insulin. 
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Figure 4.17 Insulin staining in PIs cultured on the substrates coated with different coating solutions 
 
 
The effect of the coating solution on insulin staining after 7 days of culture was assessed by immunocytochemistry using confocal microscopy. 
Microscope magnification used was a 40X objective. Scale bars = 100 µm.  
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Figure 4.18 Insulin expression in PIs cultured on the substrates coated with 
different coating solutions 
 
 
Semi quantified measurement of Insulin staining images by using ImageJ software. 
Data are presented as mean ± SD from 4-5 independent experiments conducted in 
triplicate. *P<0.05, **P<0.01 and ****P<0.0001 compared with adhesive control.  
  
 157 
 
4.4.12 Western blotting analysis of connexin 36 expressions in PIs generated on  
different coating solutions 
To further validate the expression levels of Cx36 following generation of PIs on 
different coating solutions, Western blot analysis was performed as shown in Figure 
4.19. In all instances, Cx36 expression was higher (P<0.0001) than that of cells grown 
on an adhesive surface (control). Consistent with observations from 
immunocytochemistry experiments, Cx36 expression was highest in PIs generated on 
a solution of 98% gelatin (Figure 4.19B)   
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Figure 4.19 Western blotting analysis of Connexin 36 expression in PIs 
generated on different coating solutions 
 
 
Western blotting was conducted to assess the expression of Cx36 in PIs generated on 
different coating solutions. Images representative of 4 independent experiments are 
shown in (A). Western blotting images were quantified using Alphaview software and 
expression levels relative to the loading control presented in (B). Data represented as 
mean ± SD (N= 4). ***P<0.001 and ****P<0.001 compared with Adhesive (controls). 
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4.4.13 Western blotting analysis of GLUT2 expression in PIs generated on 
substrates coated with different coating solutions 
To validate the expression levels of GLUT2 following generation of PIs on different 
coating solutions, western blot analysis was performed as shown in Figure 4.20. In all 
instances, GLUT2 expression was higher (P<0.001 - 0.0001) than that of cells grown 
on an adhesive surface (control). Consistent with observations from 
immunocytochemistry experiments, GLUT2 expression was highest in PIs generated 
on a solution of 98% gelatin (Figure 4.20B). Additionally, the expression levels in PIs 
generated on ULA plates was comparable with that of PIs generated in a solution of 
98% gelatin (Figure 4.20B). 
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Figure 4.20 Western blotting analysis of GLUT2 expression in PIs generated 
on substrates coated with different coating solutions 
 
 
Western blotting was conducted to assess the expression of GLUT2 in PIs generated 
on the substrates coated with different coating solutions for 7 days. Images 
representative of 4 independent experiments are shown in (A). Western blotting 
images were quantified using Alphaview software and expression levels relative to the 
loading control presented in (B). Data represented as mean ± SD (N= 4). ***P<0.001 
and ****P<0.001 compared with Adhesive (controls). 
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4.4.14 Western blotting analysis of insulin expression in PIs generated on  
different coating solutions. 
Finally, to validate the expression levels of insulin following generation of PIs on 
different coating solutions, Western blot analysis was performed as shown in Figure 
4.21. In all instances, insulin expression was higher (P<0.001 - 0.0001) than that of 
cells grown on an adhesive surface (control). Consistent with findings from 
immunocytochemistry experiments, PIs generated on a coating solution of 98% 
gelatin or on ULA plates showed the highest and comparable increases in the 
expression of insulin. (Figure 4.21B)  
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Figure 4.21 Western blotting analysis of insulin expression in PIs generated on 
different coating solutions 
 
 
Western blotting was conducted to assess the expression of Insulin in PIs generated 
on different coating solutions. Images representative of 4 independent experiments are 
shown in (A). Western blotting images were quantified using Alphaview software and 
expression levels relative to the loading control presented in (B). Data represented as 
mean ± SD (N= 4). ***P<0.001 and ****P<0.001 compared with Adhesive (controls) 
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4.4.15 Effect of the coating solution on oxygen distribution in PIs grown on 
substrates coated different coating solutions 
To assess the O2 distribution within PIs generated on various coating solutions, the 
oxygen-sensitive poly(9,9-dioctylfluorene) (PFO) fluorophore was used in 
conjunction with a nanosensor to allow measurement of intracellular O2 using a 
ratiometric intensity model. BRIN-BD11 cells were loaded with (reference/antennae 
dye-poly (9,9-diheptylﬂuorene-alt-9,9-di-P-tolyl-9H-ﬂuorene) (PA2 probe).(200) 
 
Figure 4.22A, B referred to O2 distribution measured on a steady state luminescent 
spectrometer. The concentration of O2 was high in PI grown on substrates coated with 
F127, 90% gelatin and ULA plates after 3 days culture. However, after 7 days culture, 
O2 concentrations were higher in PIs generated on substrates coated with 95% gelatin 
or ULA plates (Figure 4.22A, B). 
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Figure 4.22 Oxygen distribution through the PIs at day 3 and day 7 culturing 
 
 
Average oxygen distribution within PIs generated by various coating solutions was 
measured using the oxygen sensitive probe (PA2). A: quantitative measurement of 
oxygen distribution in PIs at day 3 and day 7 culture. B: Live images for PIs stained 
with PA2 at day 3 and day 7 culture for PIs grown on F127 coated substrates. 
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4.5 Discussion 
Different methodologies have been used to generate PIs from isolated beta cells in an 
attempt to mimic pancreatic islets in terms of cell-cell communication and 
physiological insulin secretion. The most important obstacle in such research is central 
necrosis of the PIs after approximately 7 days in culture. Several methods have been 
used to generate PIs. The most common and convenient protocol for PIs generation 
involves the use of ultra-low attachment (ULA) tissue culture plastic in suspension 
culture. However, it leads to the formation of PIs heterogeneous in size and often 
displaying central necrosis,(154,202). The current study, therefore, aimed to produce PIs 
of homogeneous size, improved viability and enhanced functionality by altering the 
substrates chemistry on which PIs were formed. Series of coating mixture solutions 
have been designed, which systematically changed the hydrophobicity of the substrate 
and led to larger suspended PIs than those from ULA plates. Interestingly, some of the 
large PIs exhibited better or similar biofunction and cell viability than smaller size PIs, 
which offered a convenient tool to alter the cell arrangement in PIs and investigate the 
relation of physical properties of PIs to their biofunctions. 
 
4.5.1 The effect of generation of different PIs’ sizes on cell numbers 
Previous work has shown that MIN6 PIs generated on ULA plates had an average 
diameter of 100-150 µm and comprised 3,000–4,000 cells per PI.(20,75) Consistently, 
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PIs of 150-200 µm were observed in this study when BRIN-BD11 cells were cultured 
on ULA 24 well plates with 32,000 cells per well as seeding density. However, the 
average number of cells per PI was significantly lower than those previous reports, 
likely reflecting the difference in cell lines used and surface area; because they use 
MIN6 cell line to compare insulin release from MIN6 pseudoislets and islets of 
Langerhans.(75) When PIs were generated on SOP plates coated with F127 and the 
mixture of F127 and gelatin, all PIs had sizes larger than 235 µm, the average size of 
PIs formed on ULA plates. PIs formed on a substrate coated with pure F127 were 
extremely large (up to 600 µm). A coating solution comprising gelatin alone was 
unable to generate suspended PIs suitable for experimental use. However, PIs grown 
on substrate coating with solutions containing both F127 and gelatin components 
reduced PI size than compared to that on F127 coated plate, a trend which was 
inversely proportionate to gelatin concentration. The higher F127 percentage, the 
higher the PIs sizes were. PIs grown on a coating containing 98% and 95% gelatin had 
comparable size and cell number to those generated on ULA. However, these PIs had 
a larger size than those from ULA. By 7 days culture, PIs from 98% gelatin coated 
plates reached the size of 268 ± 10 µm in comparison to ULA counterpart of 235 ±30 
µm. Importantly, populations of these PIs were more uniform in size than PIs grown 
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on ULA plates. The larger PIs’ size led to smaller numbers of total PIs when having 
the same seeding density.(75,171,203) 
 
4.5.2 The cell viability and biofunction of different PIs’ sizes 
The current investigation, therefore, sought to determine the viability/proliferative rate 
of cells within PIs after 3 and 7 days in culture to determine if any coating substrate 
used could prolong the viability of larger PIs in culture. Both MTT and CCK-8 assays 
revealed that PIs generated on F127 performed poorly in terms of 
viability/proliferation, a finding that is conducive with other studies. Prior work has 
shown that large PI size was associated with poor oxygen and nutrient diffusion, 
eventually leading to reductions in proliferation and cell death in the central 
region.(34,204) Interestedly it is found that after 3 and 7 day culture, PIs generated on 
the plates coated with a solution coated 98% gelatin performed very well on both 
assays with the comparable cell viability data to PIs generated on ULA, which had 
smaller PI size. Furthermore, PIs generated on plates coated with a 98% gelatin 
solution displayed the same level of insulin release in GSIS and Western blotting 
assays and 14% higher expression in mRNA assay than PIs formed on  ULA plates. 
This is the first time to reveal larger PIs can achieve similar or higher biofunction in 
comparison to smaller PIs. 
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4.5.3 The possible mechanisms underlying generation of different PIs’ sizes 
The primary mechanism by which PIs display enhanced functionality over monolayers 
is through the establishment or restoration of calcium-dependent gap junction 
signalling.(115) In islets, cell-cell contact  is largely facilitated by E-cadherin,(20,75,96) 
which has previously been shown to be upregulated following configuration of cells 
as PIs.(75) Communication between beta cells is regulated by Cx36.(205) Which is also 
upregulated following configuration of cells as PIs.(204) Thus, regulation of beta cells’ 
spatial arrangement and packing density during the PIs’ formation through the 
substrate property may have an impact to the expression of E-cadherin and connexin 
on beta cells. The outcomes in the current study where the larger PIs exhibited similar 
or better biofunctions to smaller counterparts may be ascribed to the better cellular 
arrangement of beta cells in the PIs. The mRNA of Cx36 expression for PIs generated 
on plates coated with 98% gelatin was displayed increased by ~41% comparing with 
mRNA of Cx36 for PIs formed on ULA plate, (control); the PIs grown on 90% and 
95% coating plates showed slight lower Cx36 expression by around 6-12% than PIs 
generated on ULA plates. Furthermore, the Western blot analysis for Cx36, GLUT2 
and insulin expersions dispayed significan increase (P<0.001-0.0001) in PIs formed 
on 98% coated plate comapred with that formed on adhesive surface. However, the 
the comparison for Western bloting bands in insulin was hard to find out the 
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differences, the semiquantative revealed improvement in the PIs grown on surfaces 
coated with 98% gelatin. The discrepancy needs to be investiged further. 
 
4.5.4 The application of series of coating solution  
The amphiphilic polymer, F127,  has been used to the modify surface properties of, 
for example, glass, polyethylene and polystyrene.(206) Olea et al.  have indicated that 
mixing F127 with a hydrophobic polymer such as alkylphenol leads to the formation 
of micelle structures with stable, large cellular aggregates due to the effect of the 
length of the PPO in the F127 which anchors to the substrate leaving the PEO chain 
dangling in the solution (air).(207) Consistent with these observations, the culture of 
BRIN-BD11 cells on suspension plate coated with F127 generated large PIs in the 
current study most probably due to the strong protein expelling capacity of PEO. 
 
Previously, it has been shown that the coating of tissue culture plastic with a 1% 
gelatin solution resulted in the generation of PIs using the MIN6 cell line.(20) However, 
in the current study, a pure gelatin solution coating suspension plate enhanced BRIN-
BD11 cell adhesion into a dense monolayer. This discrepancy might be due to the 
different cell lines and the types of culture plate used. Mixing of F127 and gelatin in 
the coating solution with different ratios of the two components enabled us to generate 
PIs with different size and internal cell arrangement and investigate the correlation of 
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physical properties of PIs and the biofunctions in a systematic way. In such a way, we 
can produce large PIs with improved cell viability and insulin production. Yang et al. 
have investigated the effect of different types of coating chemicals on PIs’ formation 
and their gene expression and insulin formation from beta cells.(83) The advantages of 
the coating solutions developed in this study are their biocompatibility of the 
components and the consistency without the interfering from coating chemical effect. 
Furthermore, the coating effect is substrate sensitive, which offer more variables to 
fine tune PIs’ configuration and in turn biofunction. 
 
It has been confirmed by that smaller PIs is better for oxygen diffusion. Also, the cell-
cell configuration has established to play an essential role for small diffusion 
molecules such as oxygen,(20) which is consistent of the results obtained in this study. 
We found that PIs formed on 95%, 98% gelatin coated and ULA surfaces facilitated 
more oxygen diffusion than other types. 
 
4.6 Conclusion 
Culture substrate influences the generation of PIs’ physical properties and 
biofunctions. PIs generated on SOP plates coating with the mixture solution of F127 
and gelatin at different ratios exhibited significantly larger size than the PIs produced 
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on ULA plates.  The lower the percentage of gelatin in the coating mixture, the higher 
the size of PIs. 95-98% gelatin coating solution produced more homogenous PIs 
compared with PI sizes formed on ULA. PIs formed on 98% gelatin coated plates had 
larger PIs sizes of 268 ± 10 µm against PIs sizes of 235 ± 30 µm formed on ULA at 
day 7 culture. The similar cell viability/proliferation, insulin production between the 
two types of PIs have been demonstrated. Western blotting and mRNA analysis further 
revealed that PIs formed on 98% gelatin coated plates expressed higher Cx36, GLUT2 
in comparison to the PIs from other types of coated substrates and PIs from ULA. The 
systematical change of coating solution for suspension culture plates demonstrates a 
valuable tool to study PIs’ internal structure and biofunction.  
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5 Chapter 5 Incorporation of beads into 
Pseudoislets and assessment of cellular 
viability 
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5.1 Introduction 
Central necrosis or apoptosis hampers the formation of functional cell aggregates from 
islet cells (Pseudoislets (PIs)) after approximately 7 days in culture. This is largely 
driven by the lack of nutrient and oxygen diffusion to the core of the PIs. Cellular 
viability and growth of the cells drop off dramatically, and insulin concentrations in 
the culture medium decline.(75,90,94) It has been reported that PIs with 150 µm are 
superior to lager PIs (>300 µm) in viability, in vitro functional assays and 
transplantation outcomes. MacGregor et al. (208) have found that smaller PIs were 20% 
more viable, consumed twice as much oxygen and released more than double the 
amount of insulin.(209) It has been confirmed for years that mammalian cells rely on 
oxygen and nutrients for their survival and the natural diffusion limits of these vital 
chemicals are approximately 100 to 200 μm. Thus, blood vessels are essential for 
larger and multicellular organisms to grow beyond 200 μm in diameter naturally.(210) 
Based on this principle; it is easy to understand that the reduction of PI size is a good 
strategy to increase the viability of PIs. Alternatively, if we can generate ‘vents’ in the 
centre of PIs allowing nutrients and oxygen to enter, block the centre for cell residence, 
or deliver anti-necrosis or anti-apoptosis drugs to the centre of PIs, the cell viability of 
larger PIs may increase. 
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Gelatin is a natural polymer commonly used in the biomedical and biotechnology 
fields and is biocompatible. Moreover, it has been found that gelatin is a good 
candidate for preparation of microspheres and microcapsules due to the ability to 
control drug release easily.(210) The highly hydrophilic properties of gelatin lend itself 
to drug absorption and then drug release. Drug release can be controlled via several 
means such as diffusion through a rate-controlling membrane, osmosis, ion exchange 
or degradation of gelatin or a part of gelatin,(211) which can be controlled by either 
varying gelatin molecular weight, or via the extent of material crosslinking.(212) 
 
Furthermore, the incorporation of gelatin beads (GBs) into vascular tissue (human 
smooth muscle) achieves improvements in the delivery of growth factors.(213) GBs can 
be used for sustained release of antibiotics, drugs, vaccines and hormones.(214) For 
instance, by taking the advantages of bead characterisation beyond basic benefits, the 
beads might provide a large surface area and possess an easier estimation of diffusion 
and mass transfer behaviour. The main advantages of using crosslinked GBs for 
incorporation into cell aggregates is that they are biocompatible, biodegradable and 
have a low degree of toxicity when dissolved.(214) Many factors affect fabrication of 
GBs such as the method of crosslinking and the sizes of GBs. Large GBs enable drugs 
delivery to a site over a long period. Additionally, drugs can be released slowly or in 
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a controlled manner by diffusion from carrier-GBs or by decomposition of the carrier 
itself.(182,214–219) 
 
IL-10 produced primarily by monocytes, has a pleiotropic effect in inflammation and 
plays a role in the regulation of immunity through down-regulation of gene expression 
of Th1 cytokines and co-stimulatory molecules on macrophages. In addition, IL-10 
helps in beta cells maintenance and proliferation through regulating of immune and 
autoimmune responses.(218) It also has the ability to block NF-kappa and controls JAK-
STAT signalling pathway.(218) IL-10 has two receptors; IL-10R1 and IL-10R2. The 
mRNA of IL-10R1 participates in all IL-10 responsive cells, while IL-10R2 found in 
the most tissues and cells tested such as human alpha and beta cells and isolated INS-
1E cells. IL-10, IL-13 and IL-4 are positively correlated with glucagon-stimulated C-
peptide levels in human beta cells.(220) The mechanism by which IL-10 helps the 
secretion of pro-inflammatory molecules is still unclear. IL-10 has been found to have 
a positive effect on BRIN-BD11 PIs which is likely to indicate that this cell line has 
IL-10R.(221) This receptor has been proved by one of our colleques in the Guy Hilton 
research centre.(221) Some studies indicated that IL-10 deficiency in mice limits 
autoimmune pathology.(222) IL-10 enhances beta survival, proliferation, antibody 
formation and reduction of the pro-inflammatory potential like TNF-α.(211) Previous 
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studies have proved that the potential of anti-inflammatory cytokines as therapeutic 
targets in type 1 diabetes. Adoptive transfer of immunomodulatory cells preferentially 
secreting anti-inflammatory cytokines, which might result from the role of pro-
inflammatory mediators such as macrophage and regulatory T-cells can be used to a 
reduction in incidents of T1DM and T2DM.(223,224) 
 
Il-1β is a cytokine that is produced by the activation of macrophage as inactive pro-
protein molecule which converts into an active form by the enzyme caspase 1. IL-1β 
acts as a mediator of the inflammatory response and plays a role in many cellular 
activities; like apoptosis, proliferation and differentiation.(220) Several studies on 
pancreatic islets and diabetes showed an increase in the concentration of pro-
inflammatory cytokines such as INF-γ, TNF-α and IL-1β. The pro-inflammatory 
cytokines which are secreted from activated macrophages invade the pancreas. A 
deficiency in regulation of pro-inflammatory cytokine production will lead to the 
development of autoimmune disease such as T1DM.(225) Therefore, increased levels 
of the cytokines are responsible for beta destruction in T1DM.(225) Some researchers 
founded that using IL-1β triggered apoptosis in pancreatic beta cells lines and 
islets.(226) In addition, pro-inflammatory cytokines have been reported to produces 
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apoptosis in beta cell and primary cells.(225) In this study, anti-IL-1β, will use to 
decrease the action of IL-1β. 
 
Based on the above, IL-10 and anti-IL-1β could be effective anti-inflammatory drug 
candidates for the fabrication of large PIs in order to reduce the inflammation-induced 
cell death in the centre and help to enhance PI biofunctionalities. 
 
5.2 Aim 
In this Chapter, we aim to resolve the issue of central necrosis within PIs through the 
incorporation of micrometre scale GBs, which may promote the construction of 
microchannel networks within PIs to help nutrient and oxygen transfer.(13) 
Furthermore, the potential use of GBs as drug carriers to deliver drugs including anti-
necrosis and anti-inflammation drugs in a sustained manner to PIs is investigated. 
In this study, we try to incorporate GBs into PIs after loading with IL-10, which will 
be released in the central region of the PIs aiming to prevent or delay apoptosis and 
inflammation in the centre of PIs. The effect of this corporation on the proliferation 
and cytotoxicity in the term of LDH assay and the ability of these PIs to produce 
insulin after stimulation with glucose will be investigated. Similarly, we try to load 
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anti-IL-1β into GBs and then incorporate the GBs into PIs in order to find out the 
effect of anti-pro-inflammatory drugs to the increase PIs’ biofunctionality.  
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5.3 Materials  
Chemicals, IL-10, anti-IL-1β, gelatin type A and reagents used in this Chapter are 
listed in Chapter 2, Section 2.1. 
 
5.4 Methods 
 
5.4.1 Generation and characterisation of GBs  
Generation, separation, washing and characterisation of GBs from gelatin type A using 
water/oil emulsion are described in Chapter 2, Section 2.2.19 and Chapter 3 Section 
3.4.4. 
 
5.4.2 Incorporation of GBs into PIs 
The incorporation of GBs into PIs via static and agitated manners using different pellet 
formation methods is described in Chapter 2 Section 2.2.20. 
 
5.4.3 Loading and assessment of the mock drug release 
The loading and assessment of the mock cytokine release from GBs are described 
Chapter 2 Section 2.2.22. 
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5.4.4 Loading IL-10, anti-IL-1β to GBs 
The various concentrations of IL-10 and anti-IL-1β were assessed  using CCK-8 assay 
to find out the best concentration which can be used for loading into GBs. The test 
procedure was described in Chapter 2 Section 2.2.21. The method of cytokines loaded 
to GBs was described in Chapter 2 Section 2.2.23. 
 
5.4.5 Measuring PI cellular viability after incorporated with GBs by MTT assay 
After incorporation GBs loaded with IL-10 or anti-IL-1β into PIs, the PIs’ 
mitochondrial respiration was measured by MTT assay as described in Chapter 2 
Section 2.2.7. 
 
5.4.6 Measuring PI cellular viability using CCK-8 
The proliferation of PIs after incorporation with GBs was measured by CCK assay, 
which is clarified in Chapter 2 Section 2.2.8 
 
5.4.7 Measuring cytotoxicity by LDH assay 
The cytotoxicity of PIs after incorporation of GBs was assessed using LDH assay, 
which is described in Chapter 2 Section 2.2.9. 
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5.4.8 Glucose-stimulated insulin secretion 
The effect of GBs loaded with IL-10 and anti-IL1β on the functionality of PIs in term 
of glucose-stimulated insulin secretion is detailed in Chapter 2 Section 2.2.11.  
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5.5 Results 
 
5.5.1 Selection and incorporation of the mock drug to GBs 
After multiple analysis (in Chapter 3), it was confirmed that 40 µm GBs formed with 
a GA vapour crosslinking reaction time of 6 hours was optimal. The swelling rate of 
these GBs was more stable than 30 µm GBs, and the larger size of the GBs offered 
more opportunity for loading of drugs. Thus, 40µm GBs were used in this Chapter 
exclusively. 
 
Goat anti-mouse IgG (H+L) secondary antibody with Alexa Fluor 568 conjugation 
(Ab-dye 568) was selected as a mock drug to be incorporated into GBs at different 
concentrations, and the release profiles of the molecule were tested. Measurement of 
fluorescence intensity allowed for the determination of the released protein. The 
reason to select Ab-dye-568 as the mock drug was its molecular weight (150 kD), 
which was close to the molecular weight of the drugs we hoped to enhance PI viability.  
 
GBs were loaded with the dye and incubated in PBS for 4 days at 37 °C. Confocal 
images of the GBs loaded with Ab-dye-568 are shown in Figure 5.1. The fluorescent 
intensity was directly proportional to the concentration of Ab-dye-568 loaded into 
GBs (Figure 5.1). In addition, after 4 days’ incubation, the fluorescence intensity in 
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GBs was still strong, indicating that the current drug incorporation method can sustain 
the drug within the GBs. 
 
Figure 5.1 Fluorescence images of 40µm GBs incorporating Ab-dye 568 with 
culturing for 4 days 
 
 
GBs were freeze dried for 2 hours then were loaded with mock drug (Ab-dye 568). 
The dye loaded GBs were incubated within PBS for 4 days at 37 °C. Confocal images 
showed the incorporation of dye into the beads with (A) 0 µg/mL; (B) 0.65 µg/mL; 
(C) 1.25 µg/mL; (D) 2.5 µg/mL; (E) 5 µg/mL and (F) 10 µg/mL. Images representative 
of 4 independent experiments performed in triplicate using a 40X objective; scale 
bar=50 µm  
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5.5.1.1 Assessment of Ab-dye 568 release from GBs  
The release of Ab-dye 568 from GBs was assessed quantitatively at different culture 
time points for GBs loaded with different dye concentrations in order to evaluate the 
effect of incubation time and dye concentration on the fluorescence release rate and 
capacity of the GBs to retain dye at 37 °C (Figure 5.2). 
 
The release was significantly elevated from day 2, with peak fluorescence observed at 
day 4, regardless of initial incorporation concentration (P <0.01-0.0001) compared 
with control (dye released at day 1). By day 7, fluorescence fell back towards control 
levels. 
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Figure 5.2 Effect of incubation time and loading concentration of Ab-dye 568 
on the dye release from GBs 
 
 
Quantitative measurement of fluorescence is released from GBs to PBS from day 1 to 
day 7 of incubation at 37 °C. Data are presented as mean ± SD from 3-4 independent 
experiments conducted in triplicate. *P<0.05, **P<0.01, ***P<0.001 and 
****P<0.0001 compared with fluorescence of control (dye released at day 1). 
 
5.5.2 Assessment of the GBs incorporation methods into PI 
Different methods have been tried to incorporate GBs into the centre of PIs in order to 
form voids in the PIs, or to block cell residence in the centre, which allowed gas and 
nutrient molecules to be diffused to PIs from media within the 100-200 m distance. 
 
5.5.2.1 Via using flat bottom ULA plate 
The first method used to incorporate GBs into PIs was using ULA flat bottom plate 
plus the shaking of the plate, which aimed to form aggregations of cells and force GBs 
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to the inner side of the aggregates. Figure 5.3A shows that this method was an 
inappropriate means of incorporation of GBs into the centre of PIs. This method also 
produced huge suspension aggregations. After 1, 3 and 7 days’ culture, both 
aggregations with and without GBs did not show compact cell aggregations as 
exhibited in Figure 5.3A. 
 
The assessment of the cellular viability of the aggregates incorporated with GBs 
showed that the proliferation of the cells was significantly increased (P<0.001) after 3 
days and 7 days of culture compared with the proliferation of the aggregation free GBs 
(control after 1 day culture). An interesting phenomenon was that the incorporation of 
GBs into the cells increased the cell viability (MTT assay) of cells (Figure 5.3B). 
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Figure 5.3 Effect of incorporating GBs into PIs by using ULA suspension 
plates with shaking 
 
 
A: Live images of BRIN-BD11 PIs generated at cell seeding density of 32,000 
cells/well using the ULA plate flat bottom. B: The impact of GBs on PIs proliferations 
assessed after 3 days and 7 days using MTT assay. Data are presented as mean ± SD 
from 3-4 independent experiments conducted in triplicate. *P<0.05, **P<0.01, 
***P<0.001 compared with PIs without GBs (control) using a 10X objective; scale 
bar = 150 µm 
 
5.5.2.2 Via using Eppendorf tube  
The second method to incorporate GBs into the PIs used Eppendorf tubes. This method 
was also found to be inappropriate for the incorporation of GBs into PIs. Figure 5.4A 
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showed that the beta cells did not form clear PIs in a spherical shape; also not all PIs 
were incorporated with GBs  
 
MTT assay was used to assess the proliferation of aggregates. The MTT assay results 
showed that the cell proliferation was significantly decreased (P<0.001) at 7 days 
culturing compared with the proliferation of the cells in PIs free of GBs after day 1 
culture (control). Similar to incorporation using ULA method, the presence of GBs 
resulted in improvements in the cell viability of the PIs after 1, 3 and 7 days culture 
comparing with control (PIs free of GBs) as shown in Figure 5.4B. 
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Figure 5.4 Effect of incorporation GBs into PIs by Eppendorf tube method on 
cell viability 
 
 
A: Live images of BRIN-BD11 PIs formed in Eppendorf tube at cell seeding density 
of 32,000 cells/well. B: The impact of GBs on PIs proliferations using Eppendorf tube 
and assessed after 1 day, 3 days and 7 days using MTT assay. Data are presented as 
mean ± SD from 3-4 independent experiments conducted in triplicate. *P<0.05, 
**P<0.01, compared with control (PIs free of GBs) using a 10X objective; scale bar = 
150 µm. 
 
5.5.2.3 Via using round bottom ULA plate 
Figure 5.5A represents the PIs incorporating GBs using ULA round bottom 96 well 
plate. This method showed that GBs have successfully incorporated in the centre of 
PIs and the PIs exhibited symmetric spheroid morphology. Many GBs were stable in 
PIs after 7 days culture.  
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MTT assay was used for a quantitative assessment of the cell viability within the PIs. 
The MTT assay results showed that proliferation of the cells of PIs incorporating with 
GBs increased about 25% after 7 days culture compared with PIs without GBs as 
shown in Figure 5.5B. 
 
Figure 5.5 Effect of incorporating GBs into PIs using round bottom ULA 
plate on cell viability 
 
 
A: Live images of BRIN-BD11 PIs generated in ULA bottom round plate at cell 
seeding density of 32,000 cells/well. B: the impact of GBs on PIs proliferations using 
ULA round bottom plate round bottom and assessed after 1, 3 and 7 days culture using 
MTT assay. Data are presented as mean ± SD from 4-5 independent experiments 
conducted in triplicate. *P<0.05, **P<0.01, compared with control (PIs free of GBs) 
using a 10X objective; scale bar = 150 µm. 
 191 
 
5.5.3 The effect GB incorporation on PIs’ size and morphology  
In order to investigate the impact of incorporating GBs into large and small PIs sizes, 
ULA round bottom plates were used to produce PIs with two seeding densities, 32,000 
cells/well and 64,000 cells/well. Incorporation of 25-30 GBs into PIs for 32,000 
cells/well and 50-60 GBs into PIs for 64,000 cells/well were performed (Figure 5.6). 
 
Figure 5.6 Live images of PIs with GBs incorporation and cultured for 7 days 
 
 
Live images of BRIN-BD11 PIs generated with cell seeding densities 32,000 
cells/well free of GBs (A); 32,000 cells/well with GBs (B); 64,000 cells/well free of 
GBs (C); 64,000 cells/well with GBs (D) using a 20X objective; Scale bar is 150 µm 
for A, B and 200 µm for C, D 
 
The size of these PIs with and without GBs was quantified using ImageJ after day 1, 
3 and 7 in culture. The sizes of PIs were significantly increased (P<0.01) after 3 days 
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and 7 days of culturing for the PIs with GBs comparing with PI free of GBs (control) 
for cell seeding densities (32,000 cells/well); while for another cell seeding density 
(64,000 cells/well) there was a significant increase  (P<0.05) for PIs incorporation of 
beads only at day 7 compared with PIs with control (Figure 5.7). 
 
Figure 5.7 Effect of the cell density and GBs on PIs size 
 
 
BRIN-BD11 cells were seeded at densities of 32,000 cells/well (A) 64,000 cells/well 
(B) and the impact of cell seeding density on PI size assessed after 1, 3, 7 days in the 
presence (‘incorporated’) or absence of GBs. Data are presented as mean ± SD from 
3 independent experiments conducted in triplicate. *P<0.05 and **P<0.01 compared 
with control (PIs free of GBs). 
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5.5.4 The effect of coated GBs on the cell viability of PIs 
The effect of coated GBs on the cell viability of PIs was assessed after 7 days culture 
(Figure 5.8A). Incorporation of GBs coated with fetal bovine serum (FBS), or 
fibronectin (FN) did not affect the proliferative rate of PIs. However, GBs coated with 
inactivated FBS showed a small improvement in proliferation (P<0.05; Figure 5.8B) 
comparing with control (PIs only) by using MTT assay. 
 
Figure 5.8 Effect of GB coating on the proliferation of PIs incorporating with 
the GBs 
 
 
A: Live images of BRIN-BD11 PIs seeded at 32,000 cells/well and incorporating GBs. 
B: the impact of coated GBs on PIs proliferations assessed after 7 days culture using 
MTT assay. Data are presented as mean ± SD from 3-4 independent experiments 
conducted in triplicate. FN refers to fibronectin. *P<0.05, compared with control (PIs 
free of GBs). Scale bar = 150 µm. 
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5.5.5 Assessment of the activity of PIs after loaded with anti-inflammatory 
drugs 
IL-10 is a regulatory cytokine which inhibits antigen presentation and subsequent pro-
inflammatory release. This cytokine has been used as a potent anti-inflammatory agent 
in various biological applications.(216) IL-1β is a potent pro-inflammatory cytokine 
which is essential for host-defence responses to infection and injury.(212) So, 
incorporating IL-10 and anti-IL-1β agents inside of PIs and achieving sustained 
release of the agents in PIs could delay the inflammation of cells and improve the 
biological functionality of PIs. 
 
5.5.5.1 The effect of IL-10 concentrations on the cell viability of PIs 
IL-10 solutions at different concentrations in culture media were used to assess the 
optimized concentration for PIs’ viability. The proliferation of PIs at day 7 culture was 
measured using CCK-8 assay (Figure 5.9A, B). The CCK-8 assay results showed that 
IL-10 concentrations between 10 ng/mL and 1000 ng/mL significantly increased 
(P<0.05-0.0001) the proliferation of the PIs. Also, it can be seen that the PIs cultured 
with 100 ng/mL of IL-10 in the media had the highest viability (P<0.0001) (Figure 5.9 
B). 
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Figure 5.9 Effect of different concentrations of IL-10 on the cell viability 
 
 
A: live image of BRIN-BD11 PIs generated at cell seeding densities of 32,000 
cells/well. B: the impact of the GBs loading with IL-10 of different concentrations on 
the proliferation of PIs after 7 days culturing using CCK-8 assay. Data are presented 
as mean ± SD from 3-4 independent experiments conducted in triplicate. *P<0.05, 
***P<0.001 and ****P<0.0001 compared with control (PIs with 0 ng/mL of IL-10). 
Scale bar = 150 µm 
 
5.5.5.2 The effect of anti- IL-1β concentrations on the cell viability of PIs 
Anti-IL-1β solutions at different concentrations in culture media were used to assess 
the optimized concentration for PIs’ viability. The proliferation of PIs at day 7 culture 
was measured using CCK-8 assay. The CCK-8 assay results displayed that anti-IL-1β 
concentrations between 0 µg/mL and 1000 µg/mL significantly increased (P<0.0001) 
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the proliferation (cell viability) of the PIs. Also, it was seen that the PIs mixed with 
100 ng/mL of IL-10 had the highest (P<0.0001) proliferation as shown in Figure 5.10B. 
 
Figure 5.10 Effect of anti-IL-1β concentrations on the cell viability of PIs 
 
 
A: live images of BRIN-BD11 PIs generated at cell seeding densities of 32,000 
cells/well. B: the impact of the GBs with anti-IL-1β in different concentrations on the 
proliferation of PIs after 7 days culturing using CCK-8 assay. Data are presented as 
mean ± SD from 4-5 independent experiments conducted in triplicate. ***P<0.001 
and ****P<0.0001 compared with control (PIs with 0 µg/mL anti-IL-1β). 
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5.5.6 Assessment of the functionality of PIs incorporated with GBs loaded IL-
10 and anti-IL-1β 
 
5.5.6.1 Assessment using CCK-8 assay 
 
5.5.6.1.1 GBs loaded with IL-10  
After a study of the dose effect of IL-10 on the cell’s viability, the GBs were loaded 
with the best effective dose, 100 ng/mL IL-10, and then incorporated into PIs. The cell 
proliferation of PIs was estimated by using CCK-8 assay after 7 days of culture. The 
results showed that the proliferation of PIs with cell seeding density 32,000 cells/well 
significantly increased (P<0.05-0.0001) after 3 7 days in culture. Furthermore, the 
incorporation of GBs without loading IL-10 showed a significantly improved (P<0.05-
0.01) proliferation of the PIs after 3 days and 7 days in the culture comparing with 
proliferation of PIs only (control). The PIs incorporating GBs only or with GBs loaded 
with IL-10 showed a significant increase (P<0.05 and P<0.01) in proliferation, at 3 
days and 7 days in comparison with control (PIs only) as shown in Figure 5.11A. 
Furthermore, the incorporation of GBs without loading IL-10 showed the same trend 
with significantly improved (0.0001) proliferation of the PIs after 3 days and 7 days. 
 
 198 
 
Figure 5.11B shows the effect of GBs loaded IL-10 and incorporated into PIs at cell 
seeding density 64,000 cells/well on the proliferation. The PIs were assessed by using 
CCK-8 assay during 7 days culture. The activity of cells within PIs which were 
incorporated with GBs loaded with IL-10 was significantly increased (P<0.05-0.0001) 
after 3 and 7 days in the culture (comparing with the activities of the control (PIs free 
of GBs) as shown in Figure 5.11B. Whereas the proliferation of PIs significantly was 
increased (P<0.05-0.01) when the PIs incorporated with GBs only. So using IL-10 to 
be sustained release in the central of PIs could improve the cell viability in PIs cultures 
with cells seeding density of 64,000 cells/well. 
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Figure 5.11 Effect of GBs loaded with IL-10 on the proliferation of PI cells 
 
 
A: Cell seeding density 32,000 cells/well. B: Cell seeding density 64,000 cells/well. 
Data are presented as mean ± SD from 4-5 independent experiments conducted in 
triplicate. *P<0.05, **P<0.01 and ****P<0.0001 compared with control (PIs only) 
 
5.5.6.1.2 GBs loaded with anti-IL-1β 
After determination, the best dose of anti-IL-1β to be loaded in GBs was found as 5 
µg/mL. Then, the GBs loaded with 5 µg/mL anti-IL-1β were incorporated into PIs. 
The cell viability of PIs was estimated by using CCK-8 assay during 7 days culture. 
The results showed that the cell viability of PIs with cell seeding density of 32,000 
cells/well without GBs did not change at day 3, but reduced at day 7 culture. The cell 
viability of PIs incorporating with GBs loaded with anti-IL-1β was significantly 
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increased (P<0.0001) in comparison with control as shown Figure 5.12A. 
Furthermore, the PIs incorporated with GBs without anti-IL-1β also showed 
significant improvements in the proliferation of the PIs after 7 days culture in PIs with 
cell seeding density of 32,000 cells/well as shown in Figure 5.12A. 
 
Figure 5.12B shows the effect of loading anti-IL-1β into GBs which were incorporated 
into PIs with cell seeding density of 64,000 cells/well on cell viability. The cell 
viability of the PIs was assessed by using CCK-8 assay during 7 days culture. The 
activity of cells within PIs which incorporated with GBs loaded with anti-IL-1β was 
significantly increased (P<0.05) after 1 day, 3 days (P<0.0001) and at 7 days 
(P<0.0001) comparing with that of control (PIs only) (Figure 5.12B). Whereas the cell 
viability of PIs significantly increased (P<0.01-0.001) at day 3 and day 7 culture 
respectively when incorporated with GBs without anti-IL-1β. So using anti-IL-1β 
loaded GBs which sustained release in the central of PIs would improve the cell 
viability in PIs with cell seeding density of 64,000 cells/well as shown in Figure 5.12B. 
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Figure 5.12 Effect of anti-IL-1β within GBs on the proliferation of PI cells 
 
 
A: Cell seeding density 32,000 cells/well. B: Cell seeding density 64,000 cells/well. 
Data are presented as mean ± SD from 4-5 independent experiments conducted in 
triplicate. * P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001 compared with control 
(PIs only). 
 
5.5.6.2 Assessment of cellular LDH release 
The cellular LDH release was used to measure the integrity of cellular membranes, 
which is elevated during cell death or cell apoptosis in PIs.(156) Four experimental 
groups have been examined: PIs only, PIs incorporating GBs, PIs incorporating GBs 
loaded with anti-inflammatory cytokines, PIs cultured with free anti-inflammatory 
cytokines in culture media. 
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5.5.6.2.1 PIs incorporating GBs loaded with IL-10 
The cellular LDH released from PIs seeded at 32,000 cells/well was investigated at 
day 7, and the results are shown in Figure 5.13A. PIs generated significance (P<0.01 
and P<0.001) lower LDH values, when incorporated with GBs or GBs loaded with IL-
10 compared with PIs only group (control) after 7 days in culture as shown in Figure 
5.13A. While adding IL-10 directly in media for PI culture did not show a significant 
decrease the LDH release compared with PIs only group (control) after 7 days in 
culture as shown in Figure 5.13A 
 
The same trend was observed for the cellular LDH released from PIs seeding at 64,000 
cells/well at day 7, and the results are shown in Figure 5.13B. PIs generated 
significance (P<0.05 and P<0.001) lower LDH values when PIs incorporated with 
GBs or GBs loaded with IL-10 compared with PIs only group ((control) after 7 days 
in culture. Therefore, using GBs and GBs loaded with IL-10 decreased the cytotoxicity 
in the term of cellular LDH release.(213). Also for large PIs (64,000 cells/well, adding 
anti-IL-10 directly to media did not show a significant decrease the LDH release 
compared with PIs only group (control) after 7 days in culture as shown in Figure 
5.13B. 
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Figure 5.13 Cellular LDH release in PIs incorporating the GBs loaded with IL-
10 at day 7 
 
 
A: Cell seeding density 32,000 cells/well. B: Cell seeding density 64,000 cells/well. 
Data are presented as mean ± SD from 4 Independent experiments conducted in 
triplicate. *P<0.05 and ***P<0.001 compared with control (PIs only).   
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5.5.6.2.2 PIs incorporating GBs loaded with anti-IL-1β 
The cellular LDH released from PIs seeded at 32,000 cells/well was investigated at 
day 7, and the results are shown in Figure 5.14A. PIs generated significance (P<0.01 
- P<0.0001) lower LDH values when incorporated with GBs, or GBs loaded with anti-
IL-1β compared with PIs only (control) after 7 days in culture shown in Figure 5.14A. 
But adding anti-IL-1β directly to media did not show a significant decrease in the LDH 
release compared with LDH release from PIs only group (control) after 7 days in 
culture Figure 5.14A. 
 
On the same trend was observed the cellular LDH released from PIs seeded at 64,000 
cells/well was investigated at day 7, and the results are shown in Figure 5.14B. PIs 
generated significance (P<0.01 - P<0.0001) lower LDH values when PIs incorporated 
with GBs or GBs loaded with anti-IL-1β compared with PIs only (control) after 7 days 
in culture. Therefore, using GBs and GBs loaded with anti-IL-1β significance (P<0.01 
- P<0.0001) decreased the cytotoxicity in the term of cellular LDH release compared 
with PIs only (control) after 7 days in culture. Also. adding anti-IL-1β directly to 
media was revealed a significant decrease (P<0.01) in the LDH release compared with 
LDH data of PIs only group (control) after 7 days in culture (Figure 5.14B).  
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Figure 5.14 Cellular LDH release in PIs incorporating the GBs loaded with 
anti-IL-1β at day 7 
 
 
A: Cell seeding density 32,000 cells/well. B: Cell seeding density 64,000 cells/well. 
Data are presented as mean ± SD from 4 independent experiments conducted in 
triplicate. *P<0.01 and ***P<0.001 compared with control (PIs only)  
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5.5.6.3 Assessment of GSIS release 
 
5.5.6.3.1 GBs loaded with IL-10 
GSIS of PIs seeded at 32,000 cells/well with and without incorporation of GBs loaded 
with recombinant IL-10 was assessed. As shown in Figure 5.15, PIs culturing with 
free IL-10 in media or PIs incorporated with GBs or PIs incorporated with GBs loaded 
with IL-10 showed significant increases (P<0.01-0.001) in GSIS comparing with PIs 
only (control) at day 7 in culture. Therefore, the addition of GBs and IL-10 into PIs 
improved the functionality of PIs regarding GSIS. 
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Figure 5.15 Effect of incorporating GBs loaded with IL-10 into PIs on GSIS  
 
 
BRIN-BD11 cells were seeded at 32,000 cells/well and allowed to form PIs over a 
one-week period. Cells were exposed to recombinant IL-10 (100 ng/mL) alone, GBs 
alone, or GBs loaded with recombinant IL-10. Data are presented as mean ± SD from 
3 Independent experiments conducted in triplicate. **P<0.01 and ***P<0.001 
compared with control (PIs only). 
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5.5.6.3.2 GBs loaded with anti-IL-1β 
GSIS of PIs seeded at 32,000 cells/well with and without incorporation of GBs loaded 
with recombinant anti-IL-1β was assessed. As shown in Figure 5.16, PIs culturing with 
free IL-10 in media and PIs incorporated with GBs loaded with anti-IL-1β showed 
significant increases (P<0.01-0.001) in GSIS comparing with PIs only (control) at day 
7 in culture. Therefore, the addition of GBs and anti-IL-1β into PIs improved the 
functionality of PIs in term of GSIS assay. 
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Figure 5.16  Effect of incorporating GBs loaded with anti-IL-1β into PIs on 
GSIS 
 
 
BRIN-BD11 cells were seeded at 32,000 cells per well and allowed to form PIs over 
a one-week period. Cells were exposed to anti-IL-1β alone, incorporated with GBs 
alone, or GBs loaded with anti-IL-1β. Data are presented as mean ± SD from 3 
Independent experiments conducted in triplicate. **P<0.01, ***P<0.001 and 
****P<0.0001 compared with control (PIs only).  
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5.6 Discussion 
Although varied approaches have been used to generate PIs from cell suspensions, 
most of these approaches involve the use of suspension surfaces,(27,83) which are often 
associated with central necrosis.(17,18) In this Chapter, we aimed to improve the central 
necrosis of large PIs to ensure high cellular viability and good functionality regarding 
glucose-stimulated insulin secretion. Two approaches were employed: firstly, GBs 
were incorporated into PIs to create the vent or reduce cell residence in the centre of 
PIs; secondly, GBs were loaded with anti-inflammation or anti-necrosis agents to 
enhance cell survival. 
 
Multiple assays confirmed that the GBs could be incorporated into PIs to produce 
voids within PIs, evidenced by the higher cell viability and insulin production. 
Synergistic use of GBs loaded with anti-inflammatory drugs further improved the cell 
viability and PIs’ functionality. 
 
5.6.1 Incorporation of GBs into PIs improved cell viability 
The incorporation of GBs into PIs resulted in enhanced cell viability of PIs regardless 
of the seeding density used. This may arise due to the creation of a void following the 
dissolution of the GBs resulting in a morphological arrangement that enabled the 
efficient and easy exchange of gases and nutrients from the media to the cells. It was 
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exhibited that PIs with GBs incorporated formed larger structures without an increase 
in cell number. This again was likely due to the space created by the GBs. This 
arrangement of cells with ‘pockets’ where the GBs were present, was likely to 
significantly improve nutrient and oxygen diffusion to the centre of the PI and may 
account for the improvements in viability observed here and elsewhere.(214,215) 
Incorporating GBs to large PIs has special benefit and interests because this method 
can create a better gas and nutrient exchange environment to overcome the 200 µm 
diffusion limit.(4) 
 
5.6.2 The synergetic effect of incorporating GBs loaded with anti-inflammatory 
cytokines on the cellular activities of PIs  
To investigate the protective effects of anti-inflammatory cytokines on the cellular 
activities of PIs, both IL-10 and anti-IL-1β were loaded into GBs and compared with 
cytokines added to culture media in free form and also, to GBs only. Adding both IL-
10 and anti-IL-1β to culture media increased PIs’ viability. The viability of PIs 
increased by only 15% for cell seeding density of 32,000 cells/well and 11% for cell 
seeding density of 64,000 when IL-10 was added directly to culture media comparing 
with PIs only (control) at day 7. Similarly, adding anti-IL-1β directly to media slightly 
improved the viability of PIs in terms of the CCK-8 assay (at day 7) by 14% for 32,000 
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cells/well and 13% for 64 cells/well at the same day (day 7) comparing with control 
(PIs with free of GBs).  
 
The sustained release of the anti-inflammatory drug from GBs showed the 
enhancement of the PIs functionality. The release of IL-10 increased cell viability by 
60% at a cell seeding density of 32,000 cells/well and 35% at a cell seeding density of 
64,000 cells/well for PIs with GBs loaded with IL-10 compared with control at day 7. 
Also, the viability was elevated by 35% at a cell seeding density of 32,000 cells/well 
and 40% at al cell seeding density of 64,000 cells/well for PIs with GBs loaded with 
anti-IL-1β compared with control at day 7. 
 
The cytokines in free form placed in cell culture environment have short activity time 
due to degradation by proteinases released from the cultured cells. The incorporation 
of GBs loaded with cytokines into PIs apparently protected the cytokines from 
degradative processes and sustained the slow release of cytokines from GBs ensuring 
prolonged anti-apoptotic or anti-necrosis. Both cell viability assay and insulin 
production assay revealed the synergetic effect when the anti-inflammatory cytokines 
were loaded into GBs, and the GBs were incorporated into PIs in comparison to the 
incorporation of GBs only or using free cytokines.  
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5.6.3 The possible working mechanisms of IL-10 and anti- IL-1β loaded GBs in 
PIs 
The improvement of the cellular activities of the PIs by GBs and further improvement 
by the GBs loaded with IL-10, and anti-IL-1β gave us the opportunity to study the 
main cause that reduced PIs’ functionality during the prolonged culture.   
 
It is well known that IL-10 is derived from macrophages and TH2 cells and exerts 
anti-inflammatory effects by inhibiting IL-12 and other pro-inflammatory macrophage 
cytokines (such as IL-1, IL-6, IL-8 and TNFα) via increasing macrophage production 
of IL-1 receptor antagonist and by inhibiting the generation of oxygen and nitrogen 
free radicals by the macrophage.(216,217) On the other hand, IL-1β works as a pro-
inflammatory cytokine with cells displaying elevated levels of the cytokine under 
inflammatory challenge.(212) Importantly, IL-1β is centrally driven by beta cell 
apoptosis in type 1 diabetes. In the current study, anti-IL-1β was employed to inhibit 
the action of IL-1β as an anti-inflammatory drug. According to the observation of 
Rubartelli and colleagues,(218) the cellular IL-1β is localised in intracellular vesicles 
and secreted by an intracellular membrane. It is elevated under stress condition,(233,234) 
but can be redirected to the extracellular space following inappropriate secretion. They 
proved that IL-1β could be blocked by using methylamine and low temperature.(219) 
The anti-IL-1β possibly delays or prevents cell signals from reaching to localised 
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cellular IL-1β, and the pro-inflammatory cytokine would delay from being secreted. 
In this study, we applied IL-10 or anti-IL-1β to PIs and improved PIs’ activities. These 
observations indicate that inflammatory reactions or cell stress in PIs due to low 
oxygen level might be the main cause of PIs’ lower cell viability and functionality 
after the prolonged culture. Hence, effective and sustained delivering of anti-
inflammatory agents to PIs will be an effective strategy to enhance PIs’ activities. 
 
5.6.4 Multiple assessment techniques 
In this study, multiple assays have been used to assess the enhancement effect of GBs. 
It is found that measurement of LDH is a feasible and sensitive assay alongside cell 
viability and GSIS assay. 
 
Through using a sustained release of IL-10, the cellular LDH release from PIs with 
GBs loaded with IL-10 displayed a significant decrease in the ratio between cellular 
LDH release at day 7 culture and day 1 from a 3-fold against control to a 1.25-fold for 
PIs with GBs loaded with IL-10. This was consistent with results obtained from the 
cell viability, which was higher in PIs with GBs loaded with IL-10. Additionally, the 
LDH release was consistent with the results of mitochondrial and membrane activity 
assessed by CCK-8 that showed decreasing at day 7 culture due to some degree of 
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hypoxia in the central region of PIs which also the changes in the cellular integrity.(150) 
The enhancement outcome of PIs with GBs in GSIS was consistent with LDH and cell 
viability assays. 
 
The cellular LDH released from the PIs showed a decline when GBs loaded with IL-
10 were incorporated into the PIs regardless of the seeding density used. Similar data 
was contained with the use of anti-IL-1β. Ultimately, the viability and functionality of 
PIs over a one-week culture were improved with insulin production increased by 1.5-
fold when IL-10 was loaded onto GBs and by 1.6-fold when anti-1L-1β was loaded 
onto the GBs over a one-week culture period. 
 
5.6.5 The effect of dose and type of anti-inflammatory cytokines 
Two types of anti-inflammation cytokines have been included into GBs. For IL-10, 
100 ng/mL was used for GB loading and then incorporated into PIs. It caused an 
increase in the viability by 62% compared with control (PI free of IL-10). While 
loading of 5 µg/mL of anti-IL-1β into GBs and incorporating to PIs has elevated the 
viability by 35% comparing with PIs free of anti-IL-1β. The direct comparison of the 
effect of IL-10 and anti-IL-1β cytokine on the enhancement of PIs’ activities is 
difficult from this study. The molecular weight and the total loaded mass of the two 
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cytokines to GBs were different. Further investigation is required to define the 
working pathway, and more candidate cytokine for GB loading should be undertaken. 
 
5.7 Conclusion 
The incorporation of GBs into the centre of PIs was successfully fabricated in this 
study. Thus GBs facilitated the creation of voids or blocked from being located in the 
centre of PIs. The proliferation of PIs significantly increased by incorporation of GBs 
into PIs. This was confirmed by both MTT and CCK-8 assays for large and small PIs. 
 
Adding free anti-inflammatory drugs directly to the media showed an improvement in 
the functionality of PIs compared with PIs free of cytokines regardless. However, the 
improvement of the free anti-inflammation agents in the culture media was lower than 
the effect by incorporating GBs loaded with these agents into PIs. Both cell viability 
assay and GSIS assay showed that incorporating GBs only to PIs improve the PIs’ 
performance. The sustained release of anti-inflammatory drug from GBs showed even 
higher enhancement of PIs’ functionality, indicating a synergetic effect. The benefit 
from the release of both IL-10 and anti-IL-1β for the PIs were manifested as the rise 
of the cellular activities, decreasing of cellular LDH release, and eventually, the 
elevated amount of insulin released. 
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The cellular LDH activity was decreased by ~30-50% after incorporated PIs with GBs 
loaded with IL-10 comparing with PIs free of IL-10 at cell seeding densities of 32,000 
cells/well and 64,000 cells/well over a one-week culture. Also, it was seen that cellular 
LDH activity declined by ~30% compared with PIs free of IL-10 at cell seeding 
density of 64,000 cells/well over a one-week culture. The results of the cellular LDH 
level could relate to the improvement in the viability of PIs with GBs loaded with IL-
10. The increase in cell viability went up to 35% with sustained released of IL-10 from 
PIs. Similarly, the results of cellular LDH released from PIs incorporating with GBs 
loaded with anti-1L-1β showed improvements in the functionality of PIs in terms of 
decreasing LDH release. There was no clear difference in the effect of IL-10 and anti-
IL-1β in the current study. 
 
The functionality of PIs over a one-week culture was increased and indicating that the 
production of insulin from incorporated PIs was increased by ~1.5-fold when IL-10 
loaded in GBs and by ~1.6-fold when anti-1L-1β loaded to the GBs. Overall, the 
inclusion of anti-inflammatory or anti-apoptotic agents bound to GBs appears to be an 
effective strategy to enhance cell survival and improve the functionality of PIs.  
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6 Chapter 6 General discussion, conclusions, and future directions 
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6.1 Overall discussion 
Type 1 diabetes mellitus is a metabolic disorder characterised by hyperglycaemia due 
to death or loss of pancreatic beta cells. It is caused mainly by autoimmune destruction 
of insulin-producing beta cells, which leads to the development of macro and 
microvascular complications. The current treatment is exogenous insulin therapy. The 
key disadvantage of insulin treatment is that injected insulin does not generate a 
physiologically representative feedback mechanism. External monitoring of glucose 
levels by patients is required. Therefore, research into a new method of treatment is 
needed. 
 
Cell therapy and pancreatic transplantation are alternative treatments for T1DM. 
Implantation of functional pancreatic tissue or cells may re-build the glucose-insulin 
feedback loop and maintain steady blood glucose levels. However, this type of 
treatment has faced a limitation due to immune rejection and insufficient supply. 
Therefore, mimicking islet through formation or generation of pseudoislets (PIs) in 
vitro could be used for insulin production or in vivo transplantation. In addition to 
other problems, the central necrosis of the PIs after the prolonged culture is still the 
main challenge. This project has studied two new techniques to battle this challenge; 
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controlling PIs’physical properties by substrate coating chemistry and incorporating 
gelatin beads into PIs to reduce inflammatory reaction. 
 
6.1.1 Rational design of coating solutions to change substrate properties  
A most convenient technique to generate a large number of PIs is through suspension 
culture. Although commercially available culture plates including bacterial Petri 
dishes and ultra-low attachment (ULA) culture plates could generate PIs, the formed 
PIs do still not possess optimal biofunctionality. Furthermore, these plates do not allow 
for a systematic study on the relation of the physical properties of PIs and their 
biofunctionality.  
 
A series of coating solutions for suspension plates have been designed and produced 
in this study to control the physical properties of the substrate of suspension plates, 
which can influence PIs’ physical properties. With the change of the ratio of gelatin 
type, A solution and F127 solution in the coating solutions and coating plates’ 
chemistry, the use of adhesion or suspension plate, various substrate properties of 
suspension plates have been generated. ATR-FTIR spectra, surface protein adsorption 
and CA assessment, revealed the differences, which aided understanding of the effect 
 221 
 
of the chemical coating of the substrate on the size of cell aggregates (28,144) and the 
corresponding mechanisms governing this. 
 
It was confirmed that using amphiphilic chemicals, such as F127, in mixture coating 
solution can tailor the substrate properties. A better coating solution could be used for 
PIs generation leading to the production of small and homogenous sized PIs in large 
numbers from each batch culture. 
 
6.1.2 Relationship of PI biofunctions to the surface properties of culture plates 
Because of the limitation of using ULA plates or bacterial Petri dishes for production 
of PIs,(148,227) a series of coating solutions have been applied to different culture plates 
aiming to fabricate PIs with high homogeneity, small sizes and large numbers, 
enabling improvements in PI viability and functionality through their physical 
properties. 
 
Coating SOP plates with F127 caused changes in the surface properties (228) through 
increasing the hydrophobicity of the surface which could cause cells to adhere to each 
other in densely packed cell aggregates.(207) The current study has proved that coating 
of SOP with F127 formed large sized PIs when culturing beta cells. Using gelatin type 
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A solution for coating SOP plates led to the formation of a 2D cell sheet over a one-
week culture period. Thus, we expect that using a mixture of F127 solution and gelatin 
solution to coat SOP can induce beta cells into different cell aggregation structures, 
enabling manipulation of PI size and cell packing properties. The underlying 
mechanisms could be that increase of gelatin content in the coating solution tuned the 
overall hydrophilicity of coated substrates due to gelatin’s medium hydrophilicity. The 
mixture coating solutions produced distinct changes of chemical and physical 
properties to SOP plates but not to TCP plates. The degree changes to SGP were 
between SOP and TCP substrates. This was mainly caused by the interaction of the 
amphiphilic F127 with the hydrophilicity of the original substrate. 
 
The crucial investigation in this study was to determine the relationship between 
viability/proliferation rate of cells within the PIs to the coating solutions used. 
Therefore, the coating of the substrate can be optimised to produce homogeneous and 
relatively larger PIs, which would maintain prolonged biofunction in culture. Both 
MTT and CCK-8 assays for measuring proliferation, immunostaining of key cell-cell 
adhesion molecules and receptors, oxygen-consuming assay, PCR and protein 
expression of key genes and proteins in insulin production have been undertaken. The 
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outcomes of these assays revealed a consistent relationship between substrate coating 
and function. 
 
It was confirmed that large PIs associated with poor central oxygen and nutrient 
diffusion lead to reductions in cellular proliferation.(34,204) The novel finding in this 
study was that 98% gelatin in mixture with F127 generated small PIs with a high 
proliferative rate at 3 and 7 days culture. Moreover, the immunohistochemistry 
staining for the PIs generated by 95%, and 98% gelatin in mixture with F127 showed 
more mRNA and protein expression for Cx36, GLUT2 and insulin. The expression of 
GLUT2 was the highest in PIs grown on a coating solution of 98% gelatin by the 
Western blotting. Thus it is easily understood that PIs grown on a coating solution of 
98% gelatin in combination with F127 generated more insulin in GSIS assay. 
Altogether, the primary glucose sensor in the beta cells was significantly enhanced by 
the optimised configuration of cells in the PIs in comparison to PIs formed on different 
coating substrates. Through the systematic change of the substrate chemistry and 
assessment of PIs physical and biochemical properties, a consistent trend was 
observed that small PIs with appropriate cell-cell package/contact was associated with 
higher proliferative rates and insulin production.(83) 
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Prior studies have demonstrated that the spherical 3D configuration of pancreatic islets 
is vital for the secretion of insulin and regulation of blood glucose levels.(34,73,229) 
Several studies have been investigated that 3D structure of PIs significantly stimulates 
insulin secretion in response to glucose and other stimulations.(83,230) Some researchers 
have shown that different coating types led to varied gene expression and GSIS 
outcome from pancreatic beta cells.(83) The initial mechanism by which PIs exhibit 
enhanced functionality over monolayers is through formation or rebuilding of 
calcium-dependent gap junction signalling.(115) In native islets, cell to cell 
communication facilitated by E-cadherin is upregulated following PI formation.(75) In 
the beta cells, the regulation or stimulation is achieved by Cx36(75) which is also 
upregulated following configuration of cells as PIs.(75,240) These mechanisms have 
been observed and confirmed in the current study, where all PIs showed improved 
expression of Cx36 at both the mRNA and protein level in comparison with cells 
grown as an adhesive monolayer. The new coating formula allowed us to compare and 
select optimal conditions for the generation of PIs. 
 
6.1.3 The distribution and detection of oxygen in PIs 
Prior studies(208) have been shown that the oxygen distribution to the cells within the 
PIs using an oxygen probe system is greater in small PIs (45-55 µm). Besides, higher 
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viability, lower cell death and better insulin release were observed compared with 
medium sizes (130-160 µm) and large (200-240 µm) PIs. In the current study, a new 
type of nano-oxygen sensor has been incorporated into PIs to detect the oxygen 
distribution non-destructively, and consuming rate among PIs formed under the 
substrates with different coating solutions. The results showed that PIs cultured on a 
substrate coated with 95%, 98% gelatin and ULA plates increased oxygen distribution 
within PIs compared with other types of PIs. This method could be explored further 
to study the cellular activities within PIs. 
 
6.1.4 Effect of incorporation of GBs into PIs  
The functionality of PIs has shown an improvement in terms of cell viability after 
incorporation of GBs. The reasons behind could be resulting from the GBs’ 
functioning as microchannels or voids inside of PIs, which helped the diffusion of 
small molecules between media and cells in PIs. It is found that the way to fabricate 
microchannel networks in cellular spheroid could be effective for cells that required a 
high supply of nutrients and oxygen in PIs. Besides, the microfabrication methodology 
of GBs might help the innovation of micro-sensors or micro-regulator or micro-
carriers, which comprise cells and other materials. 
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The generation of GBs from gelatin using W/O emulsion was a feasible technique to 
form microchannel/voids in PIs when incorporating the GBs to PIs. The GBs are 
water-soluble, so they have to be crosslinked to become water insoluble. The reaction 
of alpha-amino groups of lysine and hydroxylysine side groups with aldehydes in GA 
at gas phase produced better biocompatible GBs in comparison to using liquid phase 
GA reaction. Furthermore, other groups have used other ways for crosslinking of 
gelatin. For instance, dextran dialdehyde carboxyl, amide, imidazoyl or guanidine may 
be involved.(189,241) The protocol established in this study, in which 6 hours 
crosslinking under 5% GA vapour was taken for 40 µm GBs, has demonstrated better 
outcomes in terms of generating stable but swollen GBs for PIs. Incorporation of GBs 
into PIs showed improvements in the proliferation of PIs for both small and large sized 
PIs. The of PIs viability in term of CCK-8 elevated by 17-25% after incorporation with 
GBs. Other biofunctions of PIs have also been shown being changed in this study such 
as decreasing of cellular LDH release, and enhancements in insulin production. 
 
6.1.5 Synergetic effect of incorporating anti-inflammatory cytokines loaded 
GBs into PIs 
The incorporation of GBs loaded with anti-inflammatory cytokines (IL-10 and anti-
IL-1β) further enhanced the viability of PIs. The cell viability measured via CCK-8 
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assay was significantly increased in these PIs and LDH release was reduced. IL-10 
acts as an anti-inflammatory agent that is derived from macrophage and TH2 cells 
exerting anti-inflammatory effects by inhibiting IL-12 and other pro-inflammatory 
agents. For normal growth, there is a regulation of the inflammatory cytokines 
including IL-1β, TNFα, IL-6, IL-15, IL-17 and IL-18, and anti-inflammatory 
cytokines such as IL-4, IL-10 and IL-13,(242) which act by increasing macrophage 
production of IL-1 receptor antagonist and by inhibiting the generation of oxygen and 
nitrogen free radicals by macrophages. Loading of IL-10 can act as an anti-
inflammatory drug for any inflammation formed in the centre of PIs, which leads to a 
reduction of the cellular toxicity. So, the viability of PIs for cell seeding density 32,000 
cells/well increased by 25% when incorporated with GBs free of IL-10 and increased 
by ~60% when beads loaded with IL-10 and increased by 35% when beads loaded 
with anti-IL-1β. The results were consistent with others who added IL-10 to rat islets 
inducing its activity.(232) 
 
Il-1β works a potent pro-anti-inflammatory cytokine produced by cells of the innate 
immune system. It has been suggested that the mechanisms of IL-1β are part of a 
continuum of secretion in response to the strength of the inflammatory stimulus. 
Thereby the IL-1β release is in response to extracellular stimuli, which increases 
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inflammatory response.(227) Therefore, a slow release of anti-IL-1β into PIs should be 
capable of prolonging the viability of cells through inhibiting the release of IL-1β 
during apoptosis and necrosis. Similar to the action of IL-10, the viability of PIs for 
cell seeding density 64,000 cells/well increased by 17% when incorporated with GBs 
and the proliferation elevated by ~35-60% when beads loaded with IL-10 or anti-IL-
1β comparing with PIs free of GBs and free of drugs. Also, the results obtained in this 
study showed an increase in the viability, an increase of GSIS and decreasing in the 
cellular LDH release after incorporated with GBs loaded with anti-IL-1β. 
 
6.2 Overall conclusion 
In summary, the substrate of culture plates influences the physical and biological 
properties of the PIs. The culture of substrates has a crucial role in the production of 
BRIN-BD11 PIs. A mixture of F127 solution and gelatin type A solution 
systematically affected surface properties and PIs.  The surfaces coated with a 
variation of the ratio of Pluronic F127 and Gelatin type A generated different ATR-
FTIR spectra and CA values. Furthermore, protein adsorption on treated surfaces was 
also dependent on the coating used. These complimentary results support each other. 
The higher the F127 content, the more the hydrophilic surface was, which generated 
larger sized PIs and lower CA values of the substrate. 
 229 
 
The coating of SOP surfaces with a pure F127 solution or gelatin solution led to 
large/dense cell aggregates or cell sheets; while the mixture solution containing 95-
98% gelatin produced homogenous and small PIs. Furthermore, it was revealed that 
PIs formed on 98% gelatin solution coated plates had the lowest PIs sizes (268 ± 10 
µm) and high viability/proliferation through CCK-8 and MTT assays. Western 
blotting assays and higher expression in mRNA assay than smaller PIs formed on ULA 
plates. So, the expression of the protein using western blotting techniques showed 
higher expressions for Cx36. GLUT2 and insulin by 12%, 2% and 1% respectively for 
PIs generated on 98% gelatin surfaces comparing with these formed on ULA surface. 
On the same trend have been seen the mRNA assays for the PIs formed on 98% gelatin 
showed more of mRNA by 41% for Cx36, 10% for GLUT2 and 7% for insulin in 
comparison to PIs generated on ULA plates. Also, the diffusion of oxygen through PIs 
demonstrated more in PIs produced on 98% gelatin coated substrate. Such distinct 
coating-effect did not occur on PIs grown on coated TCP plates. The changes on SGP 
nd PIs grown on coated SGP were between SOP and TCP substrates. These findings 
were attributed to different interactions of the amphiphilic F127 with different 
hydrophilicity of the original substrate 
 
 230 
 
Water/Oil emulsion techniques have successfully generated large quantity GBs in 
short reaction times. The degree of GB swelling can be optimized by crosslinking via 
different concentrations and reaction duration with GA. Under 5% GA vapour, 6 hour 
crosslinking reaction duration can stabilise GBs and maintain appropriate swelling 
capacity for GBs. The proliferation of PIs was significantly increased by incorporation 
of 40 m GBs into PIs, which led to improvements in the cellular viability. This had 
been confirmed by both MTT and CCK-8 assay for large and small size PIs. 
 
GBs loaded with anti-inflammatory cytokines, IL-10 and anti-IL-1β, had revealed a 
synergetic effect in the improvement of the proliferation/viability of PIs regardless of 
the cell seeding density used. LDH release from the PIs was decreased dramatically 
by ~1.5-fold for PIs with cell seeding density 32,000 cells/well and by ~1.6-fold for 
cell seeding density 64,000 cells/well. Finally, the level of GSIS was elevated after 
anti-inflammatory sustained released into PIs via using GBs as drugs carrier rather 
than helping create microchannels into PIs. 
 
In summary, a large number of in vitro and in vivo model system are exciting to enable 
the find out the efficacy of new techniques which could be used for novel therapies. 
Although each way for re-aggregation of pancreatic beta cells suffers from central 
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necrosis after a few days, the incorporation of GBs into PIs might be a suitable 
technique to improve their biofunctionality. The application of these models for in 
vitro or in vivo insulin production still needs further investigation. The reasons behind 
come from the limitation of the lifespan of the PIs and most cell lines such as BRIN-
BD11 are from electrofusion with insulinoma cell lines, which cannot be used for 
transplantation. 
 
6.3 Future perspectives  
The work described in this study has raised some approaches for future work, which 
could help in the treatment of diabetes. The solutions for the treatment of suspension 
culture surfaces to generate small sized PIs from mixing of the two solutions composed 
of F127 with gelatin did not fix on the substrate permanently. The coating could lose 
or dissolute in the media. So further studies are needed to find out the best way to 
stabilise the coating for long-term cell culture.  
 
The use of large size GBs for incorporating into PIs could be investigated, for instance, 
GBs as large as 80 µm could be used, which have more space to carry more anti-
inflammatory drugs into PIs. 
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The further study of the dose and type of anti-inflammatory drugs loaded on to GBs 
and then into PIs is also warranted. Anti-apoptosis and anti-necrosis drugs with longer 
and more sustained release patterns and with more efficient loading should also be 
investigated.  
 
Future study is required to investigate reactive oxygen species in the PIs produced on 
different coating substrates and the associated effect on insulin release. 
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Figure 1 The morphology of the BRIN-BD11 cells grown on treated TCP 
under static culture  
 
 
BRIN-BD11 were seeded at cell density 8,000 cell/well (A) and 32,000 cells/well (B) 
at day 3 and day 7. Cultivation of BRIN-BD11 formed anchor monolayer cells on the 
TCP, uncoated, coated with 100% gelatin, and F127 formed 2D cell sheets. Growing 
on TCP coating with mixture of F127-and gelatin solution formed aggregates 
anchored to the surface. The investigations of cell morphologies were assessed by light 
microscopy using a x10 objective. Scale bar 200 µm. 
 
 
  
 262 
 
Figure 2 The morphology of BRIN-BD11 cells grown on treated TCP under 
agitation state  
  
 
BRIN-BD11 were seeded at cell density 8,000 cell/well (A) and cell density 32,000 
cells/well (B) at day 3 and day 7 using plate Shaker at 30 rotators/minute. Cultivation 
of BRIN-BD11 formed anchor monolayer cells (2D) on the TCP coated with F127. 
Growing on 100%-gelatin coating and mixture of F127-and gelatin coating TCP 
formed aggregates anchored to the surface. The investigations of cell morphologies 
were assessed by light microscopy using a x10 objective. Scale bar 200 µm 
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Figure 3 The morphology of BRIN-BD11 cells grown on treated SOP under 
static culture  
 
 
 
BRIN-BD11 cells were seeded at 8,000 cells/well (A) and 32,000 cells/well (B) at day 
3 and day 7. Cultivation of BRIN-BD11 on suspension plate coated with different 
coating types which formed different PI morphologies under static culture. The PIs 
were assessed using light microscopy (x10 magnification) over 7 days using a x10 
objective. Scale bar 200 µm  
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Figure 4 The morphology of BRIN_BD11 cells grown on treated SOP under 
agitation culture 
 
 
 
BRIN-BD11 cells were seeded at 8,000 cells/well (A) and 32,000 cells/well (B) at day 
3 and day 7. Cultivation of BRIN-BD11 on SOP coated with different coating solution 
which formed different PI morphologies under agitation culture. The PIs were 
assessed using light microscopy (x10 magnification) over 7 days using a x10 
objective. Scale bar 200 µm 
